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ABSTRACT 
Although brachial blood pressure (BP) is a well-recognized risk factor for 
predicting cardiovascular events, aspects of aortic BP may enhance risk prediction. 
Pulse pressure (PP) is amplified from the aorta to peripheral arteries and variations in 
differences between brachial and aortic PP (PP amplification) are determined by factors 
that influence either the aortic forward (Pf) or backward (Pb)(reflected) pressure waves. 
Although aortic Pb may be more important than Pf in mediating cardiovascular risk, the 
best approach to assessing backward wave function (augmentation pressures [Pa] and 
index [AIx] or wave separation analysis); the relative impact of aortic Pb versus Pf on 
cardiovascular damage; and whether the ability of aortic-to-brachial PP amplification 
(PPamp) to add to risk prediction reflects backward or forward wave effects, is uncertain. 
In the present thesis I therefore first assessed in 808 community participants 
whether gender influences relations between Pa or AIx and left ventricular mass (LVM), 
a well-accepted end-organ measure. Aortic haemodynamics were determined using 
radial applanation tonometry and SphygmoCor software and LVM from 
echocardiography. In men, both AIx derived from Pa/central aortic PP (Pa/PPc) (p<0.01) 
and AIx derived from the second peak/first peak (P2/P1) of the aortic pulse wave 
(p<0.0005) were associated with LVM. In contrast, in women neither AIx derived from 
Pa/PPc (p=0.08) nor AIx derived from P2/P1 (p=0.17) were associated with LVM. Both 
the strength of the correlations (p<0.001 and p<0.0005) and the slope of the AIx-LVM 
relationships (p=0.001 and p<0.0005) were greater in men as compared to women. 
Therefore, in the present study I show that AIx is independently associated with LVMI in 
men, but not in women. 
I subsequently evaluated whether in women, measures of aortic systolic pressure 
augmentation (Pa or AIx) underestimate the effects of reflected waves on cardiovascular 
risk or whether Pb plays little role in cardiovascular risk prediction. In the same 
community sample I therefore evaluated sex-specific contributions of reflected (Pb and 
the reflection index [RI]) versus augmented (Pa and AIx) pressure wave indices to 
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variations in PPc (n=1185, 65.0% women), and LVM (n=793, 64.9% women). Aortic Pb 
and Pf were determined using wave separation analysis. In both women and in men, 
independent of confounders, RI and Pb contributed more than Pf, whilst Pa and AIx 
contributed less than incident wave pressure (Pi) to variations in PPc (p<0.0001 for 
comparison of partial r values). In both men and in women Pb contributed more than Pf 
(p<0.05) to variations in LVM. Although in men Pa (partial r=0.33, p<0.0001) contributed 
to a similar extent as Pi ((partial r=0.34, p<0.0001) to variations in LVMI, in women Pa 
(partial r=0.05, p=0.36) failed to contribute to LVM, whilst Pi was significantly associated 
with LVM (partial r=0.30, p<0.0001). Similar results were obtained with AIx as opposed to 
Pa in the regression models. Therefore, in both women and in men, Pb is more closely 
associated with PPc and LVM than Pf, but indices of aortic pressure augmentation 
markedly underestimate these effects, particularly in women. 
As the relative impact of aortic Pb as compared to Pf on cardiovascular damage 
independent of brachial BP is uncertain, in 1174 participants from a community sample I 
subsequently assessed the relative impact of Pb and Pf on variations in LVM (n=786), 
aortic pulse wave velocity (PWV)(n=1019), carotid intima-media thickness (IMT)(n=578), 
transmitral early-to-late LV diastolic velocity (E/A)(n=779) and estimated glomerular 
filtration rate (eGFR)(n=1174). Independent of mean arterial pressure and confounders, 
PPc and both Pb and Pf were associated with end-organ measures or damage (p<0.05 
to <0.0001). With adjustments for brachial PP and confounders, Pb remained directly 
associated with LVM (partial r=0.10, p<0.01), PWV (partial r=0.28, p<0.0001), and IMT 
(partial r=0.28, p<0.0001), and inversely associated with E/A (partial r=-0.31, p<0.0001) 
and eGFR (partial r=-0.14, p<0.0001). Similar relations were noted with the presence of 
end-organ damage (p<0.05 to <0.0001). In contrast, with adjustments for brachial PP 
and confounders, Pf no longer retained direct relations with LVM, PWV, and IMT or 
inverse relations with E/A and eGFR. Adjustments for Pb, but not Pf diminished brachial 
PP-independent relationships between PPc and end-organ measures. Thus, although 
both Pf and Pb contribute to end-organ measures and damage, independent of brachial 
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BP, the impact of aortic BP is accounted for largely by Pb. 
PPamp is independently associated with cardiovascular outcomes. However, the 
aortic functional change most likely to account for this effect is uncertain. In 706 
community participants I subsequently aimed to identify the aortic functional change that 
accounts for relations between PPamp and LVM. In multivariate models with the 
inclusion of brachial PP, 1/PPamp (partial r=0.12, p<0.005), Pb (partial r=0,09, p<0.05), 
and aortic PWV (partial r=0.09, p<0.05) were independently associated with LVMI. 
Similarly, in multivariate models with the inclusion of brachial PP, 1/PPamp (p<0.005), 
Pb (p<0.01), and aortic PWV (p<0.01) were independently associated with LV 
hypertrophy (LVH). With adjustments for Pb, the brachial PP-independent relationships 
between 1/PPamp and LVMI or LVH were abolished (p>0.08 for both). However, 
adjustments for PWV failed to modify brachial PP-independent relations between 
1/PPamp and LVMI or LVH. Hence, independent relations between PPamp and LVM or 
LVH are largely accounted for by Pb. 
In conclusion, in the present thesis I show that the use of augmented pressures 
underestimates the impact of reflected pressure wave effects on end-organs, particularly 
in women; that brachial BP-independent relations between aortic BP and end organs is 
determined largely by Pb and that relations between PPamp and end organ measures is 
largely accounted for by Pb. These findings add to our understanding of the adverse 
effects of aortic functional changes on the cardiovascular system and suggest cost-
effective approaches to add to risk prediction. 
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PREFACE 
Cardiovascular disease is the leading cause of morbidity and mortality globally 
and a major cause of mortality in South Africa. Although several well-established risk 
factors may be employed to risk predict, these may only account for a portion of the 
overall cardiovascular risk. A major cause of cardiovascular disease is hypertension and 
hypertension is thought to be the major risk factor for cardiovascular events in South 
Africa. Although brachial blood pressure (BP) is a well-recognised predictor of 
cardiovascular events and target for drug therapy, there is increasing evidence that 
several factors that contribute to aortic BP may add to risk prediction. However, the 
relative role of these variables beyond brachial BP is uncertain. 
The present thesis is motivated by a need to better understand those aortic 
functional changes that contribute toward variations in target organ measures in a 
community of African ancestry in South Africa. These studies were performed with the 
hope that this information will provide a guide to how to best enhance risk prediction 
beyond conventional cardiovascular risk factors, including brachial BP, using simple, 
easy to measure and cost-effective approaches to aortic function measurements. 
Importantly, in the present thesis I assessed relations between aortic function and target 
organ measures, rather than cardiovascular outcomes (hard end points) as in South 
Africa 50% of death certificates indicate “natural causes” rather than a specific cause of 
death. In this regard, it is well accepted that several end-organ measures including left 
ventricular hypertrophy, carotid indices of atheroma, an index of large artery stiffness, 
and measures of renal function predict outcomes beyond conventional risk factors. 
These end-organ measures are therefore assumed to represent effective intermediate 
phenotypes to hard end-point.     
 The present thesis is written as a series of semi-independent chapters, each with 
its own introduction, methods, results and discussion section. The thesis begins with a 
review chapter which highlights the current understanding and controversies in the field 
and leads the reader through a series of arguments in support of conducting the studies 
  xxvi 
 
described in the present thesis. Furthermore, the present thesis concludes with a 
summary chapter which consolidates the findings of each chapter and underscores the 
novelty of the findings by placing the studies in the context of our present understanding 
of the field. In support of the present thesis, the data presented in chapters 2 and 3 have 
been published in the journals Hypertension Research (Sibiya et al 2014), and 
Hypertension (Booysen et al 2015) respectively, the data presented in chapter 4 in the 
Journal of Hypertension (Sibiya et al 2015), and the data in chapter 5 has received 
favourable reviews from the Journal of the American Society of Hypertension (Sibiya et 
al 2017, under review). 
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      CHAPTER 1 
 
 
                                                               INTRODUCTION: 
 
 
 Current Understanding of the Role of Aortic Pulse Pressure 
and the Determinants Thereof in Cardiovascular Disease  
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1.1 Introduction 
 
Cardiovascular disease constitutes a group of disorders of the heart and blood 
vessels which often share similar risk factors. These disorders mainly include 
cerebrovascular disorders or stroke (ischaemic and haemorrhagic), ischaemic heart 
disease including myocardial infarction, heart failure, peripheral arterial disease and 
renal failure. As identified in the Global Burden of Disease (GBD 2015) study, 
cardiovascular disease is a major cause of global mortality and morbidity (Roth et al 
2015, GBD 2015), where in 2013 cardiovascular disease contributed to 32% (17 million) 
of the more than 54 million deaths recorded world-wide. The GBD study was a 
comprehensive study that accounted for outcomes based on both death registrations, as 
well as verbal autopsies, and determined mortality for 240 diseases from 188 countries 
globally from the year 1990 to 2013. Of the four major categories of non-communicable 
diseases (diabetes mellitus, cardiovascular disease, cancer and chronic obstructive lung 
disease) cardiovascular disease was noted to be the most common cause of death 
compared to the other three categories (Roth et al 2015). 
The GBD study (2015) was limited by the fact that data from low income or 
developing countries was not readily available. Economic challenges leading to a lack of 
education and malnutrition play a major role in the epidemiology of non-communicable 
disease. Therefore, understanding the burden of non-communicable diseases in 
developing countries is of critical importance. It is essential to note that approximately 
80% of cardiovascular deaths in the year 2005 occured in low-to-middle income 
countries (Mendis et al 2007). When comparing mortality rates between high and low 
income countries using age standardized methods, the mortality rate attributable to 
cardiovascular disease in low income countries decreased from 381 per 100 000 people 
in 1990 to 332 per 100 000 in the year ending 2013 (13% decline) whilst in high income 
countries, the mortality rate decreased from 283 per 100 000 people in 1990 to 160 per 
100 000 in the year ending 2013 (43% decline) (Roth et al 2015). Thus, the decline in 
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mortality rate from cardiovascular disease was markedly worse for low as compared to 
high income countries. Moreover, there was a significant increase in the number of 
deaths attributed to cardiovascular disease in low income countries from 7.2 million to 12 
million (66% increase) in the year ending 2013 (Roth et al 2015). This marks a striking 
increase over a two-decade period. In 2013, cardiovascular disease caused 
approximately a million deaths sub-Saharan Africa (Mensah et al 2015). These data 
suggest that the burden of cardiovascular disease is far greater in developing nations 
rather than economically developed countries. Why is cardiovascular disease becoming 
more important in developing countries? 
An epidemiologic transition is thought to exist in developing nations. Whilst 
previously diseases of poverty, malnutrition and infectious diseases were the main 
causes of morbidity and mortality, this spectrum of disease is now changing into 
diseases of lifestyle. In Africa, the burden of non–communicable disease is attributed to 
cardiovascular disease (Mocumbi 2013). Although people in Africa present with 
traditional risk factors for cardiovascular disease, the condition is exacerbated by the 
scourge of infectious disease. In Africa, especially, sub- Saharan Africa, the high rate of 
human immunodeficiency virus infections, which for several reasons increases the 
prevalence of conventional risk factors and may itself have direct effects on the 
cardiovascular system, has complicated the management of cardiovascular risk factors 
(Mocumbi et al 2012, Temu et al 2015). In sub-Saharan Africa the low doctor-to-patient 
ratio and scarcely resourced healthcare systems as noted by the World Health 
Origination (WHO) add to the threat of inadequate healthcare provision. 
In 2007 and 2008 greater than 19.4% of deaths in South Africa were from 
cardiovascular disease. This represents a similar burden of disease as that given for the 
leading reported cause of death, which is tuberculosis (21.8%) (Statistics SA 2010). Age-
adjusted mortality rate attributable to cardiovascular disease in South Africa indicates the 
range to be between 250-to-325 per 100 000 people in the year 2013 (GBD 2015). As 
with other developing countries, this is higher than developed nations. These figures 
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represent similar figures of reported deaths as those given in 2003/2004 (Statistics SA 
2006) and are in-line with the WHO prediction that during the period 2006 to 2015, 
deaths from non-communicable diseases will increase by more than 24% in Africa, and 
that a substantial portion of families with heart disease will experience catastrophic 
expenditure which will drive families below the poverty line (Zarocostas 2010). These 
figures are also in-line with WHO predictions that by 2020, 69% of diseases in 
developing countries such as South Africa will be non-communicable diseases, of which 
the greatest burden will derive from cardiovascular disease (Zarocostas 2010, Boutayeb 
2006).  
 
1.1.1 Hypertension as cause of cardiovascular disease  
 
Of all the risk factors for cardiovascular disease, which include hypertension, 
diabetes mellitus, dyslipidaemia, obesity, smoking, and alcohol consumption, most 
population attributable risk for cardiovascular events is determined by hypertension 
(Steyn et al 2005, Rayner et al 2010, Huang et al 2013, Park et al 2015). As an important 
example of such a study conducted in those of African ancestry, in The Atherosclerosis 
Risk in Communities Study which evaluated a large multi-center and biracial community-
based cohort; diabetes mellitus and hypertension accounted for most of the risk for 
cardiovascular disease (Cheng et al 2014). It is not only blood pressure values over 
presently accepted thresholds of 140/90 mm Hg that predict risk. Indeed, there is 
considerable evidence that blood pressure values over a lower range predict risk and 
that this is noted irrespective of age, gender, ethnicity, or follow-up duration and that the 
impact of blood pressure on risk prediction in the pre-hypertensive range was unaffected 
by adjustments for comorbidities (Huang et al 2013). In this regard, the high population 
attributable risk of hypertension and pre-hypertension may be explained by the fact that 
of all of the cardiovascular risk factors, the prevalence rate of hypertension and pre-
hypertension is by far the highest. Importantly however, it should be acknowledged that 
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hypertension is strongly associated with other risk factors and these risk factors often 
precede the development of hypertension. Indeed, those with pre-hypertension have at 
least one other cardiovascular risk factor (Greenlund et al 2004). 
 
1.1.2 Differences in hypertension prevalence rates between populations. 
  
There are considerable differences in the prevalence of hypertension in 
developed and developing countries. In this regard, in population-based measurement 
surveys from 200 countries of 19.1 million participants 18 years and above, when 
compared to most countries in most continents, based on age-standardized blood 
pressure the prevalence of hypertension was noted to be the highest in sub-Saharan 
Africa and South Asia when it used to predominately affect high-income countries or 
regions (NCD-RisC [NCD Risk Factor Collaboration] 2017). In this survey, age-
standardized adult mean blood pressure remained virtually unchanged between the 
years 1975 to 2015 in men, whilst a slight decrease of blood pressure in women was 
noted. The cause of hypertension in different populations may vary and this may 
contribute to variations in the prevalence rate of hypertension between communities. For 
example, in African populations salt sensitivity may be a more important cause of 
hypertension than in alternative populations and hence prevalence rates may depend 
more on the average salt intake of a community (Maseko et al 2006). Socio-economic 
status also determines the prevalence of hypertension in various populations. High 
income population groups tend to have a lower prevalence of hypertension as compared 
to low income populations and this may be attributed to a greater ability to afford 
healthier foods, a better understanding of what healthier foods are or higher levels of 
activity (Yusuf et al 2011).  
 
1.1.3 Half of cardiovascular deaths may not be accounted for by conventional risk 
factors 
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Previous studies have estimated that about 50% of cardiovascular deaths or 
events may not be accounted for by conventional risk factors (Yusuf et al 2004, 
Chockalingam et al 2000, Yusuf et al 2001). More recently however, some studies have 
reported that when taken together, conventional risk factors account for approximately 
90% or more of cardiovascular risk (Ôunpuu et al. 2001, Yusuf et al 2004, McQueen et al 
2008, O’Donell et al 2010a, O’Donell et al 2010b, O’Donell et al 2016). However, these 
studies (Ôunpuu et al 2001, Yusuf et al 2004, McQueen et al 2008, O’Donell et al 2010a, 
O’Donell et al 2010b, O’Donell et al 2016) are case-control studies and in none of these 
studies did the authors indicate how they avoided a selection bias in the control groups. 
In these studies (Ôunpuu et al 2001, Yusuf et al 2004, McQueen et al 2008, O’Donell et 
al 2010a, O’Donell et al 2010b, O’Donell et al 2016) controls were convenience samples 
including the use of hospital patients who had not had a cardiovascular event. Moreover, 
in these studies (Ôunpuu et al 2001, Yusuf et al 2004, McQueen et al 2008, O’Donell et 
al 2010a, O’Donell et al 2010b, O’Donell et al 2016) the authors failed to indicate 
whether the control samples showed risk factor profiles comparable with randomly 
selected population or community samples from which the cases were derived. Hence, it 
is likely that the results are in-part attributed to population stratification. Thus, these 
studies have not hampered the search for biomarkers of cardiovascular risk beyond 
conventional risk factors. 
 
1.2 Aortic as opposed to brachial blood pressure in risk prediction 
 
 In the present thesis I studied the possibility of measures of aortic blood pressure 
(BP) adding to risk prediction beyond brachial BP and additional cardiovascular risk 
factors. Hence, in the present chapter I will provide a critical review of the current 
evidence supporting or refuting a role of aortic function (with a focus on aortic BP 
measurements) in risk prediction. Central to an understanding of why aortic BP was 
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considered as a measurement that may add to risk prediction is the landmark findings of 
a more important role of brachial systolic as opposed to diastolic BP in risk prediction.  
 
1.2.1 Why has the emphasis moved from diastolic to systolic BP in risk prediction? 
 
The presence of hypertension is diagnosed on the basis of a raised brachial 
artery systolic or diastolic BP. However, risk prediction using brachial BP measurements 
has over the years changed from a focus on diastolic BP (DBP) to that of systolic BP 
(SBP). In this regard, the most important risk factor for cardiovascular disease, that is 
advancing age, is associated with linear increases in SBP across the adult lifespan, 
whilst DBP increases during early to mid-life and then begins to decline during old age 
(Franklin et al 1999). Importantly, the Framingham Heart Study showed that SBP is a 
stronger predictor of cardiovascular risk than DBP in older persons (Kannel et al 1971). 
Moreover, several observational studies subsequently reported on a direct relationship 
between SBP and cardiovascular risk whilst an inverse relationship was noted between 
DBP and cardiovascular risk (Franklin et al 1999, Benetos et al 2000, Staessen et al 
2000). Nevertheless, when predicting risk, DBP is now recognized as being more 
important than brachial SBP in those younger than 45 years of age (Chobanian et al 
2003, Mancia et al 2007), but this has been suggested to be attributed to the 
overestimation of aortic SBP with brachial SBP measurements in this age group 
(McEniery et al 2008). 
With the recognition of a more important role for brachial SBP than DBP in 
cardiovascular risk prediction, the question has arisen as to whether SBP measured at 
the brachial artery is the best SBP measurement for risk prediction? In this regard, 
through amplification of BP from the aorta to the brachial artery (see later discussion for 
the mechanisms), aortic SBP may be considerably lower than brachial SBP whilst DBP is 
similar in the aorta and the brachial artery. As it is hypothesized that the BP in the aorta 
rather than the brachial artery is more likely to be responsible for end-organ damage, it is 
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possible that brachial SBP may not be an adequate surrogate of the BP thought to 
produce cardiovascular damage. Hence, in the following sections of this chapter I will 
discuss the differences in the determinants of aortic and brachial BP and the evidence 
for or against a role for aortic as opposed to brachial BP or their determinants as the 
better measures of end-organ damage. I will simultaneously highlight the missing 
evidence which prompted me to perform the studies conducted in the present thesis.  
 
1.2.2  Central aortic BP is lower than brachial BP 
 
Aortic SBP is generally lower than brachial SBP because of the higher stiffness 
(and hence impedance) of more peripheral arteries as compared to the aorta (Nichols et 
al 2011). In other words the pulse is amplified from the aorta to the brachial artery 
because the aorta is an elastic artery whilst peripheral arteries are less compliant. This 
difference in stiffness occurs because peripheral arteries are muscular with a relatively 
small radius, whilst the aorta is a distensible conduit (high quantity of elastic tissue) and 
has a much wider radius. Importantly, there is little difference between DBP in the aorta 
as compared to peripheral arteries and hence the main distinction between aortic and 
brachial BP is in the difference between SBP and DBP, that is, the main difference 
between aortic and brachial BP is in the pulse pressure (PP). Hence, differences 
between brachial and aortic BP are often referred to as PP amplification. What are the 
factors that determine aortic as opposed to brachial PP and hence PP amplification? 
 
1.2.3 Determinants of aortic versus brachial PP 
 
Although during youth and early adulthood the aorta represents a highly elastic 
conduit, with ageing and with the effects of several risk factors (hypertension, smoking, 
diabetes mellitus, dyslipidaemia and chronic inflammation), the aorta becomes stiffer.  As 
the aorta stiffens, aortic pressures are enhanced during aortic ejection when blood is 
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pumped into a stiffer conduit. Increasing stiffness of the aorta with age and 
cardiovascular risk factors involves destruction of elastic tissue, increases in aortic 
collagen content and changes in the properties of collagen (e.g. increased collagen 
cross-linking as may occur with enhanced glycosylation of collagen in diabetes mellitus or 
in conditions where lysyl oxidase activity [the enzyme responsible for cross-linking of 
collagen] increases) (Nichols et al 2011). Importantly, the magnitude of the pressure 
waveform generated when blood is ejected into a stiffer aorta (the aortic forward pressure 
wave, Figure 1.1) is determined largely by two factors. In this regard, the forward wave 
pressure increases with an enhanced stroke volume which in-turn increases with 
increments in left ventricular contractility and the Frank-Starling effect (improved 
ventricular filling causing a greater force of contraction). In addition, the forward wave 
pressure is also augmented by aortic impedance, which increases as the aorta stiffens. 
Across the adult lifespan whilst aortic stiffness may increase, especially with the ageing 
process, the stiffness of peripheral arteries in the upper limb increases to a lesser degree 
(Nichols et al 2011). Hence, with ageing and disease, it is proposed that as aortic BP 
increases, BP in peripheral arteries increases far less and hence brachial BP begins to 
approximate aortic BP (Nichols et al 2011, McEniery et al 2008). Indeed, on average, 
brachial BP increases by 25 mm Hg between the ages of 20–80 years, whilst central 
aortic BP increases by 40 mm Hg over this same age range (Vlachopoulos & O’Rourke 
2000). Thus, with increasing age, and with more cardiovascular risk factors, aortic BP 
increases far more than brachial BP and PP amplification decreases. Hence, increases in 
aortic BP in excess of brachial BP and a reduced PP amplification may be surrogate 
indices of an increased aortic stiffness that occurs with advancing age and the presence 
of cardiovascular risk factors. Consequently, it has been proposed that either aortic BP or 
PP amplification may be better indices than brachial BP, or at least indices that add to the 
ability of brachial BP to predict cardiovascular events. 
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Figure 1.1 Aortic pressure wave (upper panel) as determined by the combined effect of 
the aortic forward (Pf) and aortic backward (Pb) pressure waves (lower panel). Definitions 
of various measures of arterial pulse wave analysis are also shown. The figure shows 
actual data obtained from SphygmoCor recordings. 
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To recapitulate, a higher brachial as compared to aortic BP (PP amplification) is 
attributed to the differences in stiffness between the distensible aorta and stiff peripheral 
arteries (brachial). Thus, decreases in PP amplification are attributed in-part to increases 
in aortic stiffness with lesser increases in peripheral artery stiffness. However, variations 
in aortic backward wave pressure (Figure 1.1) also determine the variability of PP 
amplification. In this regard, pressure waves travelling down arteries encounter reflection 
points which may occur at innumerable sites in the arterial bed (Nichols et al 2011). 
These reflection points are generated by discontinuities in the arterial tree produced by 
branch points, changes in wall structure and tapering of vessels. Increases in tapering of 
vessels may occur with vasoconstriction of either arterioles or of more proximal vessels. 
At these sites pressure waves are reflected back and return to the ascending aorta. 
Summation of reflected waves derived from multiple reflection points results in a single 
backward wave returning to the aorta. 
The backward wave may return sufficiently early that the pressure generated by 
this wave (Pb) adds to the pressure generated by the forward wave (Pf) and hence Pb 
augments aortic SBP (Figure 1.1). In this regard, two pressure waves appear in the aorta 
and the peak of the backward wave (second systolic shoulder) appears as the peak of 
the aortic pressure wave (Figure 1.1). In contrast, the peak of the forward wave 
approximates the inflection point of the first systolic shoulder and appears as a lower 
value than the peak of the backward wave (Figure 1.1). Hence, in the aorta, although the 
backward wave is of smaller amplitude than the forward wave, the backward wave clearly 
contributes to peak aortic SBP. However, the aortic backward wave appears in a different 
form in the brachial pressure wave. 
As with the aorta, in the brachial artery two pressure waves are also generated, 
and these include a percussion wave (first systolic shoulder), which largely reflects the 
effect of blood flow generated by aortic Pf, and a later tidal wave (second systolic 
shoulder), which largely reflects aortic backward wave pressures (Figure 1.2). In contrast 
to what occurs in the aorta however, where the backward wave clearly adds to peak  
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Figure 1.2. The contribution of aortic forward and aortic backward waves to aortic and 
radial (approximate of brachial) pulse waves. The dashed lines show temporal alignment 
of 1st and 2nd systolic shoulders (left panels) and alignment of the magnitude (left versus 
right panels) of pressure waves. The figure shows actual data obtained from 
SphygmoCor recordings. 
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aortic pressures, in peripheral e.g. brachial) arteries the backward wave (second systolic 
shoulder) appears as a lower value than the forward wave (the percussion wave is larger 
than the tidal wave), and hence makes little contribution to brachial pressures. Because 
SBP is considered to be the maximum pressure generated in the brachial artery, the 
pressure generated by the forward wave (percussion wave) is therefore recorded as 
SBP, whilst the pressures generated largely by backward waves (the tidal wave) are not 
recorded (Figure 1.2). 
With aging, because backward wave pressures (Pb) begin to increase from as 
early as 20-30 years of age, brachial SBP increases less than aortic SBP from early adult 
life to old age. This is because brachial SBP only detects the peak of the percussion 
wave which is driven by the forward wave pressure (Pf) (Figure 1.3). In contrast, aortic 
SBP increases more than brachial SBP as aortic SBP is determined by both Pf and Pb 
(Figure 1.3). With advanced age, Pb may be sufficiently large that peak brachial SBP 
reflects either Pf or Pb (Figure 1.3) (Nichols et al 2011). Under these circumstances peak 
brachial BP closely approximates the peak of Pb and PP amplification is close to 0. 
Hence, variations in differences between aortic and brachial BP and in PP amplification 
may not only be attributed to differences in stiffness between the distensible aorta and 
stiff peripheral arteries, but also to the effects of age on wave reflection. Importantly, 
unlike aortic stiffness, which only increases to any marked extent from age 50 to 60 
years, the aortic reflected wave begins to increase from age 20 years. Hence, although 
aortic pressures are lower than brachial pressures because of differences in stiffness 
between these vascular beds, peak brachial SBP in most adults, especially the young 
and in middle-aged adults, largely ignores the impact of Pb on aortic BP (tidal wave) and 
assesses mainly the impact of Pf (percussion wave) (Figure 1.2). 
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Figure 1.3. Age effects on aortic and radial artery pressure waves (which approximate 
brachial pressure waves). The figure shows changes in the combined effect of the aortic 
forward and aortic backward waves on pressure waveforms with age. The dashed line 
show how the forward and backward pressure waves contribute to radial and aortic 
pressure waves in a young and an old participant. The figure shows actual data obtained 
from SphygmoCor recordings.   
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1.2.4 Aortic versus brachial BP in risk prediction and associations with end-organ changes 
 
Over the past two-to-three decades a number of simple and reliable approaches to 
aortic BP measurement have become commercially available. Several studies employing 
these approaches support the view that aortic BP is associated with cardiovascular end-organ 
measures better than or independent of brachial BP (Boutouyrie et al 1999, Covic et al 2000, 
(Safar et al 2002, Williams et al 2006, Wang et al 2009, Benetos et al 2010, Roman et al 
2010, Wohlfahrt et al 2012, Benetos et al 2012, Neisius et al 2012, Norton et al 2012, 
Regnault et al 2012) and this topic has been extensively reviewed by Roman and Devereux 
(2014). Moreover, a recent meta-analysis provides evidence to show that aortic SBP or PP is 
more strongly associated with end-organ measures than brachial SBP or PP (Kollias et al 
2016). However, the results of the relative role of aortic versus brachial BP in cardiovascular 
risk prediction are more contradictory. 
A number of studies have demonstrated that aortic BP predicts cardiovascular 
outcomes better than or independent of brachial BP (Safar et al 2002, Williams et al 2006, 
Roman et al 2007, Jankowski et al 2008, Pini et al 2008, Roman et al 2009, Wang et al 2009, 
Benetos et al 2010, Benetos et al 2012, Regnault et al 2012). These findings were reported in 
patients with end-stage renal disease (Safar et al 2002), in patients undergoing coronary 
angiography (Jankowski et al 2008), in the elderly (Pini et al 2008), and in the general 
population (Roman et al 2007, Roman et al 2009). In contrast, however, in female 
hypertensives, brachial, but not central aortic BP was reported to predict cardiovascular 
outcomes (Dart et al 2006). Moreover, in a meta-analysis of these studies (Vlachopoulos et al 
2010), the comparative ability of aortic versus brachial BP to cardiovascular risk predict did 
not achieve significance, although a trend for a better effect was noted for aortic as compared 
to brachial PP (p=0.057). This meta-analysis (Vlachopoulos et al 2010) however, excluded 
data from the The Conduit Artery Function Evaluation (CAFE) study (and obviously other later 
studies) which also reported on relations between aortic versus brachial BP and 
cardiovascular outcomes (Williams et al 2006) as well as a study conducted in Taiwan which 
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had not as yet been published at the time of the meta-analysis (Wang et al 2009) which 
similarly demonstrated an enhanced ability of aortic as compared to brachial BP in risk 
prediction. Moreover, this meta-analysis (Vlachopoulos et al 2010) was criticized for the 
inclusion of data from the study which failed to show relations between aortic BP whilst 
brachial BP did (Dart et al 2006). This criticism was based on the possibility that aortic BP 
values had not been adequately calibrated in that study (Dart et al 2006). Nevertheless, the 
Framingham Heart Study, which similarly had not been published at the time of the meta-
analysis, demonstrated that neither aortic SBP or PP, nor PP amplification offered an ability 
to risk predict beyond brachial BP (Mitchell et al 2010a). However, in the Framingham Heart 
Study, little difference between aortic and brachial BP (PP amplification) was noted across 
the adult lifespan (Mitchell et al 2010b) and hence the chances of demonstrating a better or 
independent ability of aortic BP to risk predict than brachial BP were low. Although several 
subsequent and more contemporary studies also failed to show that aortic SBP or PP adds 
much to risk prediction beyond brachial SBP or PP, at the same time these studies 
demonstrated that PP amplification does add to risk prediction (Benetos et al 2010, Regnault 
et al 2012, Benetos et al 2012, Chirinos et al 2012, Bursztyn et al 2016). Hence, it is possible 
that PP amplification rather than aortic BP is more likely to act as a useful biomarker of risk 
prediction beyond brachial BP measurements. 
Because of the inconsistencies in the ability of aortic BP and even PP amplification (in 
the Framingham Heart Study) to predict risk beyond brachial BP, the focus has shifted to the 
question of the importance of the factors which determine differences between aortic and 
brachial BP in risk prediction. As indicated in previous discussion there are two possible 
determinants of the differences in aortic and brachial SBP and PP and these include 
increases in aortic stiffness and increases in aortic backward waves. As the role of aortic 
stiffness as indexed using aortic pulse wave velocity (PWV) is now a well-established risk 
factor for cardiovascular events beyond brachial BP (Vlachopoulus et al 2010, Ben-Sehlomo 
et al 2014), further work on this topic is unlikely to significantly add to this field. However, as 
will be discussed there is still considerable uncertainty as to the role of aortic backward waves 
- 17 - 
 
  
in risk prediction. Hence, in the present thesis I have focused my efforts on evaluating the role 
of aortic backward waves as determinants of cardiovascular end-organ measures. 
 
1.3 Role of aortic backward versus forward waves 
 
  In the following section I will discuss the methods of assessing aortic backward wave 
function; the evidence to support a particularly important role of aortic backward waves in 
groups of African ancestry, and the evidence to either support or refute a role for aortic 
backward waves in cardiovascular risk prediction or in associations with end-organ measures 
beyond brachial BP. In doing so I will highlight the unanswered areas in the field which 
prompted me to perform the studies conducted in the present thesis. 
 
1.3.1 Approaches to assessing aortic backward wave function 
 
Figure 1.1 shows the two approaches to assessing aortic reflected wave (backward 
wave) function. In this regard, aortic reflected waves have mainly been determined by 
evaluating the extent to which aortic systolic pressure is augmented by reflected waves and is 
derived from the difference between peak systolic pressure and the inflection point on the first 
systolic shoulder of the aortic pulse. This is called augmented pressure (Pa). Augmented 
pressure is expressed as a proportion of aortic pulse pressure and this is called augmentation 
index (AIx). Augmentation index as opposed to Pa is often employed to assess reflected 
wave function in order to avoid calibration errors (errors in calibration will appear in both the 
numerator and the denominator and hence will largely be eliminated by expressing the data 
as a ratio or proportion) and to demonstrate the relative importance of the backward 
(reflected) wave versus the forward wave. The latter argument is based on the fact that the 
portion of aortic PP that is not determined by the reflected wave will obviously be determined 
by the forward wave. To avoid negative values in younger persons (when backward wave 
pressures appear as a lower value than forward wave pressures), aortic augmentation index 
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is sometimes calculated as aortic SBP/pressure at the first systolic shoulder of the aortic 
pressure wave x 100. 
In addition to the use of aortic augmentation pressures or index, aortic backward 
waves can be separated from forward waves using “wave separation analysis” to produce two 
distinct waveforms illustrated in the lower panel of Figure 1.1. From these waveforms, the 
peak pressure generated by the forward (Pf) and backward (Pb) waves can be determined 
and the relatively greater role of the aortic backward wave is sometimes identified as the ratio 
of Pb to Pf (reflected wave magnitude [RM] or the reflection coefficient). The backward and 
forward waveforms may be separated using simultaneous aortic pressure and flow 
measurements (Westerhof et al 2006). The following formula is used to calculate Pf and Pb:  
 
Pf(t)=[P(t) + Zc • F(t)]/2 
Pb(t)=[P(t) – Zc • F(t)]/2 
 
where P(t) is the measured pressured wave, F(t) is the flow wave, and Zc is characteristic 
impedance of the proximal aorta (Westerhof et al 2006). Characteristic impedance (Zc) is 
derived from the 4th to 7th harmonic (Westerhof et al 2006). In the calculation of Pb and Pf, Zc 
• F appears, where Zc is a ratio of (P/F). Therefore the product of Zc • F is independent of 
flow calibration (Westerhof et al 2006). 
As simultaneous pressure and flow waveforms are laborious to acquire and are 
therefore unlikely to ever be used for risk prediction at a primary healthcare level, “assumed” 
aortic flow waves have been employed for wave separation analysis. This approach to “wave 
separation” analysis is depicted in Figure 1.4. The aortic flow wave is assumed to either be a 
triangular waveform or to assume a single “physiological” waveform shape (Kips et al 2009, 
Westerhof et al 2006). The more readily usable approach is to assume that the flow wave is  
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Figure 1.4. Approach to separating aortic forward and backward pressure waves using an 
assumed triangular aortic flow wave. (Modified from Mitchell 2006). 
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triangular in shape. From comparisons against actual flow measurements, it was noted that 
one can approximate a flow waveform using a triangulation technique (Westerhof et al 2006). 
To apply a triangular flow waveform all that is required is the identification of the start, peak 
and end of the aortic flow (Westerhof et al 2006). As indicated in Figure 1.4, the start is at the 
beginning of the ejection period, the peak occurs at the inflection point of the first systolic 
shoulder or at 30% of the ejection time, and the end of flow is at the dicrotic notch where the 
aortic valve closes. The three points of the triangle are placed at these points (Figure 1.4) and 
the forward and backward waves determined as shown in Figure 1.4. As the aortic flow wave 
is often not a precise triangle, a better approach to wave separation analysis may be the use 
of a “physiological waveform”, which represents the average aortic flow waveform for a 
particular community (Kips et al 2009). Indeed, relationships between aortic backward waves 
derived from actual aortic flow waves and “physiological waveforms” may be stronger than 
relationships between aortic backward waves derived from actual aortic flow waves and 
“triangular waveforms” (Kips et al 2009). However, this approach assumes that every person 
has the same flow waveform shape, which is obviously not the case.  
 
1.3.2. Aortic backward waves and pulse pressure. 
 
  The debate as to the factors that contribute most to increases in aortic PP with age is 
still ongoing. In this regard, the misconception that aortic stiffness is the main determinant of 
age-related increases in aortic PP is still propagated. However, as previously indicated aortic 
pulse wave velocity, a gold-standard measure of aortic stiffness only increases to any 
significant degree from around age 50 years, whilst aortic PP begins to increase from early 
adulthood (Hodson et al 2016, McEniery et al 2008, Mitchell et al 2010b). In contrast to 
significant increases in aortic stiffness occurring from only around 50 years of age, aortic 
backward wave pressures increase from early adulthood (20-30 years of age) and closely 
track age-related increases in aortic PP (Hodson et al 2016, Namasivayam et al 2009). A 
number of studies indicate that across the adult age range, as compared to aortic forward 
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wave pressures (or incident wave pressures) reflected waves, assessed from either indices of 
pressure augmentation, or from wave separation analysis, dominate age-related increases in 
aortic pressure (McEniery et al 2008, Namasivayam et al 2009, Cecelja et al 2009, Booysen 
et al 2015) and that reflected waves account for increases in aortic pressure in hypertension 
(Sibiya et al 2015). Hence, there is significant evidence that aortic backward waves are more 
important than forward waves in contributing toward increases in aortic PP. However, the 
contribution of aortic backward waves to increases in aortic PP may be more important in 
some as compared to other ethnic groups. What is the evidence to suggest an ethnic-specific 
effect on aortic backward waves? 
It is well recognized that groups of African ancestry have a higher prevalence of salt 
sensitivity. Recently, our group have demonstrated an independent relationship between the 
ratio of urinary sodium to potassium derived from 24-hour urinary samples, and aortic 
augmented pressures or augmentation index and hence aortic pulse pressure (Redelinghuys 
et al 2010), thus suggesting a relationship between salt intake and aortic reflected wave 
function. This may explain the markedly higher aortic augmentation indexes noted in this 
ethnic group as compared to alternative populations around the world (Chirinos et al 2011).  
The possibility that there may be an ethnic-specific effect of aortic backward waves is 
underscored by the fact that unlike in may studies, aortic forward waves have been 
demonstrated to contribute far more to age-related increases in aortic PP than aortic 
backward waves in the Framingham Heart Study (Mitchell et al 2010b). However, in that 
study (Mitchell et al 2010b) a very high proportion of participants were receiving 
antihypertensive therapy and it is now well-recognized that antihypertensive agents produce 
marked decreases in aortic backward waves and the relationship between backward and 
forward wave pressures (see section1.3.6). 
 
1.3.3 Aortic pressure augmentation in risk prediction and associations with end-organ 
measures 
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Several earlier studies demonstrated that aortic backward (reflected) waves, as 
determined from indices of pressure augmentation (Pa or AIx) are associated with 
cardiovascular damage (Hashimoto et al 2007, Hashimoto et al 2006, Weber et al 2006, 
Westerbacka et al 2005, Sibiya et al 2014), and predict cardiovascular outcomes (Chirinos et 
al 2005, London et al 2001, Ueda et al 2004, Weber et al 2005) independent of brachial BP. A 
meta-analysis of these and other outcome driven studies provides clear evidence that indices 
of pressure augmentation predict outcomes beyond brachial BP (Vlachopoulos et al 2010). 
Hence, based on measures of aortic pressure augmentation, aortic reflected waves were 
considered to be an important determinant of aortic pressure effects on cardiovascular 
damage independent or beyond brachial BP. However, the Framingham Heart Study failed to 
show that indices of aortic pressure augmentation predict outcomes independent of brachial 
BP (Mitchell et al 2010). Further, all of the earlier studies suggesting an important role for 
aortic wave reflection in mediating cardiovascular damage (Hashimoto et al 2007, Hashimoto 
et al 2006, Weber et al 2006, Westerbacka et al 2005, Chirinos et al 2005, London et al 2001, 
Ueda et al 2004, Weber et al 2005) employed Pa or AIx as a measure of wave reflection. As 
shown in Figure 1.1, the obvious error which may be introduced when assessing wave 
reflection with indices of pressure augmentation is that the point where the forward wave 
peaks and the reflected wave begins is obscure. Indeed, reflected wave pressures derived 
from wave separation analysis are considerably higher than that reported from Pa. The use of 
Pa or AIx as measures of aortic wave reflection have recently been criticized (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014a, Torjesen et al 2014, Schultz et 
al 2013). In this regard, several studies suggest that many factors other than the magnitude of 
the aortic backward wave influence Pa and AIx (Cheng et al 2012, Fok et al 2014a, Torjesen 
et al 2014, Schultz et al 2013) and hence these measures may be poor indices of wave 
reflection. Indeed, there may be a weak relationship between the magnitude of the reflected 
wave and Pa or AIx with increases in aortic reservoir function, the timing or magnitude of the 
Pf or incident (Pi) wave pressures (aortic PP- [Pressure at the first systolic shoulder of the 
aortic pressure wave-DBP]) (Figure 1.1), and left ventricular systolic function playing a more 
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important role than wave reflection in contributing to variations in Pa and AIx (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013, Fok et al 2014a, Torjesen et al 2014, Schultz et 
al 2013). Furthermore, there is some evidence that whilst reflected wave magnitude derived 
from wave separation analysis is independently associated with cardiovascular events, 
augmentation index is not (Chirinos et al 2012) and that adjustments for augmented 
pressures and augmentation index do not influence the independent relationship between 
wave-separation analysis-derived backward wave pressures and cardiovascular events 
(Wang et al 2010). However, both augmentation index and the reflected wave magnitude 
have also been demonstrated to independently predict cardiovascular events (Weber et al 
2012). Hence, there is considerable controversy as to whether relations between Pa or AIx 
and end-organ measures or cardiovascular outcomes reflect an impact of backward waves or 
alternative factors that influence Pa or AIx.   
An impact of gender on Pa or AIx is well-recognised. In this regard, women have a 
higher AIx than men (Hughes et al 2013, Mitchell et al 2010b), but these differences may be 
attributed to factors unrelated to the magnitude of aortic wave reflection (Hughes et al 2013, 
Mitchell et al 2010a). Indeed, gender-specific effects on AIx in women of the Framingham 
Heart Study were attributed to increases in forward wave peak width, slope of the backward 
pressure wave, and forward wave amplitude, but not backward wave amplitude (Torjesen et 
al 2014). Whether these other factors (forward wave peak width, slope of the backward 
pressure wave, and forward wave amplitude) contribute as much as backward wave 
amplitude to cardiovascular damage is unknown. Hence, the impact of AIx on cardiovascular 
damage in women may not be as strong as that in men. Indeed, while AIx predicts outcomes 
in men, similar relationships may be diminished in women (Wang et al 2010). Nevertheless, in 
that study (Wang et al 2010) unadjusted relationships between AIx and end-organ changes 
were no different in women as compared to men. However, multivariate adjusted 
relationships between AIx and end-organ changes were not reported on (Wang et al 2010). 
To clarify whether gender influences relationships between AIx and cardiovascular end-organ 
changes, in the present thesis I aimed to compare the association between AIx and left 
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ventricular mass index (LVMI) in men and women in a large, community-based sample and to 
evaluate whether these effects are attributed to differences in backward wave pressures 
effects. These data are described in chapters 2 and 3 of the present thesis and have been 
published in the journals Hypertension Research (Sibiya et al 2014) and in-part in the journal 
Hypertension (Booysen et al 2015). 
 
1.3.4 Relative contribution of aortic backward versus forward waves as determined using 
wave separation analysis to cardiovascular risk and end-organ measures. 
 
As there is significant evidence to suggest that the use of aortic Pa or AIx are 
inadequate indices of aortic backward wave function, the question arises as to the relative 
contribution of aortic forward and backward waves, as determined using wave separation 
analysis, to cardiovascular end-organ measures and events. In the past few years, several 
studies have described an association of reflected waves (Pb or the reflected wave index-RI) 
derived from wave separation analysis with end-organ changes (Wang et al 2010, Weber et 
al 2012) or an ability of Pb or RI (or reflected wave magnitude-RM) to risk predict beyond 
brachial BP (Wang et al 2010, Weber et al 2012, Chirinos et al 2012, Zamani et al 2014). In 
this regard, in 1272 normotensive and untreated hypertensives, over an average of 15 years 
of follow-up, an increased wave reflection predicted cardiovascular mortality (n=64 events) in 
both men and women (Wang et al 2010). However, the extent to which the forward wave also 
contributed to cardiovascular end-organ changes and events was uncertain. In this regard, 
these authors (Wang et al 2010) showed that forward wave pressures were also predictive of 
events and similar relations between aortic forward wave pressures and end-organ measures 
as those noted between aortic backward wave pressures and end-organ measures were 
noted, but they failed to adjust for confounders or brachial BP. Further, in 725 patients 
undergoing coronary angiography, over an average of 3.83 years of follow-up, backward, but 
not forward wave pressures independently predicted cardiovascular events (n=139 events) 
(Weber et al 2012). However, again the extent to which the forward wave also contributed to 
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cardiovascular end-organ changes was uncertain (Weber et al 2012). In this regard, these 
authors (Weber et al 2012) also showed equivalent relations between aortic forward wave 
pressures and end-organ measures as those noted between aortic backward wave pressures 
and end-organ measures. In addition, in 5960 participants of a multi-ethnic community 
sample followed for an average of 7.61 years, the reflective wave magnitude was predictive of 
cardiovascular events and heart failure (n=281 events) (Chirinos et al 2012), but in this study 
it was uncertain as to whether the forward wave also predicted events. Nevertheless, in this 
same multi ethnic study, analysis of a much larger cohort of 6814 participants followed for 9.8 
years, the backward, but not the forward wave was independently associated with all-cause 
mortality (n=617 events) (Zamani et al 2014). In contrast to the ability of several groups to 
show independent relations between aortic backward waves and outcomes, neither backward 
wave pressures nor the reflected wave index were independently associated with outcomes 
in the Framingham Heart study (Cooper et al 2014). Nevertheless, as pointed out in previous 
sections, a high proportion of the participants of the Framingham Study were receiving 
antihypertensive therapy, and as will be discussed in section 1.3.6, antihypertensive agents 
reduce aortic backward wave pressures. Consequently, aortic backward waves in the 
Framingham Heart Study failed to contribute as much as aortic forward waves to age-related 
increases in aortic PP as did aortic forward wave pressures (Mitchell et al 2010b). 
In summary, despite the evidence in favor of aortic backward waves derived from 
wave separation analysis contributing to end-organ changes and cardiovascular risk (Wang et 
al 2010, Weber et al 2012, Chirinos et al 2012, Zamani et al 2014), whether forward wave 
pressures also associate with cardiovascular damage independent of brachial BP, and the 
relative contribution of forward wave and backward wave pressures to the brachial BP-
independent relationship between PPc and cardiovascular damage is uncertain. This is 
particularly important for relations between the backward and forward wave components of 
aortic pulse pressure and end-organ measures. As highlighted above, the two studies which 
previously described these relations (Wang et al 2010, Weber et al 2012) failed to provide 
convincing evidence of a stronger brachial BP-independent relationship between aortic 
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backward as opposed to forward wave pressures and end-organ measures. Hence, as part of 
the present thesis I aimed to assess in a community of African ancestry whether brachial BP-
independent associations between Pb, Pf or both and end-organ measures or damage occur 
and whether brachial BP-independent associations between PPc and cardiovascular end-
organ measures or damage are accounted for by an impact of Pb, Pf or both. These data are 
described in chapter 4 of the present thesis and have been published in the Journal of 
Hypertension (Sibiya et al 2015). 
 
1.3.5 Relative contribution of aortic backward versus forward waves to the impact of PP 
amplification on cardiovascular risk. 
 
 As indicated in the aforementioned discussion, PP amplification is determined by a 
greater stiffness of peripheral arteries as compared to the central aorta. However, as also 
indicated in previous sections the age-associated decline in PP amplification that occurs in 
most individuals is attributed to two factors. These include an increased aortic stiffness so 
that the aortic stiffness approximates or even becomes greater than peripheral arterial 
stiffness. The consequence is that whilst aortic PP increases markedly with age, peripheral 
arterial PP increases to a lesser extent for a given increase in age. In addition, age-related 
increases in aortic backward wave pressures occur, and these increases are reflected mainly 
in increases in the peak of the aortic pulse, but do not contribute as much to the peak of the 
peripheral arterial pulse (see section 1.2.3 for explanation). Importantly, as previously 
indicated, because aortic backward wave pressures increase markedly from young 
adulthood, whilst aortic stiffness only begins to significantly increase from 50-60 years of age, 
age-related decreases in PP amplification are mainly attributed to increases in aortic 
backward wave pressures (Hodson et al 2016). 
As summarized in section 1.2.4 of the present chapter, PP amplification has on 
several occasions been shown to predict cardiovascular risk (Benetos et al 2010, Regnault et 
al 2012, Benetos et al 2012, Chirinos et al 2012, Bursztyn et al 2016). Importantly, these 
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associations have frequently been demonstrated in studies where aortic PP was imputed 
from simple clinical measures (Benetos et al 2010, Bursztyn et al 2016). Hence, PP 
amplification can be determined using approaches which cost little and hence are ideal for 
resource-limited settings. Because age-related increases in aortic backward waves are 
largely responsible for age-related decreases in PP amplification, we hypothesize that the 
mechanism responsible for associations between PP amplification and cardiovascular risk is 
mainly attributed to age-related increases in aortic backward wave pressures. However, no 
study has assessed whether increases in aortic stiffness or backward waves account for the 
brachial BP-independent association between PP amplification and cardiovascular end-organ 
changes. As one of the key end-organ changes that occur in response to aortic 
haemodynamic loads is left ventricular hypertrophy (LVH), as part of the present thesis I 
therefore aimed to determine first whether PP amplification adds to brachial BP in 
associations with LV mass index (LVMI) and LVH in a large randomly selected community-
based sample of largely young-to-middle aged participants. I further aimed to assess whether 
this relationship can be accounted for either by aortic stiffness as indexed by PWV, and/or by 
aortic backward wave function. These data are shown in chapter 4 of the present thesis and 
have been accepted for publication in the Journal of the American Society of Hypertension 
(Sibiya et al 2017). 
 
1.3.6 Antihypertensive effects on aortic forward and backward waves and PP amplification 
 
 As summarized in the preceding discussion there is still considerable uncertainty as 
to the role of PP amplification and aortic backward waves in mediating cardiovascular 
damage, whilst the gold-standard measure of aortic stiffness, PWV, is now recognized as a 
measure that will enhance risk prediction beyond brachial BP (Vlachopoulus et al 2010, Ben-
Shlomo et al 2014). It is therefore important to understand whether current antihypertensive 
therapy modifies aortic stiffness and hence forward wave pressures, aortic backward wave 
pressures and/or PP amplification. Several antihypertensive drug classes have been 
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demonstrated to reduce aortic PP in-part through decreases in wave reflection, as indexed 
using Pa or AIx (Agabiti-Rosei et al 2007, Manisty et al 2012, Williams et al 2006, Miyashita 
et al 2010, Jiang 2007, Vinereanu et al 2014, Agnoletti et al 2013). Whether antihypertensive 
effects on aortic PP are mainly through reductions in Pb is nevertheless uncertain with a 
meta-analysis (Manisty et al 2012) and a large recent study (Agnoletti et al 2013) 
demonstrating little effect on AIx. In this regard vasodilator agents may also reduce Pf by 
decreasing distending pressures and hence aortic stiffness without altering vascular structure 
(McDonald’s 2011). Moreover, diuretic agents may decrease Pf by reducing stroke volume. 
Thus, decreases in Pf rather than Pb may be the main mechanism of antihypertensive drug 
effects on aortic PP. However, if aortic backward waves and consequent decreases in PP 
amplification are central to mediating cardiovascular damage, it is important to first identify 
the role of these indices of aortic function and then to detect those antihypertensive agents 
that best modify these indices. Hence, in the present thesis I focused my efforts on 
contributing to our understanding of the role of aortic backward waves and PP amplification 
on end-organ measures. 
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1.4 Aims 
 
In the present thesis, I therefore aimed to: 
 
1) compare the association between AIx and left ventricular mass index (LVMI) in men 
and women in a large, community-based sample and to evaluate whether these effects are 
attributed to differences in backward wave pressures effects. These data are described in 
chapters 2 and 3 of the present thesis and have been published in the journals Hypertension 
Research (Sibiya et al 2014) and in-part in the journal Hypertension (Booysen et al 2015). 
2) assess in a community of African ancestry whether brachial BP-independent 
associations between Pb, Pf or both and end-organ measures or damage occur and whether 
brachial BP-independent associations between PPc and cardiovascular end-organ measures 
or damage are accounted for by an impact of Pb, Pf or both. These data are described in 
chapter 3 of the present thesis and have been published in the Journal of Hypertension 
(Sibiya et al 2015). 
3) whether PP amplification adds to brachial BP in associations with LV mass index 
(LVMI) and LVH in a large randomly selected community-based sample of largely young-to-
middle aged participants. I further aimed to assess whether this relationship can be 
accounted for either by aortic stiffness as indexed by PWV, and/or by aortic backward wave 
function. These data are shown in chapter 4 of the present thesis and have been accepted 
for publication in the Journal of the American Society of Hypertension (Sibiya et al 2017). 
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CHAPTER 2 
 
 
Gender-Specific Contribution of Aortic Augmentation Index to Variations in Left 
Ventricular Mass Index in a Community Sample of African Ancestry. 
 
This chapter has been published as follows 
 
Moekanyi J Sibiya, Gavin R Norton, Bryan Hodson, Michelle Redelinghuys, Muzi J Maseko, 
Olebogeng HI Majane, Elena Libhaber, Angela J Woodiwiss. Gender-specific contribution of 
aortic augmentation index to variations in left ventricular mass index in a community sample 
of African ancestry. Hypertension Research 2014;37:1021-1027 
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2.1 Abstract 
 
Although indices of aortic augmentation derived from radial applanation tonometry are 
independently associated with adverse cardiovascular effects, whether these relationships 
are influenced by gender is uncertain. I compared the brachial BP-independent contribution 
of augmentation index (AIx) to variations in left ventricular mass index (LVMI) in a community 
sample of 808 participants, 283 of whom were men. Aortic haemodynamics were determined 
using radial applanation tonometry and SphygmoCor software and LVMI from 
echocardiography. In men, both AIx derived from aortic augmentation pressure/central aortic 
pulse pressure (AP/PPc) (partial r=0.17, β-coefficient±SEM=0.55±0.20, p<0.01) and AIx 
derived from the second peak/first peak (P2/P1) of the aortic pulse wave (partial r=0.21, β-
coefficient±SEM=0.42±0.12, p<0.0005) were associated with LVM indexed to body surface 
area (LVMI-BSA). In contrast, in women neither AIx derived from AP/PPc (partial r=-0.08, β-
coefficient±SEM=-0.20±0.11, p=0.08) nor AIx derived from P2/P1 (partial r=-0.06, β-
coefficient±SEM=-0.07±0.05, p=0.17) were associated with LVMI-BSA. Both the strength of 
the correlations (p<0.001 and p<0.0005 with z-statistics) and the slope of the AIx-LVMI 
relationships (p=0.001 and p<0.0005) were greater in men as compared to women. The lack 
of relationship between AIx and LVMI was noted in both premenopausal (n=285)(AP/PPc vs 
LVMI-BSA, partial r=0.01, p=0.95, P2/P1 vs LVMI-BSA, partial r=0.02, p=0.77), and 
postmenopausal (n=240)(AP/PPc vs LVMI-BSA, partial r=-0.06, p=0.37, P2/P1 vs LVMI-BSA, 
partial r=-0.03, p=0.64) women. Similar differences were noted in the relationships between 
AIx and LVM indexed to height2.7 in men and women. In conclusion, radial applanation 
tonometry-derived AIx may account for less of the variation in end organ changes in women 
as compared to men. 
 
Key words: Central aortic augmented index, left ventricular mass index, gender. 
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2.2 Introduction 
 
  Although pulse pressure (PP) measured at the brachial artery is closely correlated 
with central PP (PPc), PPc may be considerably lower than in brachial arteries (Aviolo et al 
2009, Agabiti-Rosei et al 2007). The factors that determine aortic PP differ markedly from 
those that determine brachial PP. In this regard, aortic PP is augmented by changes in aortic 
reservoir function, the timing or magnitude of both the forward and reflected waves, and left 
ventricular systolic function (Aviolo et al 2009, Agabiti-Rosei et al 2007, Davies et al 2010, 
Cheng et al 2012, Hughes et al 2013). Several studies have demonstrated that indices of 
aortic pressure augmentation predict cardiovascular events (London et al 2001, Ueda et al 
2004, Weber et al 2005, Chirinos et al 2005, Wang et al 2010, Chirinos et al 2012, 
Vlachopoulos et al 2010), or are associated with end-organ damage independent of or better 
than brachial blood pressure (BP) (Hashimoto et al 2006, Hashimoto et al 2007, Weber et al 
2006, Westerbacka et al 2005). As indices of aortic pressure augmentation may be derived 
from simple, and highly reproducible tonometric assessments of the radial artery, these 
indices are attractive additions to routine risk prediction. However, some studies 
(Vlachopoulos et al 2010, Mitchell et al 2010a, Hayashi et al 2014) including the Framingham 
Heart Study (Mitchell et al 2010a), have failed to show similar relations between indices of 
aortic augmentation and cardiovascular outcomes. The factors that determine whether 
indices of aortic pressure augmentation predict cardiovascular damage therefore require 
identification. 
 The impact of gender on aortic augmentation index (AIx) (augmentation 
pressure/aortic pulse pressure), is well-recognised. In this regard, women may have a higher 
AIx than men (Hughes et al 2013, Mitchell et al 2010b), but these differences may be 
attributed to factors unrelated to aortic wave reflection (Hughes et al 2013). Hence, the 
impact of AIx on cardiovascular damage in women may not be as strong as that in men. 
Indeed, while AIx predicts outcomes in men, similar relationships may be diminished in 
women (Wang et al 2010). Nevertheless, in that study (Wang et al 2010) unadjusted 
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relationships between AIx and end-organ changes were no different in women as compared 
to men. However, multivariate adjusted relationships between AIx and end-organ changes 
were not reported on (Wang et al 2010). To clarify whether gender influences relationships 
between AIx and cardiovascular end-organ changes, the aim of the current chapter is to 
compare the association between AIx and left ventricular mass index (LVMI) in men and 
women in a large, community-based sample. In this regard, LVMI and the regression thereof 
with antihypertensive therapy are well-recognised independent predictors of cardiovascular 
outcomes (Casale et al 1986, Levy et al 1990, Koren et al 1991, Levy et al 1994, Verdecchia 
et al 1996, Ghali et al 1998, Devereux et al 2004, Okin et al 2004). 
 
2.3 Methods 
 
2.3.1 Study group. 
 
The present study was conducted according to the principles outlined in the Helsinki 
declaration. The Committee for Research on Human Subjects of the University of the 
Witwatersrand approved the protocol (approval number: M02-04-72 and renewed as M07-04-
69 and M12-04-108). Participants gave informed, written consent. The present study design 
has previously been described (Norton et al 2008, Woodiwiss et al 2009, Redelinghuys et al 
2010). Briefly, 808 participants from randomly recruited families of black African descent 
(Nguni and Sotho chiefdoms) with siblings older than 16 years from the South West 
Township of Johannesburg, South Africa, and with central haemodynamic measurements 
and high quality echocardiograms were studied. 
 
2.3.2 Clinical, demographic and anthropometric measurements. 
 
A standardized questionnaire was administered to obtain demographic and clinical 
data (Norton et al 2008, Woodiwiss et al 2009, Redelinghuys et al 2010). Height and weight 
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were measured using standard approaches and participants were identified as being 
overweight if their body mass index (BMI) was ≥25 kg/m2 and obese if their BMI was ≥30 
kg/m2. High quality BP measurements were obtained by a trained nurse-technician using a 
standard mercury sphygmomanometer (Woodiwiss et al 2009). Korotkoff phases I and V 
were employed to identify systolic and diastolic BP respectively and care was taken to avoid 
auscultatory gaps. Hypertension was defined as a mean systolic/diastolic BP≥140/90 mm Hg 
or the use of antihypertensive medication. Laboratory blood tests of renal function, liver 
function, blood glucose, haematological parameters, and percentage glycated haemoglobin 
(HbA1C) were performed. Diabetes mellitus (DM) or abnormal blood glucose control was 
defined as the use of insulin or oral hypoglycaemic agents or an HbA1C value greater than 
6.1%. Menopause was confirmed with measurements of follicle stimulating hormone 
concentrations. 
 
2.3.4 Pulse wave analysis. 
 
Central aortic systolic BP (SBPc), PPc and AIx were estimated using techniques 
previously described (Redelinghuys et al 2010, Norton et al 2012). Briefly, after participants 
had rested for 15 minutes in the supine position, arterial waveforms at the radial (dominant 
arm) pulse were recorded by applanation tonometry during an 8-second period using a high-
fidelity SPC-301 micromanometer (Millar Instrument, Inc., Houston, Texas) interfaced with a 
computer employing SphygmoCor, version 6.21 software (AtCor Medical Pty. Ltd., West 
Ryde, New South Wales, Australia). The pulse wave was calibrated by manual measurement 
(auscultation) of brachial BP taken immediately before the recordings. The peripheral 
pressure waveform was converted into a central aortic waveform using a validated 
generalized transfer function incorporated in SphymoCor software. Recordings where the 
systolic or diastolic variability of consecutive waveforms exceeded 5% or the amplitude of the 
pulse wave signal was less than 80 mV were discarded. All measurements were made by a 
single experienced trained technician unaware of the clinical history of the participants and 
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with a low degree of intra-observer variability and a high degree of reproducibility 
(Redelinghuys et al 2010, Norton et al 2012). Central aortic PP was determined as the 
difference between SBPc and diastolic BP (DBP). Augmented pressure (AP) was determined 
using SphygmoCor software and identified as the difference between PPc and the first 
systolic shoulder of the aortic pulse wave.  Aortic AIx was determined as AP/aortic PP 
(AP/PPc) expressed as a percentage. To avoid obtaining negative aortic AIx values in young 
participants, AIx was also determined as the pressure at the second systolic peak of the 
aortic pulse wave/the pressure at the first systolic peak of the aortic pulse wave (P2/P1) 
expressed as a percentage (Chirinos et al 2011). 
 
2.3.5 Echocardiography. 
 
Left ventricular end diastolic internal diameter and septal (anterior wall) and posterior 
wall thickness were determined from transthoracic two-dimensional targeted M-mode 
echocardiographic images obtained in the parasternal long-axis as previously described 
(Norton et al 2008, Woodiwiss et al 2009, Norton et al 2012). Variables were analysed 
according to the American Society of Echocardiography convention (Sahn et al 1978). All 
measurements were recorded and analysed off-line by experienced investigators (CDL and 
AJW) who were unaware of the clinical data of the participants and whom had a low degree 
of inter- and intra-observer variability (Norton et al 2008, Woodiwiss et al 2009, Norton et al 
2012). Only M-mode images of acceptable quality were analysed (see Figure 2.1). In this 
regard, acceptable quality was considered to exist when appropriate visualization of both the 
right and the left septal surfaces occurred and where the endocardial surface of the septal 
and posterior wall were clearly visible when imaging at the optimal angle of incidence 
(perpendicular to the posterior wall) and close to the mitral leaflets. Left ventricular mass 
(LVM) was determined using a standard formula (Devereux et al 1986) and indexed (LVMI) 
to height2.7 (LVMI-ht2.7) and to body surface area (LVMI-BSA). Left ventricular relative wall 
thickness (RWT) was defined as (LV anterior + posterior wall thickness at end diastole)/LV  
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Figure 2.1. Example of an M-mode echocardiographic image obtained in the parasternal 
long-axis of the heart. M-mode images were used to determine left ventricular end diastolic 
internal diameter and septal and posterior wall thickness dimensions. 
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end diastolic diameter. LVH was identified as an LVMI-BSA>95 g/m2 for women and >115 
g/m2 for men. Concentric LV remodelling was identified as a RWT ≥0.42, and eccentric LVH 
as a RWT<0.42 with an increased LVMI-BSA.    
 
2.3.6 Statistical analysis. 
 
For database management and statistical analysis, SAS software, version 9.1 (SAS 
Institute Inc., Cary, NC) was employed. To determine relationships between PPc or AIx and 
LVMI, multivariate linear regression analysis was performed. To determine relationships 
between AIx and concentric LV remodelling, LVH or eccentric LVH in sex-specific groups, 
multivariate logistic regression analysis was performed. In multivariate models adjustments 
were made for the impact of brachial BP (PP, systolic BP [SBP] or mean arterial pressure 
[MAP]), age, body weight, body height (for LVMI-BSA), the presence of diabetes mellitus or 
an HbA1C>6.1%, treatment for hypertension, regular tobacco use, and regular alcohol intake. 
To determine probability values, further adjustments for non-independence of family 
members was performed using non-linear regression analysis (mixed procedure as defined 
in the SAS package). To ensure that relationships occurred independent of the use of 
antihypertensive therapy, sensitivity analysis was conducted in participants not receiving 
antihypertensive therapy. Regression coefficients were compared with z statistics. 
 
2.4 Results 
 
2.4.1 Characteristics of the participants. 
 
The clinical and demographic characteristics of women and men are shown in Table 
2.1. 1.9% of participants had a history of cardiovascular disease. Importantly, 45.2% of 
participants with hypertension were not receiving therapy. Moreover, 35.4% of all participants 
and 28.0% of participants not receiving antihypertensive therapy had uncontrolled 
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hypertension. 19.1% of participants had concentric LV remodelling, and 17.3% had LVH 
(7.1% concentric and 10.2% eccentric LVH). More women than men had concentric LV 
remodelling, but a similar proportion had LVH, with no differences noted in the proportion 
with concentric and eccentric LVH (Table 2.1). Women had a higher AIx than men, but PPc 
was similar in men and women (Table 2.1). 
 
2.4.2 Relationships between aortic BP and LVMI independent of brachial BP in gender-
specific groups. 
 
Aortic pulse pressure (PPc) was related to LVMI independent of MAP in both men 
and women (Table 2.2, Figure 2.2). However, the strength of the relations (partial r) was 
greater in men than in women (Table 2.2). In men, but not in women PPc was related to  
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Table 2.1. Characteristics of the study sample. 
              Men (n=283)     Women (n=525)     p-value 
_________________________________________________________________________ 
Age (years)                 43.0±19.0    45.3±17.5           =0.09 
Body mass index (kg/m2)                        25.9±16.1    32.6±13.6           <0.0001 
Body weight (kg)              71.9±17.6    80.2±29.2           <0.0001 
Body height (m)              168.5±8.7    157.4±7.1           <0.0001 
% obese                 17.7         56.6           <0.0001 
Regular tobacco (% subjects)                33.6         4.8           <0.0001 
Regular alcohol (% subjects)            33.2         12.4           <0.0001 
% with DM or HbA1C>6.1%                               21.2         28.4           <0.05 
% women postmenopausal        -         45.7                - 
% hypertensive      40.3         45.3             =0.17 
% treated for hypertension     15.6         30.7           <0.0001 
% hypertensives controlled to target BP#        28.1         39.1           <0.05 
% of all with uncontrolled BP##               38.9         33.5           =0.14 
Pulse rate (beats/min)                                      62±12                 68±11           <0.0001 
Conventional SBP/DBP (mm Hg)                131±22/85±13   128±23/83±13        =0.07/<0.05 
Conventional pulse pressure (mm Hg)          45.9±18.0            44.5±15.3           =0.26      
Central SBP (mm Hg)                                    121±22                 120±23           =0.29 
Central pulse pressure (PPc) (mm Hg)         35.9±17.1              35.7±14.1           =0.90           
Aortic augmentation index (AP/PPc)† (%)     23.9±12.8              28.8±12.5           <0.0001 
Aortic augmentation index (P2/P1)†† (%)        135±22                  145±25           <0.0001   
Left ventricular mass index (g/m2.7)              40.4±14.8               42.3±15.1           =0.07 
Left ventricular mass index (g/m2)                82.8±34.4                72.1±27.7          <0.0001 
Left ventricular relative wall thickness          0.38±0.08                0.39±0.08           <0.05 
Concentric LV remodelling (%)                        14.8                        21.3            <0.05 
Concentric LV hypertrophy (%)                        7.4                           6.9            =0.77 
Eccentric LV hypertrophy (%)                          8.5                          11.1            =0.25 
__________________________________________________________________________  
Data are expressed as mean±SD or proportions. Data were compared with Chi-squared 
analysis or a Student’s unpaired t-test. DM, diabetes mellitus; HbA1C, glycosylated 
haemoglobin; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; AP, aortic 
augmentation pressure; LV, left ventricular. †(Augmentation pressure/aortic pulse pressure) x 
100, ††(Pressure at the second systolic peak of the aortic pulse wave/Pressure at the first 
systolic peak of the aortic pulse wave) x 100. #indicates conventional SBP/DBP<140/90 mm 
Hg.  ##indicates conventional SBP/DBP≥140/90 mm Hg. 
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Table 2.2. Brachial blood pressure-independent relations between central aortic pulse 
pressure (PPc) and left ventricular mass (LVM) index in men and women from a community 
sample. 
 
          Men      Women 
        Adjustments      n= partial r* (95% CI)  p-value    n=   partial r* (95% CI)  p-value 
__________________________________________________________________________ 
PPc vs LVM indexed to body surface area 
      * + brachial SBP       283   0.25 (0.14 to 0.36) <0.0001   525  0.05* (-0.03 to 0.14) =0.23 
      * + brachial PP          283   0.14 (0.02 to 0.25) <0.05   525  0.02 (-0.07 to 0.10)  =0.71 
      * + brachial MAP     283   0.27 (0.16 to 0.38) <0.0001   525 0.13* (0.04 to 0.21) <0.005 
PPc vs LVM indexed to height2.7 
      * + brachial SBP       283   0.27 (0.16 to 0.38) <0.0001   525  0.06* (-0.03 to 0.14) =0.18 
      * + brachial PP         283   0.18 (0.06 to 0.29) <0.005   525  0.02* (-0.07 to 0.11) =0.65 
      * + brachial MAP    283   0.29 (0.18 to 0.39) <0.0001   525  0.11* (0.02 to 0.19) <0.05 
__________________________________________________________________________ 
SBP, systolic blood pressure; PP, pulse pressure, OR, odds ratio. *Adjustments are for age, 
body weight, height (for LVM indexed for BSA), the presence of diabetes mellitus or an 
HbA1c>6.1%, pulse rate, treatment for hypertension (in all participants), regular tobacco use, 
and regular alcohol intake and brachial BP as indicated. Probability values are derived after 
further adjustments for the non-independence of family members. *p<0.05 for comparison of 
r values between men and women using z-statistics. 
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Figure 2.2. Multivariate adjusted left ventricular mass indexed for body surface area (BSA) 
(LVMI in g/m2) or height2.7 (LVMI in g/m2.7) across quartiles of central aortic pulse pressure in 
men and women from a community sample. Adjustments are for age, mean arterial pressure, 
body weight, body height (for LVM indexed for BSA), the presence of diabetes mellitus or an 
HbA1C>6.1%, pulse rate, treatment for hypertension, regular tobacco use, and regular alcohol 
intake. Probability values are derived after further adjustments for the non-independence of 
family members. p for trend effects: LVM indexed for BSA; men, p<0.0001, women, p<0.005; 
, LVM indexed for height2.7; men, p<0.0001, women, p<0.05. See Table 2 for comparison of 
relationships between men and women. *p<0.05, **p<0.01, ***p<0.0001 vs quartile1, †p<0.01, 
††p<0.0005 vs quartile 2. 
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LVMI independent of confounders and brachial PP and SBP (Table 2.2). However, no 
differences were noted in the strength (partial r values, Table 2, p=0.09 using z-statistics) or 
slopes (β-coefficients, p=0.06) of the brachial PP adjusted PPc-LVMI-BSA relations in men 
versus women. In contrast to the brachial BP-independent relations between PPc and LVMI 
in men, SBPc was not related to LVMI-BSA independent of brachial SBP or PP in men 
(p=0.36-0.38) or brachial SBP in women (p=0.43). Moreover, SBPc was not related to LVMI-
ht2.7 independent of brachial SBP or PP in men (p=0.07-0.73) or brachial SBP in women 
(p=0.68). These brachial BP-independent relations between PPc or SBPc and LVMI were 
largely reproduced in participants not receiving antihypertensive therapy and in pre- and 
post-menopausal women (data not shown). 
 
2.4.3 Gender-specific relationships between AIx and LVMI. 
 
On bivariate analysis, AIx was associated with LVMI in both men (p<0.0001 for all) 
and women (p<0.05 to p<0.0001). However, the relationship between AIx (P2/P1) and LVM 
indexed to BSA was stronger in men (r=0.28, 95% CI=0.16 to 0.38, p<0.0001) as compared 
to women (r=0.11, 95% CI=0.02 to 0.19, p<0.05)(p<0.05 for comparison of relationships 
using z-statistics). Furthermore, men showed a trend for a stronger AIx (AP/PPc)-LVM 
indexed for BSA relationship (p=0.05 for comparison of relationships) and for a stronger AIx 
(P2/P1)-LVM indexed for height2.7 relationship (p=0.05 for comparison of relationships) than 
women. 
On multivariate regression analysis independent of MAP and alternative confounders, 
AIx was associated with LVMI in men, but not in women (Table 2.3, Figure 2.3). Moreover, 
the strength (partial r values) and the slope (β-coefficients) of the relationships between AIx 
and LVMI were greater in men as compared to women (Table 2.3). Independent relationships 
between AIx and LVMI were noted in neither pre-, nor postmenopausal women (Table 2.3).  
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Table 2.3. Brachial blood pressure-independent relations between aortic augmentation 
indices and left ventricular mass indexed to body surface area (LVMI-BSA) or height2.7 (LVMI-
ht2.7) in men and in women from a community sample. 
 
                n=     partial r (95% CI)*    β-coefficient±SEM   p-value    
__________________________________________________________________________ 
Augmentation index (AP/PPc)† vs LVMI-BSA 
      Men             283    0.17‡ (0.05 to 0.28)        0.55±0.20#  <0.01      
      Women             525   -0.08  (-0.16 to 0.01)      -0.20±0.11  =0.08      
      Premenopausal women           285    0.01  (-0.11 to 0.12)       0.01±0.14  =0.95      
      Postmenopausal women           240   -0.06  (-0.19 to 0.07)      -0.18±0.21  =0.37      
Augmentation index (P2/P1)†† vs LVMI-BSA 
      Men             283    0.21‡ (0.10 to 0.32)        0.42±0.12#  <0.0005      
      Women             525   -0.06  (-0.14 to 0.03)      -0.07±0.05  =0.17      
      Premenopausal women           285    0.02  (-0.10 to 0.14)       0.02±0.08  =0.77      
      Postmenopausal women            240   -0.03  (-0.16 to 0.10)      -0.04±0.09  =0.64      
Augmentation index (AP/PPc)† vs LVMI-ht2.7 
      Men             283    0.19‡ (0.07 to 0.30)       0.25±0.08#  <0.005      
      Women             525   -0.04  (-0.13 to 0.04)     -0.05±0.06  =0.34      
      Premenopausal women           285    0.09  (-0.02 to 0.21)      0.09±0.06  =0.12      
      Postmenopausal women           240   -0.09  (-0.21 to 0.04)     -0.15±0.12  =0.19      
Augmentation index (P2/P1)†† vs LVMI-ht2.7 
      Men             283    0.23‡ (0.11 to 0.34)        0.18±0.05#  =0.0001      
      Women             525   -0.04  (-0.13 to 0.04)      -0.03±0.03  =0.32      
      Premenopausal women           285    0.09  (-0.02 to 0.21)       0.05±0.03  =0.12      
      Postmenopausal women           240   -0.07  (-0.20 to 0.05)      -0.06±0.05  =0.26      
__________________________________________________________________________ 
*Adjustments are for age, mean arterial pressure, body weight, height (for LVM indexed for 
BSA), the presence of diabetes mellitus or an HbA1C>6.1%, pulse rate, treatment for 
hypertension, regular tobacco use, and regular alcohol intake. Probability values are derived 
after further adjustments for the non-independence of family members. †(Augmentation 
pressure/aortic pulse pressure) x 100, ††(Pressure at the second systolic peak of the aortic 
pulse wave/Pressure at the first systolic peak of the aortic pulse wave) x 100. ‡p<0.005 vs 
partial r value for women. #p<0.005 vs β-coefficient for women. 
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Figure 2.3. Multivariate adjusted left ventricular mass indexed for body surface area (BSA) 
(LVMI in g/m2) or height2.7 (LVMI in g/m2.7) across quartiles of aortic augmentation index 
([Pressure at the second systolic peak of the aortic pulse wave/Pressure at the first systolic 
peak of the aortic pulse wave] x 100) in men and women from a community sample. 
Adjustments are for age, mean arterial pressure, body weight, body height (for LVM indexed 
for BSA), the presence of diabetes mellitus or an HbA1C>6.1%, pulse rate, treatment for 
hypertension, regular tobacco use, and regular alcohol intake. Probability values are derived 
after further adjustments for the non-independence of family members. p for trend effects: 
LVM indexed for BSA; men, p<0.0005, women, p=0.17; , LVM indexed for height2.7; men, 
p=0.0001, women, p=0.32. See Table 2 for comparison of relationships between men and 
women. *p<0.001, **p<0.0005 vs quartile1, †p<0.05, ††p<0.005 vs quartile 2, #p<0.05, 
##p<0.01 vs quartile 3. 
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In participants not receiving antihypertensive therapy, an independent relationship between 
AIx (P2/P1) and LVMI-BSA was noted in men (n=239, partial r=0.16, p<0.05), whilst no 
relationship between AIx and LVMI-BSA was noted in women (n=364, partial r=-0.02, 
p=0.76)(p<0.05 for comparison using z-statistics). Moreover, in participants not receiving 
antihypertensive therapy, a trend for an independent relationship between AIx (P2/P1) and 
LVM indexed for height2.7 was noted in men (partial r=0.13, p=0.05), whilst no relationship 
between AIx and LVM indexed for height2.7 was noted in women (partial r=-0.003, p=0.96). 
 
2.4.4 Relationships between AIx and LV remodelling or LVH. 
 
In neither men (AIx [AP/PPc], Odds ratio=1.029, Wald statistics=2.31, p=0.13; AIx 
[P2/P1], Odds ratio=1.013, Wald statistics=1.70, p=0.19) nor in women (AIx [AP/PPc], Odds 
ratio=0.99, Wald statistics=0.65, p=0.42; AIx [P2/P1], Odds ratio=1.00, Wald statistics=0.001, 
p=0.98), was AIx independently associated with LVH (concentric + eccentric) (Table 4). No 
relations between AIx and concentric LV remodelling or AIx and the type of LVH (eccentric 
versus concentric) were noted in either men or women (data not shown). 
 
2.5 Discussion 
 
The main finding of the present study is that in a large, community-based sample, AIx 
was associated with LVMI in men, but not in women. Although there is considerable debate 
as to the factors that determine AIx (Davies et al 2010, Cheng et al 2012, Hughes et al 
2013), this does not detract from the evidence provided from several studies demonstrating 
that AIx is associated with cardiovascular damage beyond brachial BP (London et al. 2001, 
Ueda et al 2004, Weber et al 2005, Chirinos et al 2005, Wang et al 2010, Chirinos et al 2012, 
Vlachopoulos et al 2010, Hashimoto et al 2007, Hashimoto et al 2006). However, as in some 
studies AIx does not predict cardiovascular outcomes (Vlachopoulos et al 2010, Mitchell et al 
2010a, Hayashi et al 2014) the possible factors that influence this relationship require 
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identification. In this regard, although AIx predicts outcomes in men, similar relationships may 
be diminished in women (Wang et al 2010). The present study provides support for a 
decrease in the relationship between AIx and end-organ damage in women as compared to 
men. This is in contrast to the comparable unadjusted relations previously demonstrated 
between AIx and LVMI or alternative end-organ changes between men and women in a large 
community-based study (Wang et al 2010). However, whether in that study (Wang et al 
2010) similar relations between AIx and end-organ changes were also noted in men and 
women after multivariate adjustments is unclear (Wang et al 2010). 
Previous studies that have demonstrated that AIx derived from radial applanation 
tonometry is independently associated with LVM reduction, or LVH, (Hashimoto et al 2007, 
Hashimoto et al 2006) were not statistically powered to report on whether these associations 
were sex-specific. Interestingly however, in both studies 70% or more of study participants 
were men (Hashimoto et al 2007, Hashimoto et al 2006). Hence, both of these studies 
(Hashimoto et al 2007, Hashimoto et al 2006)  may reflect a dominant impact of AIx on LVMI 
in men. 
 An explanation for the gender-specific impact on relations between AIx and LVMI 
noted in the present study, or between AIx and cardiovascular outcomes in a previous study 
(Wang et al 2010), requires consideration. In this regard, in contrast to what was previously 
thought, AIx is not an appropriate index of wave reflection (Davies et al 2010, Cheng et al 
2012, Hughes et al 2013). Rather, unlike more suitable indices of wave reflection, AIx may be 
influenced by aortic reservoir function (Davies et al 2010), left ventricular systolic function 
(Cheng et al 2012), as well as height and female gender (Davies et al 2010). Some of these 
factors may have little impact on cardiovascular risk. Indeed, measures of reflective wave 
function are better risk markers than AIx (Wang et al 2010, Mitchell et al 2010a). 
Alternatively, although aortic PP is associated with cardiovascular damage, reflective wave 
function may contribute little toward the impact of aortic PPc on cardiovascular damage in 
women. Indeed, in a large, community-based study, both AIx and the reflection index 
predicted cardiovascular outcomes in men, but not in women (Wang et al 2010). Hence, 
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further studies are required to establish whether the sex-specific relations between AIx and 
LVMI or alternative end-organ changes are attributed to the poor relationship between AIx 
and reflective wave function (Davies et al 2010, Cheng et al 2012, Hughes et al 2013), or to 
the lack of impact of reflective waves on end-organ changes in women as compared to men. 
 Several differences were noted between men and women in the present study, 
differences which may account for the sex-specific effects of AIx on LVMI. In this regard, 
more women than men were obese or had diabetes mellitus or an abnormal HbA1c and 
hence obesity or diabetes mellitus may play a more important role than BP in mediating 
increases in LVMI in women. In addition, although a similar proportion of men and women 
were hypertensive, fewer hypertensive men were receiving antihypertensive medication. 
Hence, the sensitivity to detect an impact of AIx on LVMI may have been greater in men than 
in women.  
 The clinical implication of the present study is that when considering the contribution 
of central aortic haemodynamic measurements as predictors of cardiovascular damage, AIx 
may serve as an appropriate predictor in men, but not in women. Hence, in women, either 
aortic BP per se may be a better aortic haemodynamic index to predict damage beyond 
brachial BP, or wave separation analysis may be required to identify the impact of reflective 
waves on cardiovascular damage. 
 The limitations of the present study are as follows: First, the cross-sectional nature of 
the study precludes conclusions being drawn regarding cause and effect. Second, in the 
present study calibration of the radial waveform from brachial BP measurements ignores 
amplification of BP from brachial to radial arteries. Hence, aortic pressures are likely to have 
been underestimated using the current approach. Third, because the present study was 
community-based, only a small proportion of participants had LVH. Hence, we were not 
statistically powered to show sex-specific relations between AIx and LVH. Thus, further 
studies are necessary in untreated hypertensives to evaluate whether the relationship 
between AIx and LVH is sex-specific. Last, the present study was conducted in one ethnic 
group. Hence further studies in communities of alternative ethnic origins are required. 
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In conclusion, in the present study I show that despite an independent relationship 
between aortic BP and LVMI in both men and women, AIx is independently associated with 
LVMI in men, but not in women. These data suggest that AIx may not be an appropriate 
predictor of the extent of cardiovascular end-organ changes in women. 
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                  CHAPTER 3 
 
 
The Relationship Between Aortic Reflected Waves, Derived From Wave 
Separation Analysis, and Aortic Pulse Pressure or Left Ventricular Mass Index 
is Not Gender-Specific 
 
This chapter has been published as a component of the following paper: 
 
Hendrik L Booysen, Angela J Woodiwiss, Moekanyi J Sibiya, Bryan Hodson, Andrew 
Raymond, Elena Libhaber, Pinhas Sareli, Gavin R Norton. Indexes of aortic pressure 
augmentation markedly underestimate the contribution of reflected waves toward variations 
in aortic pressure and left ventricular mass. Hypertension 2015;65:540-546 
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3.1 Abstract 
 
Although indices of aortic wave reflection enhance risk prediction, the extent to which 
measures of aortic systolic pressure augmentation (augmented pressures [Pa] or 
augmentation index [AIx]) underestimate the effects of reflected waves on cardiovascular risk 
in women is uncertain. From a community sample (age>16 years) I therefore evaluated sex-
specific contributions of reflected (backward wave pressures [Pb] and the reflection index 
[RI]) versus augmented (Pa and AIx) pressure wave indices to variations in central aortic 
pulse pressure (PPc) (n=1185, 65.0% women), and left ventricular mass index (LVMI [n=793, 
64.9% women]). Aortic haemodynamics and LVMI were determined using radial applanation 
tonometry (SphygmoCor) and echocardiography. In both women and in men, independent of 
confounders, RI and Pb contributed more than forward wave pressures (Pf), whilst Pa and 
AIx contributed less than incident wave pressure (Pi) to variations in PPc (p<0.0001 for 
comparison of partial r values). In both men and in women Pb contributed more than Pf 
(p<0.05 for comparison of r values) to variations in LVMI. Although in men Pa (partial r=0.33, 
p<0.0001) contributed to a similar extent as Pi (partial r=0.34, p<0.0001) to variations in 
LVMI, in women Pa (partial r=0.05, p=0.36) failed to contribute to LVMI, whilst Pi was 
significantly associated with LVMI (partial r=0.30, p<0.0001). Similar results were obtained 
with AIx as opposed to Pa in the regression models. In conclusion, the contribution of aortic 
backward wave pressures to variations in aortic PP and LVMI is similar in women as it is in 
men; in both women and in men indices of aortic pressure augmentation markedly 
underestimate the contribution of aortic backward wave pressures to variations in LVMI; and 
in women this effect is sufficiently marked that augmentation indices are unrelated to LVMI. 
 
Key words: Central blood pressure, aortic pulse pressure, reflected waves, augmentation 
index, left ventricular mass index. 
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3.2 Introduction 
 
Although pulse pressure (PP) measured at the brachial artery is closely correlated 
with central aortic PP (PPc), PP may be considerably higher in brachial arteries as compared 
to the aorta (Aviolo et al 2009, Agabiti-Rosei et al 2007). A key determinant of PPc is an 
increase in aortic wave reflection, which enhances backward wave pressures (Pb) and hence 
augments aortic systolic blood pressure (BP) if returning to the ascending aorta sufficiently 
early (Aviolo et al 2009, Agabiti-Rosei et al 2007). An enhanced aortic wave reflection is 
thought to be a major cause of cardiovascular damage. Indeed, several studies have 
demonstrated that aortic augmented pressures (Pa), and augmentation index (AIx), indexes 
of wave reflection, are associated with cardiovascular outcomes (London et al 2001, Ueda et 
al 2004,Weber et al 2005, Chirinos et al 2005, Davies et al 2010, Vlachopoulos et al 2010, 
Cheng et al 2012) and end-organ damage (Hashimoto et al 2007, Hughes et al 2013, 
Hashimoto et al 2006, Fok et al 2014a, Weber et al 2006, Torjesen et al 2014, Westerbacka 
et al 2005, Sibiya et al 2014) independent of brachial BP. However, more recently the use of 
Pa or AIx as indexes of wave reflection in risk prediction has been challenged (Davies et al 
2010, Cheng et al 2012, Hughes et al 2013). 
Marked overlap between aortic forward and reflected waves may confound Pa and 
AIx and hence these measures may be poor indexes of wave reflection (Davies et al 2010, 
Cheng et al 2012, Hughes et al 2013). Indeed, there is a weak relationship between the 
magnitude of the reflected wave and Pa or AIx, and increases in aortic reservoir function, the 
timing or magnitude of the forward (Pf) or incident (Pi) wave pressures, and left ventricular 
systolic function may play a more important role than wave reflection in contributing to 
variations in Pa and AIx (Davies et al 2010, Cheng et al 2012, Hughes et al 2013). More 
recent studies have therefore focused on the role of reflected waves (Pb and reflected wave 
index-RI), as determined using wave separation analysis, as independent determinants of 
age-related increases in PPc or cardiovascular damage (Wang et al 2010, Chirinos et al 
2012, Weber et al 2012, Mitchell et al 2010b). However, in these studies (Wang et al 2010, 
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Chirinos et al 2012, Weber et al 2012, Mitchell et al 2010b) the extent to which Pb or RI are 
more closely associated with PPc or cardiovascular damage than Pa or AIx is uncertain. In 
this regard in these studies, relations with end-organ damage were not adjusted for 
confounders (Wang et al 2010, Chirinos et al 2012, Weber et al 2012); discrepancies in the 
index of wave reflection that was better associated with end-organ damage beyond forward 
wave pressures were noted (Wang et al 2010, Chirinos et al 2012, Weber et al 2012); and 
forward wave pressure rather than Pb was reported to be the main determinant of PPc in a 
community sample with a high prevalence of well-controlled BP values (Mitchell et al 2010b). 
In the previous chapter and recently reported on (Sibiya et al 2014), I have demonstrated that 
Pa and AIx associate with left ventricular mass index (LVMI) and left ventricular hypertrophy 
(LVH) in men, but not in women. However, in that study (Sibiya et al 2014, chapter 2), I did 
not have access to wave separation analysis to determine the actual relationship between 
aortic reflected (backward) waves and LVMI. As the manufacturer of the measurement 
system that I employed to determine aortic function (SphygmoCor) has recently developed 
the software to perform wave separation analysis, in the present study I aimed to determine 
whether the lack of association between Pa or AIx and LVMI or LVH can be attributed to a 
lack of impact of aortic backward waves on aortic PP or LVMI, or because Pa and AIx are 
poor indices of backward wave effects in women as opposed to men. 
 
3.3 Methods 
 
3.3.1 Study group. 
 
The present study was conducted according to the principles outlined in the Helsinki 
Declaration. The Committee for Research on Human Subjects of the University of the 
Witwatersrand approved the protocol (approval number: M02-04-72 and renewed as M07-04-
69 and M12-04-108). Participants gave informed, written consent. The present study design 
has previously been described (Norton et al 2008, Woodiwiss et al 2009, Redelinghuys et al 
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2010, Norton et al 2012). Briefly, 1185 participants from families of black African descent 
(Nguni and Sotho chiefdoms) with siblings older than 16 years with central haemodynamic 
measurements were randomly recruited from the South West Township (SOWETO) of 
Johannesburg, South Africa. In a sub-study, 793 participants had LVMI determined using 
echocardiography. 
 
3.3.2 Clinical, demographic and anthropometric measurements. 
 
For details see section 2.3.2 
 
3.3.3 Pulse wave analysis. 
 
For further details see section 2.3.4. Aortic Pb and Pf were determined using 
SphygmoCor software which separates the aortic waveform using a triangular flow wave 
(Westerhof et al 2006). In the present study we did not employ a “physiological aortic flow 
waveform” approach to wave separation analysis as in a pilot study conducted in 26 
participants, the previously described physiological aortic flow waveform did not closely 
approximate aortic flow waveforms in the present community sample. Moreover, a wide 
variety of aortic flow waveforms were identified in the 26 participants studied, precluding the 
possibility of identifying a single “representative waveform” which could be used for wave 
separation analysis. Reflected wave index (RI) was determined as previously described 
(Hughes et al 2013). Aortic augmented pressure (Pa) was determined using SphygmoCor 
software and identified as the difference between SBPc and the first systolic peak of the 
aortic pulse wave. Incident wave pressure (Pi) was defined as PPc-Pa. To avoid obtaining 
negative aortic AIx values in young participants, AIx was determined as the pressure at the 
second systolic peak of the aortic pulse wave/the pressure at the first systolic peak of the 
aortic pulse wave expressed as a percentage. 
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3.3.4 Echocardiography. 
 
For details see section 2.3.5 Acceptable quality of images was considered to exist 
when appropriate visualization of both the right and the left septal surfaces occurred and 
where the endocardial surface of the septal and posterior wall were clearly visible when 
imaging at the optimal angle of incidence (perpendicular to the posterior wall) and close to 
the mitral leaflets. Left ventricular mass was determined using a standard formula (Devereux 
et al 1986) and indexed (LVMI) to body surface area (LVMI-BSA) or height1.7 (LVMI-ht1.7). Left 
ventricular hypertrophy (LVH) was identified as an LVMI-BSA>95 g/m2 for women and >115 
g/m2 for men. Stroke volume was evaluated from the difference between LV end diastolic and 
systolic volumes determined using the Z-derived method (de Simone et al 1996). 
 
3.3.5 Statistical analysis. 
 
For database management and statistical analysis, SAS software, version 9.1 (SAS 
Institute Inc., Cary, NC) was employed. To determine relationships multivariate regression 
analysis was performed with appropriate adjustments. Adjustments included in multivariate 
models were those correlated with central hemodynamic variables or LVMI in bivariate 
analysis. To assess the relative contribution of incident and augmented waves to variations in 
PPc, in stepwise regression analysis, Pi and AIx were included in multivariate models. AIx 
rather than Pa was included in the same regression model with Pi to avoid the confounding 
effect of forward wave amplitude on the amplitude of the augmented wave (Mitchell et al 
2010b). To determine probability values, further adjustments for non-independence of family 
members was performed using non-linear regression analysis (mixed procedure as defined 
in the SAS package). To ensure that relationships occurred independent of the use of 
antihypertensive therapy, sensitivity analysis was conducted in participants not receiving 
antihypertensive therapy. Regression coefficients were compared with z statistics. 
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3.4 Results 
 
3.4.1 Characteristics of the participants. 
 
The clinical and demographic characteristics of the participants are shown in Table 
3.1. 1.9% of participants had a history of cardiovascular disease. Importantly, a high 
proportion (45.9%) of participants had hypertension, and 47.2% of hypertensives were not 
receiving therapy. Moreover, 36.4% of all participants and 60.6% of participants receiving 
antihypertensive therapy had uncontrolled hypertension. Of the participants with 
echocardiography, 17% had LVH. Although of a similar age, women were more obese, had a 
higher prevalence of DM, and a higher pulse rate, but regularly smoked or consumed alcohol 
less, and more were receiving antihypertensive therapy than men. Women had higher values 
for indices of wave reflection (Pb, RI, Pa and AIx). 
 
3.4.2 Age-related increases in aortic hemodynamics. 
 
In multivariate-adjusted models, including adjustments for mean arterial pressure  
(MAP), all aortic haemodynamic parameters were independently associated with age (Table 
3.2). In both men and in women the association between age and Pa was stronger (partial r) 
than the association between age and Pi (Table 3.2). However, in men the strength (partial r) 
of the association between age and either aortic forward or backward wave pressures was 
similar, whilst in women the association between age and aortic backward wave pressures 
was stronger than the association with forward wave pressures (Table 3.2). 
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Table 3.1. Characteristics of the study sample. 
Characteristics         All                  Women  Men 
      (n=1185)      (n=771)          (n=414) 
____________________________________________________________________ 
% Female              65.0          -      - 
Age (years)                  44.3±18.3   44.8±17.6      43.3±19.4 
Body mass index (kg/m2)                         29.6±8.1   32.0±8.2***      24.9±5.2 
% Obese                    43.3        57.8***         16.2 
Regular tobacco (% subjects)                       15.2          5.8***         32.7 
Regular alcohol (% subjects)              20.9        13.6***            34.6 
% with DM or HbA1c>6.1%                                 25.8        28.8**         20.3 
% Hypertensive          45.9         45.9         45.8 
% Treated for hypertension               24.2         28.1***         16.7 
% Hypertensives controlled to target BP             20.8         24.9***         12.7 
% of all with uncontrolled BP               36.4         34.5               39.9 
Pulse rate (beats/min)                                        66±12                 68±11***         63±11 
Brachial SBP/DBP (mm Hg)                      130±22/84±13    129±23*/83±13**  131±21/85±12 
Brachial pulse pressure (mm Hg)                       46±16                44±16              46±18         
Brachial mean arterial pressure (mm Hg)         100±16              100±17            101±15    
Central aortic SBP (mm Hg)                             120±23               119±23            122±23 
Central aortic pulse pressure (PPc) (mm Hg)    35±15                  35±14         35±17 
Aortic forward wave pressure (Pf) (mm Hg)       24±9                    24±9*         25±9  
Aortic reflected wave pressure (Pb)(mm Hg)      17±8                   17±8         17±9 
Aortic reflected wave index                             0.16±0.06            0.16±0.06      0.15±0.06  
Aortic augmented pressure (Pa)                         11±8                   11±8**            10±8 
Aortic Pi                                                               25±9                   24±8**         26±10 
Aortic augmentation index (AIx) (%)                  142±25               146±26***      135±23 
Stroke volume (mls)(n)                                      63±17 (793)       60±17*** (515)    67±17 (278) 
Left ventricular mass index (g/m2)(n)                 76±31 (793)       72±29*** (515)   82±33 (278) 
Left ventricular mass index (g/m1.7)(n)                67±24 (793)       67±24 (515)   68±25 (278) 
____________________________________________________________________                          
Data expressed as mean ± SD or proportions. DM, diabetes mellitus; HbA1C, glycosylated 
haemoglobin; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; Pi=PPc-Pa. 
*p<0.05,**p<0.005, ***p<0.0005 versus men.  
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Table 3.2 Multivariate adjusted relations between age and central aortic hemodynamics in 
sex-specific categories in a group of African ancestry (n=1185). 
 
    Age versus                    Estimate (mm Hg)*       partial r (95% CI)      p-value 
                      (±SEM)   
____________________________________________________________________ 
Women (n=771) 
Forward wave pressure (Pf)                     0.27±0.06       0.15 (0.08 to 0.22) <0.0005  
Reflected wave pressure (Pb)         0.94±08           0.39 (0.32 to 0.44)† <0.0001  
Reflected wave index (RI=Pb/Pf)              120±10            0.41 (0.35 to 0.47) <0.0001 
Aortic Pi                                                      0.40±0.07          0.21 (0.14 to 0.28)       <0.005 
Aortic augmented pressure (Pa)                 1.17±0.08         0.44 (0.38 to 0.49)†      <0.0001 
Aortic augmentation index (AIx)         0.20±0.02        0.30 (0.24 to 0.37) <0.0001 
Stroke volume (n=515)          0.06±0.04        0.07 (-0.01 to 0.16)         =0.09 
Men (n=414) 
Forward wave pressure (Pf)                     0.46±0.09        0.24 (0.15 to 0.33) <0.0001  
Reflected wave pressure (Pb)         1.30±0.10         0.24 (0.15 to 0.33) <0.0001  
Reflected wave index (Pb/Pf)                      169±12           0.57 (0.50 to 0.63) <0.0001 
Aortic Pi                                                       0.46±0.09         0.26 (0.16 to 0.34)       <0.0001 
Aortic augmented pressure (Pa)                 1.47±0.10          0.57 (0.51 to 0.64)†     <0.0001 
Aortic augmentation index (AIx)          0.45±0.04        0.52 (0.45 to 0.59) <0.0001 
Stroke volume (n=278)           0.07±0.06        0.07 (-0.04 to 0.19)         =0.22 
____________________________________________________________________ 
CI, confidence intervals; Pi=Aortic pulse pressure-Pa. *β-coefficient (slope) of the relations. 
Pi=aortic pulse pressure-Pa. Adjustors are mean arterial pressure, body height, body weight, 
pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol intake. 
†p<0.0001 for comparisons of partial r values with Pf. 
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3.4.3 Relative independent contribution of reflected versus forward waves to variations in 
PPc. 
 
When included in separate models (Table 3.3) or in the same multivariate stepwise 
models (Figure 3.1), in both women and in men a stronger relationship was noted between 
RI and PPc or Pb and PPc than between Pf and PPc or AIx and PPc. In contrast, in both 
women and in men a stronger relationship was noted between Pi and PPc, than between Pa 
and PPc (Table 3.3) or between AIx and PPc (Table 3.3, Figure 3.1). In both women and in 
men with RI and AIx in the same multivariate model, a distinctly stronger relationship was 
noted between RI and PPc than between AIx and PPc (Figure 3.1). Similar findings were 
noted in participants not receiving antihypertensive therapy (Table 3.4). Stroke volume was 
modestly correlated with PPc (r=0.20, p<0.0001). With the inclusion of stroke volume in 
multivariate models, similar differences between aortic hemodynamic-PPc relations were 
noted (Table 3.5). 
 
3.4.4 Comparison of independent relations between aortic hemodynamics and LVMI. 
 
In both men and in women Pb was more closely associated with LVMI than Pf (Figure 
3.2). In a multivariate model in women with Pb and Pf in the same model, Pb (partial r=0.32, 
CI=0.22 to 0.40, p<0.0001), but not Pf (partial r=0.02, CI=-0.06 to 0.10, p=0.59) was 
independently associated with LVMI. Similarly, in a multivariate model in men with Pb and Pf 
in the same model, Pb (partial r=0.34, CI=0.22 to 0.45, p<0.0001), but not Pf (partial r=0.02, 
CI=-0.10 to 0.13, p=0.75) was independently associated with LVMI. In contrast however, in 
men Pa showed similar associations with LVMI as did Pi and in women Pi, but not Pa was 
independently associated with LVMI (Figure 3.2). In addition, RI was more closely associated 
with LVMI than AIx in both men and in women (Figure 3.2). Importantly, although the 
relations between Pa or AIx and LVMI were stronger in men than in women (p=0.01 to 
0.0001 for comparison of r values) (Figure 3.2), these differences were not attributed to  
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Table 3.3 Independent relationships between aortic hemodynamics and central aortic pulse 
pressure (PPc) in women versus men of African ancestry. 
 
        Women (n=771)          Men (n=414) 
PPc vs          partial r (CI)*        p value          partial r (CI)*         p value 
__________________________________________________________________ 
Pb        0.97 (0.90 to 1.04)†  <0.0001      0.92 (0.82 to 1.02)†   <0.0001 
Pf        0.80 (0.73 to 0.87)   <0.0001      0.75 (0.65 to 0.85)    <0.0001 
Pa       0.88 (0.81 to 0.95)    <0.0001      0.90 (0.80 to 1.00)    <0.0001 
Pi       0.90 (0.83 to 0.97) #    <0.0001      0.94 (0.84 to 1.04) #    <0.0001 
RI       0.88 (0.81 to 0.95) $   <0.0001      0.86 (0.76 to 0.96) $    <0.0001 
AIx       0.02 (-0.05 to 0.09)    =0.46      0.34 (0.24 to 0.44)    <0.0001 
__________________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are age, 
mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus or an 
HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for comparisons of 
partial r values with Pf, # p<0.05, ##p<0.005 for comparisons of partial r values with Pa, 
$p<0.0001 for comparisons of partial r values with AIx (z-statistics). 
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Table 3.4 Independent relationships between aortic hemodynamics and central aortic pulse 
pressure (PPc) in women and men of group of African ancestry not receiving 
antihypertensive therapy. 
 
PPc vs             Women (n=554)                  Men (n=342) 
  partial r (CI)*  p value partial r (CI)*  p value 
___________________________________________________________________ 
Pb  0.97 (0.89 to 1.05)†  <0.0001  0.89 (0.78 to 0.99)†  <0.0001 
Pf  0.83 (0.75 to 0.91)   <0.0001  0.70 (0.59 to 0.81)   <0.0001 
Pa  0.85 (0.77 to 0.93)   <0.0001  0.90 (0.79 to 1.01)   <0.0001 
Pi  0.88 (0.80 to 0.96)#  <0.0001  0.94 (0.83 to 1.05)## <0.0001 
RI  0.88 (0.80 to 0.96)$  <0.0001  0.83 (0.72 to 0.94)$  <0.0001 
AIx            -0.01 (-0.09 to 0.08)  =0.84  0.33 (0.22 to 0.44)   <0.0001 
___________________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are age, 
mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus or an 
HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for comparisons of 
partial r values with Pf, #p<0.05,##p<0.0005 for comparisons of partial r values with Pa, 
$p<0.0001 for comparison of partial r values with AIx (z-statistics). 
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Figure 3.1. Relative contribution of aortic hemodynamic variables to variations in central 
(aortic) pulse pressure (PPc) in sex-specific groups in a group of African descent. Closed 
circles indicate indexes of wave reflection; open circles indicate indexes of forward or 
incident wave pressures. Data show multivariate adjusted correlation coefficients (partial r) 
derived from stepwise regression analysis with Pf and Pb (model 1), Pf and RI (model 2), Pi 
and AIx (model 3), or RI and AIx (model 4) + confounders included in the same regression 
models. Potential confounders included in the model are age, mean arterial pressure, body 
height, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and 
regular alcohol intake. Those factors not independently associated with PPc were forced into 
the model. Pi=Aortic pulse pressure-Pa. *p<0.0001 for comparisons of partial r values with Pf 
or AIx (z-statistics). 
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Table 3.5. Impact of adjustments for stroke volume (SV) on the independent relationships between indexes of aortic wave reflection and central 
aortic pulse pressure (PPc) in women and men of African ancestry. 
 
PPc vs                       Women (n=515)               Men (n=278) 
SV adjusted      Before            After         Before            After 
  partial r (CI)*   p value        partial r (CI)*    p value  partial r (CI)*       p value       partial r (CI)*       p value 
_______________________________________________________________________________________________________ 
Pb  0.97 (0.88 to 1.05)†  <0.0001      0.97 (0.88 to 1.05)†  <0.0001 0.89 (0.77 to 1.01)†  <0.0001   0.89 (0.77 to 1.01)†  <0.0001            
Pf  0.78 (0.69 to 0.86)  <0.0001      0.78 (0.69 to 0.86)  <0.0001 0.69 (0.57 to 0.81)  <0.0001   0.69 (0.57 to 0.81)  <0.0001                    
Pa            0.86 (0.77 to 0.94)  <0.0001      0.86 (0.77 to 0.94)  <0.0001 0.91 (0.79 to 1.03)  <0.0001   0.91 (0.79 to 1.03)  <0.0001            
Pi            0.90 (0.81 to 0.99)##  <0.0001      0.90 (0.81 to 0.99)##  <0.0001 0.95 (0.83 to 1.07)#  <0.0001   0.95 (0.83 to 1.07)#  <0.0001            
RI            0.87 (0.78 to 0.95)$  <0.0001      0.87 (0.78 to 0.95)$  <0.0001 0.84 (0.72 to 0.96)$  <0.0001   0.84 (0.72 to 0.96)$  <0.0001            
AIx           -0.04 (-0.12 to 0.04)  =0.19     -0.03 (-0.12 to 0.05) =0.26  0.46 (0.34 to 0.58)  <0.0001   0.46 (0.34 to 0.58)  <0.0001            
_______________________________________________________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are stroke volume (as indicated), age, mean arterial pressure, 
body height, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, #p<0.01,##p<0.005 for comparison of partial r values with Pa, $p<0.0001 for comparison of partial r values 
with AIx (z-statistics). 
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Figure 3.2. Contribution of aortic hemodynamic variables to variations in left ventricular mass 
indexed to body surface area (LVMI-BSA) in sex-specific categories in a group of African 
descent. Closed circles indicate indexes of wave reflection; open circles indicate indexes of 
forward or incident wave pressures. Potential confounders included in the model are age, 
mean arterial pressure, body height, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular 
smoking and regular alcohol intake. Those factors not independently associated with LVMI 
were forced into the model. Pi=Aortic pulse pressure-Pa. *p<0.05 for comparisons of partial r 
values with Pf and AIx, †p<0.05 for comparison of partial r values with AIx, #p<0.05 for 
comparison of partial r values with Pa and AIx (z-statistics). 
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reflected wave effects. Indeed, Pb or RI-LVMI relations were similar in men and women 
(Figure 3.2). Similar findings were also noted in participants not receiving antihypertensive 
therapy (Table 3.6). Stroke volume was correlated with LVMI (r=0.64, p<0.0001). However, 
with further adjustments for stroke volume, relative differences in relations between reflected 
versus forward wave indexes and LVMI were retained (Table 3.7).   
 
3.5 Discussion 
  
The main findings of the present study are as follows: In a large (n=1185), 
community-based sample of African ancestry, independent of confounders including MAP 
(distending pressures), reflected waves (RI or Pb) accounted for more of the variation in PPc 
and LVMI than did forward wave pressures (Pf) in both women and men. However, incident 
wave pressure (Pi) accounted for more of the variation in PPc than did aortic systolic 
pressure augmentation (AIx or Pa) in both women and in men, and Pi accounted for as much 
of the variation in LVMI as Pa or AIx in men, whilst Pi, but not Pa or AIx accounted for 
variations in LVMI in women. 
Several prior studies have reported on a relatively greater contribution of Pa as 
compared to Pi to age-related increases in PPc (McEniery et al 2005, Namasivayam et al 
2009, Cecelja et al 2009). However, it is now recognised that Pa may be confounded by 
considerable overlap between forward and backward waves and that there is a poor 
relationship between the magnitude of the reflected wave and Pa (Davies et al 2010, Cheng 
et al 2012, Hughes et al 2013). Nevertheless, studies which have employed approaches to 
separate Pb from Pf, suggest that Pb contributes little to age-related increases in PPc 
(Mitchell et al 2010b, Segers et al 2007). These studies were nonetheless conducted either 
in a sample where BP values were largely well-controlled (Mitchell et al 2010b), or in a 
sample with a narrow age range. In contrast, using wave separation analysis in the present 
study  
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Table 3.6. Independent relationships between aortic hemodynamics and left ventricular mass 
indexed to body surface area (LVMI-BSA) in women and men of African ancestry not 
receiving antihypertensive therapy. 
 
   Women (n=354)       Men (n=231) 
LVMI-BSA vs      partial r (CI)* p value              partial r (CI)*  p value 
___________________________________________________________ 
Pb   0.34 (0.24 to 0.49)†  <0.0001   0.39 (0.26 to 0.52)†  <0.0001 
Pf   0.15 (0.05 to 0.25)   <0.005     0.17 (0.04 to 0.300  <0.01 
Pa   0.05 (-0.05 to 0.15)  =0.36      0.33 (0.20 to 0.46)   <0.0001 
Pi   0.30 (0.19 to 0.40)#  <0.0001   0.34 (0.21 to 0.47)  <0.0001 
RI   0.30 (0.20 to 0.40)$  <0.0001   0.39  (0.26 to 0.52)$ <0.0001  
AIx           -0.06 (-0.16 to 0.05)  =0.27       0.10 (-0.03 to 0.22)  =0.18 
____________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are age, 
mean arterial pressure, body height, body weight, pulse rate, diabetes mellitus or an 
HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.05 for comparisons of partial 
r values with Pf, #p<0.0001 for comparison of partial r values with Pa, $p<0.005 for 
comparison of partial r values with AIx (z-statistics). 
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Table 3.7 Impact of adjustments for stroke volume (SV) on the independent relationships between indexes of aortic wave reflection and left 
ventricular mass indexed to body surface area (LVMI-BSA) in women and men of African ancestry. 
 
 LVMI-BSA vs                          Women (n=515)               Men (n=278) 
SV adjusted      Before            After         Before            After 
  partial r (CI)*   p value        partial r (CI)*    p value  partial r (CI)*       p value       partial r (CI)*       p value 
_______________________________________________________________________________________________________ 
Pb  0.31 (0.22 to 0.40)†  <0.0001       0.15 (0.06 to 0.23)†  <0.0001 0.34 (0.22 to 0.45)†  <0.0001  0.22 (0.10 to 0.34)†  <0.0001          
Pf  0.08 (0.01 to 0.16)   <0.05       0.03 (-0.05 to 0.11)  =0.33 0.14 (0.02 to 0.25)   <0.05  0.06 (-0.06 to 0.17)  =0.18          
Pa          0.03 (-0.05 to 0.11)  =0.40       0.01 (-0.07 to 0.09)  =0.72 0.31 (0.19 to 0.42)  <0.0001  0.21 (0.09 to 0.33)   <0.0001          
Pi           0.29 (0.20 to 0.37)##  <0.0001      0.15 (0.06 to 0.23)#  <0.0001 0.30 (0.18 to 0.41)  <0.0001  0.18 (0.06 to 0.29)   <0.0001          
RI           0.30 (0.21 to 0.38)$  <0.0001       0.14 (0.05 to 0.22)$  <0.0001 0.35 (0.23 to 0.46)$  <0.0001  0.22 (0.10 to 0.33)$  <0.0001          
AIx          -0.07 (-0.15 to 0.01)   =0.08      -0.05 (-0.14 to 0.03)  =0.11 0.12 (0.01 to 0.23)   <0.05  0.10 (-0.01 to 0.22)  =0.10          
_______________________________________________________________________________________________________ 
CI, confidence intervals. See tables 1 and 2 for further abbreviations. *Adjustors are stroke volume (as indicated), age, mean arterial pressure, 
body height, body weight, pulse rate, diabetes mellitus or an HbA1c>6.1%, regular smoking and regular alcohol intake. †p<0.0001 for 
comparisons of partial r values with Pf, #p<0.01,##p<0.0005 for comparison of partial r values with Pa, $p<0.0001 for comparison of partial r 
values with AIx (z-statistics). 
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conducted in a community sample with a wide age range and with a high prevalence of 
uncontrolled hypertension, I show that Pb has a far stronger relationship with PPc than Pf, and 
that these associations occurred independent of gender. Hence, the present study provides the 
first direct evidence to show that in both women and in men reflected waves account for more of 
the variation in PPc than do forward wave pressures and that indexes of aortic pressure 
augmentation underestimate the contribution of aortic wave reflection to variations in PPc. 
 A few prior studies have suggested that indexes of reflected waves derived from wave 
separation analysis (Pb or RI) are more closely associated with end-organ damage than 
augmented pressure indexes (Pa and AIx) (Wang et al 2010, Weber et al 2012). However, in 
neither study were these comparisons made with adjustments for confounders. Hence, the 
differences reported on (Wang et al 2010) may be attributed to confounders including distending 
pressures and heart rate. Furthermore, in one study (Weber et al 2012) no comparisons were 
made between correlation coefficients and similar relations were noted between reflected wave 
indices derived from wave separation analysis and end-organ changes as compared to relations 
between indices of aortic systolic pressure augmentation and end-organ changes (Weber et al 
2012). In the present study I provide clear evidence that relations between indices of wave 
reflection and LVMI were markedly stronger than forward wave pressure effects, whilst indices 
of aortic systolic pressure augmentation considerably underestimated the contribution of 
reflected as compared to forward wave pressures. As previously described (chapter 2, Sibiya et 
al 2014), the lack of ability of augmentation indices to independently relate to LVMI was 
particularly striking in women where no significant relations were noted, whilst in men, although 
the effect was still diminished, a significant relation was still noted. Importantly, the present 
study advances this previous work by demonstrating that differences in the independent 
relationships between aortic augmentation indices and LVMI are not attributed to a sex-specific 
effect of aortic backward wave pressures on LVMI. 
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Prior studies have demonstrated that impact of aortic pressure augmentation on end-
organ changes (Sibiya et al 2014) or cardiovascular outcomes (Wang et al 2010) is attenuated 
in women as compared to men. In the present study we similarly show that relations between 
Pa or AIx and LVMI were diminished in women as compared to men. However, these 
differences were not attributed to disparities in reflected wave effects. Indeed, Pb or RI-LVMI 
relations were similar in men as compared to women. Hence, the weaker associations between 
augmentation indexes and cardiovascular damage in women as compared to men (Sibiya et al 
2014, Wang et al 2010) are likely to be attributed to a greater degree of inaccuracy of pressure 
augmentation as an index of wave reflection in women as compared to men. 
Increases in indices of augmentation index are not just determined by increases in 
reflected wave magnitude, but also by an enhanced aortic reservoir function as well as factors 
that influence the forward traveling wave amplitude (Chirinos et al 2005, Davies et al 2010, 
Vlachopoulos et al 2010, Cheng et al 2012, Hashimoto et al 2007, Hughes et al 2013, 
Hashimoto et al 2006, Fok et al 2014a), the magnitude of the forward wave (Weber et al 2006, 
Torjesen et al 2014), forward wave peak width (Weber et al 2006, Torjesen et al 2014), and the 
slope of the backward wave upstroke (Weber et al 2006, Torjesen et al 2014). Although a 
shorter stature, and hence an earlier return of reflected waves has generally been the 
explanation for an increased AIx in women, more recently an increased forward wave peak 
width, slope of the backward pressure wave, and forward wave amplitude, but not backward 
wave amplitude have been suggested to be the main determinants of an increased AIx in 
women of the Framingham Heart study (Weber et al 2006). In this regard, if one or more of 
these factors contributes little to increases in LVMI, but influences augmentation indices in 
women more so than men, then this could explain the lack of relationship between aortic 
augmentation indices and LVMI in women, whilst a significant relationship was still noted in 
men. As the manufacturer’s software does not allow for the determination of the forward wave 
peak width or slope of the backward pressure wave, I could not assess whether one or more of 
- - 69 - 
 
  
these additional factors modified the relationship between augmentation indices and LVMI to a 
greater extent in women as compared to men.  
 As previously demonstrated (Kips et al 2009) the assumptions intrinsic to the use of the 
‘triangulation method’ of aortic wave separation are not ideal. However, this approach produces 
correlations between reflected wave indexes derived from the ‘triangulation method’ and actual 
aortic flow waveforms (r2=0.55) that are considerably stronger than between AIx and indexes 
derived from actual aortic flow waveforms (r2=0.34) (Kips et al 2009). Thus, the triangulation 
method of wave separation is better than augmentation indices at identifying reflected wave 
effects. Despite employing a relatively imprecise method of identifying reflected wave magnitude 
and index, we were still able to show that indices of aortic wave reflection were more closely 
associated with PPc and LVMI than forward wave pressures, whilst indices of aortic pressure 
augmentation showed weaker associations than forward wave pressures with PPc and LVMI. 
Hence, the present study provides evidence that improved measures of wave reflection are 
indeed better than augmentation indexes at detecting relations between reflected wave effects 
and both PPc and LVMI. 
 Dobutamine, which enhances PPc through increases in myocardial contractility and 
stroke volume, largely increases forward wave pressures (Fok et al 2014b). In contrast, 
norepinephrine, which augments PPc through marked vasoconstriction, mainly increases 
backward wave pressures but does not produce as much of an increase in PPc (Fok et al 
2014b). Further, increases in forward wave pressures may account for more of the increment in 
PPc in hypertensives than reflected wave pressures (Fok et al 2014b). It has therefore been 
suggested that forward wave pressures, mediated by increases in stroke volume may be more 
important than reflected wave pressures in determining variations in PPc in hypertension (Fok et 
al 2014b). However, as in the present and previous (Cecelja et al 2009, Segers et al 2007) 
studies where no increase (Segers et al 2007) or only modest increases (present study) in 
stroke volume were noted with increasing age, or where stroke volume contributed little to 
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variations in PPc (Cecelja et al 2009), increases in stroke volume are unlikely to explain a 
significant proportion of age-related increases in PPc in either women or men. Moreover, 
norepinephrine-induced effects on aortic reflected waves (Fok et al 2014b) are more likely to 
represent the hypertensive state where a major effect on BP is through increases in vascular 
smooth muscle tone. Further, in the present study the greater impact of Pb as compared to Pf 
on variations in PPc and LVMI were replicated even when stroke volume was included in 
multivariate adjusted analysis. 
 Additional limitations of the present study are as follows: The present study was a cross-
sectional design. Therefore, I cannot determine whether the age-related changes reported on 
are attributed to the long-term impact of age or a cumulative effect of alternative risk factors 
over time or whether relations between aortic hemodynamics and LVMI are indeed cause and 
effect. Further longitudinal studies are required to determine these effects. Moreover, in the 
present study calibration of the radial waveform from brachial BP measurements ignores 
amplification of BP from brachial to radial arteries. Hence, aortic pressures are likely to have 
been underestimated using the current approach. 
 In conclusion, in the present study conducted in a community sample with a high 
prevalence of uncontrolled hypertension, I show that in both women and in men, reflected 
waves are more closely associated with PPc and LVMI than forward waves, but that indices of 
aortic systolic pressure augmentation markedly underestimate these effects. These data provide 
support for a role of reflected wave function in mediating the adverse effects of aortic PP, effects 
which nonetheless cannot be accurately detected using indices of aortic systolic pressure 
augmentation. Moreover, given the high prevalence of hypertension and related cardiovascular 
events in urban communities in Africa, the present study suggests that approaches to 
decreasing age-related increases in aortic wave reflection may produce a major impact on the 
burden of disease in these communities. 
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              CHAPTER 4 
 
 
Reflected Rather than Forward Wave Pressures Account for Brachial 
Pressure-Independent Relations Between Aortic Pressure and End-Organ 
Changes in an African Community. 
 
 
This chapter has been published as follows: 
 
Moekanyi J Sibiya, Angela J Woodiwiss, Hendrik L Booysen, Andrew Raymond, Aletta ME 
Millen, Muzi J Maseko, Olebogeng HI Majane, Pinhas Sareli, Elena Libhaber, Gavin R Norton. 
Reflected Rather than Forward Wave Pressures Account for Brachial Pressure-Independent 
Relations Between Aortic Pressure and End-Organ Changes in an African Community. J 
Hypertens 2015;33:2083-2090 
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4.1 Abstract 
 
As the relative impact of aortic backward as compared to forward wave pressures on 
cardiovascular damage independent of brachial blood pressure (BP) is uncertain, I aimed to 
determine whether brachial BP-independent relations between aortic pressure and 
cardiovascular damage are better explained by reflected (backward)(Pb) or forward (Pf) wave 
pressure effects. In 1174 participants from a community sample of African ancestry I assessed 
central aortic pulse pressure (PPc), Pb and Pf (radial applanation tonometry, SphygmoCor 
software) as well as left ventricular mass index (LVMI)(n=786), aortic pulse wave velocity 
(PWV)(n=1019), carotid intima-media thickness (IMT)(n=578), transmitral early-to-late LV 
diastolic velocity (E/A)(n=779) and estimated glomerular filtration rate (eGFR)(n=1174). 
Independent of mean arterial pressure and confounders, PPc and both Pb and Pf were 
associated with end-organ measures or damage (p<0.05 to <0.0001). With adjustments for 
brachial PP and confounders, Pb remained directly associated with LVMI (partial r=0.10, 
p<0.01), PWV (partial r=0.28, p<0.0001), and IMT (partial r=0.28, p<0.0001), and inversely 
associated with E/A (partial r=-0.31, p<0.0001) and eGFR (partial r=-0.14, p<0.0001). Similar 
relations were noted with the presence of end-organ damage (p<0.05 to <0.0001). In contrast, 
with adjustments for brachial PP and confounders, Pf no longer retained direct relations with 
LVMI, PWV, and IMT or inverse relations with E/A and eGFR. Adjustments for Pb, but not Pf 
diminished brachial PP-independent relationships between PPc and end-organ measures. 
Independent relations between Pb, but not Pf and end-organ measures were largely attributed 
to Pb accounting for most of the variation in brachial-to-aortic PP amplification. In conclusion in 
communities of African ancestry, brachial BP-independent relations between aortic pressure 
and end-organ changes are largely attributed to an impact of reflected rather than forward wave 
pressures.  
Key words: aortic pressure, reflected waves, forward waves, end organ changes.  
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4.2 Introduction 
 
Although pulse pressure (PP) measured at the brachial artery is closely correlated with 
central aortic PP (PPc), amplification of PP occurs from the aorta to brachial arteries (Avolio et 
al 2009, Agabiti-Rosei et al 2007). As there may be marked differences in aortic versus brachial 
blood pressure (BP) (Avolio et al 2009, Agabiti-Rosei et al 2007) and because of the close 
proximity of the aorta to end organs, aortic BP has been proposed to be of greater 
pathophysiological significance than brachial BP. Indeed, several studies have demonstrated 
that PPc or the ratio of brachial and aortic BP, an index of PP amplification, are associated with 
cardiovascular outcomes (Safar et al 2002, Roman et al 2007, Jankowski et al 2008, Pini et al 
2008, Wang et al 2009, Williams et al 2006, Benetos et al 2010, Regnault et al 2012, Benetos et 
al 2012, Vlachopoulos et al 2010) and end-organ measures (Roman et al 2014) either 
independent of or better than brachial BP. However, the exact changes that determine PPc and 
account for brachial BP-independent relations between PPc and cardiovascular damage are 
uncertain. 
Numerous factors contribute toward PPc and these may influence PPc by modifying 
either aortic forward (Pf) or backward (reflected) (Pb) wave pressures. Several studies have 
evaluated the contribution of Pf and Pb to age-related increases in PPc (Segers et al 2007, 
Mitchell et al 2010a) and the contribution of Pf and Pb to variations in end-organ measures or 
cardiovascular outcomes (Wang et al 2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 
2014, Hughes et al 2014). Importantly, in some of these studies (Wang et al 2010, Chirinos et al 
2012, Zamani et al 2014, Hughes et al 2014) indices of reflected waves predicted 
cardiovascular outcomes independent of brachial BP. However, whether forward wave 
pressures also associate with cardiovascular damage independent of brachial BP, and the 
relative contribution of Pf and Pb to the brachial BP-independent relationship between PPc and 
cardiovascular damage is uncertain. In the present study, I therefore aimed to assess in a 
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community of African ancestry whether brachial BP-independent associations between Pb, Pf or 
both and end-organ measures or damage occur and whether brachial BP-independent 
associations between PPc and cardiovascular end-organ measures or damage are accounted 
for by an impact of Pb, Pf or both. 
 
4.3 Methods 
 
4.3.1 Study group. 
 
The present study was conducted according to the principles outlined in the Helsinki 
declaration. The Committee for Research on Human Subjects of the University of the 
Witwatersrand approved the protocol (approval number: M02-04-72 and renewed as M07-04-69 
and M12-04-108). Participants gave informed, written consent. The present study design has 
previously been described (Norton et al 2008, Woodiwiss et al 2009, Redelinghuys et al 2010, 
Norton et al 2012). Briefly, 1174 participants from families of black African descent (Nguni and 
Sotho chiefdoms) with siblings older than 16 years with central hemodynamic measurements 
were randomly recruited from the South West Township (SOWETO) of Johannesburg, South 
Africa. In a series of sub-studies, 1019 had aortic pulse wave velocity (PWV), 786 had left 
ventricular mass index (LVMI) (echocardiography), 578 had carotid intima media thickness 
(IMT), and 779 had LV diastolic function (transmitral velocity) determined. 
 
4.3.2 Clinical, demographic and anthropometric measurements. 
 
See section 2.3.2 for details 
 
4.3.3 Pulse wave analysis. 
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 See section 2.3.4 for details 
 
4.3.4 End-organ measures. 
 
Echocardiographic measurements were recorded and analysed off-line by experienced 
investigators who were unaware of the clinical data of the participants and whom had a low 
degree of inter- and intra-observer variability (Norton et al 2012). Left ventricular mass index 
(LVMI) was determined as described in section 2.3.5. Left ventricular mass was determined 
using a standard formula (Devereux et al 1986) and indexed (LVMI) to height2.7. Left ventricular 
hypertrophy (LVH) was identified as LVMI >51 g/m2.7 (Woodiwiss et al 2015). Left ventricular 
diastolic function was assessed from a pulsed wave Doppler examination of the mitral inflow at 
rest (Libhaber et al 2014). Transmitral flow velocity in early (E) and late (atrial) diastole was 
assessed and data expressed as E/A. A reduced E/A was identified as <0.75 (Quinones et al 
2002). 
Aortic PWV was determined from sequential waveform measurements at carotid and 
femoral sites using applanation tonometry and SphygmoCor software as previously described 
(Norton et al 2008, Woodiwiss et al 2009) (see figure 4.1). The time delay in the pulse waves 
between the carotid and femoral sites was determined using an electrocardiograph-derived R 
wave as a fiducial point. Pulse transit time was taken as the average of 10 consecutive beats. 
The distance which the pulse wave travels was determined as the difference between the 
distance from the femoral sampling site to the suprasternal notch, and the distance from the 
carotid sampling site to the suprasternal notch. Aortic PWV was calculated as the ratio of the 
distance to the transit time (m/sec). An increased PWV was identified as >10 m/sec (Mancia et 
al 2013). 
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Figure 4.1. Photograph of the SphygmoCor device (upper panel) used to determine aortic pulse 
wave velocity. Images in the lower panel show carotid and femoral pressure waves together 
with the electrocardiographic trace showing R waves which were used as fiducial points to 
calculate transit time. The transit time is the difference between time A and B. 
A 
Time of aortic wave travel=A-B  
B 
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Carotid intima-media thickness (IMT) was determined using high resolution B-mode 
ultrasound (SonoCalc IMT, Sonosite Inc, Bothell, Washington) employing a linear array 7.5 MHz 
probe as described previously (Norton et al 2012). Images of at least 1cm length of the far wall 
of the distal portion of the right common carotid artery from an optimal angle of incidence 
(defined as the longitudinal angle of approach where both branches of the internal and external 
carotid artery are visualized simultaneously) at least 1 cm proximal to the flow divider were 
obtained. Carotid IMT measurements were determined using semi-automated border-detection 
and quality control software (see figure 4.2). An increased IMT was identified as >0.90 mm 
(Mancia et al 2013). 
Estimated glomerular filtration rate (eGFR) was determined using the abbreviated 
Modification of Diet in Renal Disease (MDRD) study group equation: 186.3 x (serum creatinine 
in mg/decilitre-1.154) x (age in years-0.203) x 1.212 x 0.742 (if female). A reduced eGFR was 
identified as <60 ml/min/1.73 m2 (Mancia et al 2013). 
 
4.3.5 Statistical analysis. 
 
For database management and statistical analysis, SAS software, version 9.1 (SAS 
Institute Inc., Cary, NC) was employed. Multiple linear regression analysis was performed to 
determine the independent effects of aortic BP on end-organ measures considered as 
continuous traits. Logistic regression analysis was performed to determine the independent 
effects of aortic BP on end-organ damage considered as categorical traits. Adjustments 
included in multivariate models were those correlated with central haemodynamic variables or 
end-organ measures in bivariate analysis. In order to avoid the effects of co-linearity, in primary 
analysis age was not included as an adjustor as Pb and Pf are strongly related to age over the 
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adult age range. However, in secondary analysis, age was included as an adjustor to confirm 
the impact of Pb or Pf beyond age. To determine probability values, further adjustments for non-  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Ultrasonic image of the right common carotid artery showing semi-automated border 
detection (yellow lines) to obtain intima-media thickness measurement (of 1cm length, between 
blue lines) at least 1cm proximal to the flow divider. 
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 independence of family members was performed using non-linear regression analysis (mixed 
procedure as defined in the SAS package). To ensure that relationships occurred independent 
of the use of antihypertensive therapy or as a result of sex-specific effects of aortic function, 
sensitivity analysis was conducted in participants not receiving antihypertensive therapy and in 
sex-specific groups. Regression coefficients were compared with z statistics. 
 
4.4 Results 
 
4.4.1 Characteristics of the participants. 
 
Table 4.1 gives the demographic and clinical characteristics of the participants. Tables 
4.2-4.4 give the demographic and clinical characteristics of the participants recruited in the sub-
studies where LVMI, E/A or IMT were measured as compared to participants without these 
measurements. More women than men participated in the study. As compared to those without 
IMT measurements, those with IMT measurements were modestly younger with a trend toward 
higher BP values (Table 4.3). Otherwise, no differences were noted in participants recruited in 
the sub-studies where LVMI and E/A were measured as compared to participants without these 
measurements (Tables 4,2 and 4.4). A high proportion of participants had an increased LVMI 
and decreased E/A (Table 4.1). A low-to-intermediate proportion had an increased IMT, PWV or 
a reduced eGFR (Table 4.1). 
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Table 4.1. Characteristics of the study sample. 
  
__________________________________________________________ 
Sample number (% female)    1174 (65.1%)   
Age (years)           44.2±18.2 
Body mass index (kg/m2)                     29.5±8.0 
% Overweight/obese        23.0/43.1 
Regular tobacco (% subjects)               15.3 
Regular alcohol (% subjects)                 21.1   
% Diabetes mellitus or an HbA1c>6.1%           25.7   
% Hypertensive            45.6 
% Treated for hypertension           24.0 
Total cholesterol (mmol/l)        4.62±1.35 
HDL cholesterol (mmol/l)        1.40±0.43 
Estimated GFR (eGFR) (mls/min/1.73 m2)        116±32 
Brachial SBP/DBP (mm Hg)                                        128±22/84±13 
Brachial pulse pressure (mm Hg)         44±15 
Aortic SBP (mm Hg)        120±22 
Aortic pulse pressure (mm Hg)          35±14 
Forward wave pressure (Pf) (mm Hg)          24±8 
Backward (reflected) wave pressure (Pb) (mm Hg)           17±8 
Reflected wave index (RI)(Pb/Pf)       71.6±21.5 
Left ventricular mass index (LVMI)(g/m2.7)  41.7±15.1 (n=786) 
Left ventricular E/A  1.28±0.49 (n=779) 
Aortic pulse wave velocity (PWV)(m/sec)  6.39±2.65 (n=1019) 
Carotid intima-media thickness (mm)                          0.64±0.13 (n=578) 
LVMI>51 g/m2.7 (%)           20.7 
PWV>10 m/sec (%)           8.5 
IMT>0.90 mm (%)           3.3 
E/A<0.75 (%)          13.5 
eGFR<60 mls/min/1.73 m2)(%)           1.4 
___________________________________________________________  
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Data are shown as mean±SD or proportions (%). HDL, high density lipoprotein; GFR, 
glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic BP; E/A, transmitral 
early/atrial diastolic blood flow velocity. 
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Table 4.2. Characteristics of the study sample with and without left ventricular mass 
measurements. 
            With      Without 
___________________________________________________________ 
Sample number (% female)   786 (65.0)     388 (65.2)  
Age (years)        44.7±18.0     43.0±18.5  
Body mass index (kg/m2)                 29.6±7.8     29.4±8.6   
% Overweight/obese    23.8/44.0      21.4/41.2 
Regular tobacco (% subjects)           14.9         16.2   
Regular alcohol (% subjects)             19.9          23.7      
% Diabetes mellitus or an HbA1c>6.1%       26.1         25.0     
% Hypertensive         46.6         43.6  
% Treated for hypertension        25.7         20.6  
Total cholesterol (mmol/l)   4.64±1.44     4.56±1.15 
HDL cholesterol (mmol/l)   1.38±0.39     1.43±0.43 
Brachial SBP/DBP (mm Hg)                      128±22/84±13      128±21/84±13         
Brachial pulse pressure (mm Hg)                     44±15                 43±13        
Aortic SBP (mm Hg)                                        120±22                119±22        
Aortic pulse pressure (mm Hg)                        35±14                  34±13        
Forward wave pressure (Pf) (mm Hg)               24±8                    23±7        
Backward wave pressure (Pb) (mm Hg)           17±8                    17±7 
Reflected wave index (RI)(Pb/Pf)                   71.8±21.4       71.2±21.7 
____________________________________________________________        
Data are shown as mean±SD or proportions (%). SBP, systolic blood pressure; DBP, diastolic 
BP. 
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Table 4.3. Characteristics of the study sample with and without carotid intima-media thickness 
measurements. 
           With      Without 
___________________________________________________________ 
Sample number (% female)   578 (65.2)     596 (64.9)  
Age (years)        45.3±18.1     43.0±18.2*  
Body mass index (kg/m2)                 29.9±8.2     29.2±7.9   
% Overweight/obese    22.7/44.5      23.3/41.8 
Regular tobacco (% subjects)           16.1         14.6   
Regular alcohol (% subjects)             21.3          21.0      
% Diabetes mellitus or an HbA1c>6.1%       25.6         25.8     
% Hypertensive         45.3         45.8  
% Treated for hypertension        25.4         22.7  
Total cholesterol (mmol/l)   4.66±1.08     4.58±1.57 
HDL cholesterol (mmol/l)   1.40±0.43     1.40±0.43 
Brachial SBP/DBP (mm Hg)                      126±21/83±13      130±23**/85±13*         
Brachial pulse pressure (mm Hg)                     43±14                 45±15*        
Aortic SBP (mm Hg)                                        118±21                121±23*        
Aortic pulse pressure (mm Hg)                        34±13                  36±14*        
Forward wave pressure (Pf) (mm Hg)               23±8                    24±8        
Backward wave pressure (Pb) (mm Hg)           17±7                    18±8* 
Reflected wave index (RI)(Pb/Pf)                   71.1±21.5       72.1±21.5 
___________________________________________________________        
Data are shown as mean±SD or proportions (%). SBP, systolic blood pressure; DBP, diastolic 
BP. * p<0.05, **p<0.005 vs with. 
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Table 4.4. Characteristics of the study sample with and without left ventricular diastolic function 
measurements. 
           With      Without 
___________________________________________________________ 
Sample number (% female)   779 (65.0)     395 (65.3)  
Age (years)        44.6±17.9     43.3±18.7  
Body mass index (kg/m2)                 29.6±7.8     29.4±8.5   
% Overweight/obese    23.8/43.9      21.5/41.5 
Regular tobacco (% subjects)           15.0         16.0   
Regular alcohol (% subjects)             20.0          23.3      
% Diabetes mellitus or an HbA1c>6.1%      25.8          25.6     
% Hypertensive        46.2          44.3  
% Treated for hypertension        25.3         21.5  
Total cholesterol (mmol/l)   4.64±1.45     4.57±1.14 
HDL cholesterol (mmol/l)   1.38±0.39     1.43±0.43 
Brachial SBP/DBP (mm Hg)                      128±22/84±13      128±22/84±13         
Brachial pulse pressure (mm Hg)                     44±15                 44±14        
Aortic SBP (mm Hg)                                        120±22                119±22        
Aortic pulse pressure (mm Hg)                        35±14                   34±14        
Forward wave pressure (Pf) (mm Hg)               24±8                    24±8        
Backward wave pressure (Pb) (mm Hg)           17±8                    17±8 
Reflected wave index (RI)(Pb/Pf)                   71.8±21.2       71.2±21.9 
___________________________________________________________        
Data are shown as mean±SD or proportions (%). SBP, systolic blood pressure; DBP, diastolic 
BP. 
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4.4.2 Both reflected and forward wave pressures are independently associated with end-organ 
measures and damage. 
 
With adjustments for confounders including mean arterial pressure, PPc, Pb, Pf, and RI 
were independently associated with end-organ measures (Table 4.5) and damage (Table 4.6). 
The magnitude of the effect on end-organ measures (slope or β-coefficient) was greater for Pb 
as compared to Pf (Table 4.5). Moreover, for several end-organ measures relations with Pb 
were stronger than with Pf (comparison of partial r values in Table 4.5). 
 
4.4.3 Brachial BP-independent associations between reflected or forward wave pressures and 
end-organ measures or damage. 
 
With adjustments for brachial PP (Figure 4.3) or SBP (Figure 4.4) in addition to 
confounders, PPc, Pb and RI were directly associated with LVMI, PWV, and IMT or increases in 
these variables and inversely associated with E/A and eGFR or decreases in these variables. 
However, with adjustments for brachial PP (Figure 4.3) or SBP (Figure 4.4) in addition to 
confounders, Pf was inversely associated with LVMI, PWV, and IMT or increases in these 
variables and directly associated with E/A and eGFR or decreases in these variables. With 
further adjustments for age, the independent relations between Pb and  
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Table 4.5. Multivariate adjusted (including adjustments for mean arterial pressure) relationships 
(partial correlation coefficients [r] and 95% confidence intervals [CI]) between central aortic 
haemodynamics and end-organ measures. 
  n=        β-coefficient               Partial r*              p value 
                (±SEM)*            (95% CI) 
________________________________________________________ 
Left ventricular mass index (LVMI) vs 
    PPc  786 0.29±0.05            0.22 (0.15 to 0.29)      <0.0001 
    Pf  786 0.31±0.07            0.16 (0.09 to 0.23)      <0.0001 
    Pb  786 0.53±0.09†           0.21 (0.15 to 0.28)      <0.0001 
    RI  786 0.08±0.03            0.10 (0.03 to 0.17)       <0.01 
Aortic pulse wave velocity (PWV) vs 
    PPc  1019 0.08±0.01            0.38 (0.33 to 0.43)      <0.0001 
    Pf  1019 0.08±0.01            0.25 (0.19 to 0.31)      <0.0001 
    Pb  1019 0.16±0.01†††        0.40 (0.34 to 0.44)†††   <0.0001 
    RI  1019 0.03±0.04            0.22 (0.16 to 0.28)      <0.0001 
Carotid intima-media thickness (IMT) vs 
    PPc  578 0.004±0.0004      0.33 (0.25 to 0.40)       <0.0001 
    Pf  578 0.003±0.0007      0.20 (0.12 to 0.28)       <0.0001 
    Pb  578 0.007±0.0008†††  0.35 (0.27 to 0.41)††     <0.0001 
    RI  578 0.001±0.0003      0.21 (0.13 to 0.29)       <0.0001 
Left ventricular E/A vs  
    PPc  779     -0.008±0.001       -0.21 (-0.27 to -0.14)       <0.0001 
    Pf  779     -0.004±0.002       -0.06 (-0.13 to 0.01)       =0.08 
    Pb  779     -0.016±0.003†††   -0.23 (-0.30 to -0.16)††   <0.0001 
    RI  779     -0.006±0.0008     -0.25 (-0.31 to -0.18)      <0.0001 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  1174   -0.43±0.008         -0.15 (-0.21 to -0.09)       <0.0001 
    Pf  1174   -0.35±0.13           -0.08 (-0.14 to -0.02)       <0.01 
    Pb  1174   -0.84±0.16†          -0.16 (-0.21 to -0.10)†     <0.0001 
    RI  1174   -0.23±0.05           -0.13 (-0.19 to -0.08)      <0.0001 
__________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
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blood flow velocity.*Adjusted for mean arterial pressure, sex, body mass index (except for LVMI 
which was adjusted for body weight), total cholesterol, HDL cholesterol, regular tobacco use, 
regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. †p=0.05, ††p<0.005, 
†††p<0.0005 versus β-coefficient or partial r with the forward wave (z-statistics for comparison of 
partial r values). 
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Table 4.6. Multivariate adjusted (including adjustments for mean arterial pressure) relationships 
(partial correlation coefficients [r] and 95% confidence intervals [CI]) between central aortic 
haemodynamics and end-organ damage. 
  n= n with damage   Odds ratio (95% CI)     p value        
____________________________________________________________ 
Left ventricular mass index (LVMI) >51 g/m2.7 vs 
    PPc  786       163     1.03 (1.01 to 1.05)     <0.005 
    Pf  786       163     1.02 (1.00 to 1.05)     <0.05 
    Pb  786       163     1.06 (1.03 to 1.09)     <0.0005 
    RI  786       163     1.01 (1.00 to 1.02)     <0.05 
Aortic pulse wave velocity (PWV)>10 m/sec vs 
    PPc  1019        87       1.09 (1.07 to 1.12)     <0.0001 
    Pf  1019        87       1.10 (1.07 to 1.14)     <0.0001 
    Pb  1019        87       1.19 (1.14 to 1.24)     <0.0001 
    RI             1019        87       1.03 (1.02 to 1.05)     <0.0001 
Carotid intima-media thickness (IMT) >0.90 mm vs 
    PPc  578        19                  1.08 (1.03 to 1.12)     <0.005 
    Pf  578        19                  1.07 (1.01 to 1.14)     <0.05 
    Pb  578        19              1.14 (1.05 to 1.23)     <0.005 
    RI  578        19       1.03 (1.01 to 1.06)     <0.02 
 Left ventricular E/A <0.75 vs 
    PPc  779         105       1.05 (1.03 to 1.07)    <0.0001 
    Pf  779         105       1.05 (1.02 to 1.08)    <0.005 
    Pb  779         105       1.08 (1.04 to 1.12)    <0.0001 
    RI  779         105       1.01 (1.00 to 1.03)    =0.05 
Estimated glomerular filtration rate (eGFR) <60 mls/min/1.73 m2 vs 
    PPc  1174         16       1.06 (1.01 to 1.11)    <0.05 
    Pf  1174         16       1.05 (0.99 to 1.12)    =0.09 
    Pb  1174         16       1.12 (1.03 to 1.21)    <0.01 
    RI  1174         16       1.02 (0.996 to 1.05)   =0.09 
__________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
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blood flow velocity. Adjusted for mean arterial pressure, sex, body mass index (except for LVMI 
which was adjusted for body weight), total cholesterol, HDL cholesterol, regular tobacco use, 
regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Figure 4.3. Brachial pulse pressure (PP)-independent relations between central aortic 
haemodynamics and end-organ measures (upper panel) or damage (lower panel). Pb, aortic 
backward (reflected) wave pressure; Pf, aortic forward wave pressure; LVMI, left ventricular 
mass index; PWV, aortic pulse wave velocity; IMT, carotid intima-media thickness; E/A, 
transmitral early/atrial diastolic blood flow velocity; eGFR, estimated glomerular filtration rate; 
LVH, LV hypertrophy; Incr., increased; Decr., decreased. *Adjustments are for brachial PP as 
well as sex, body mass index (except for LVMI which was adjusted for body weight), total 
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cholesterol, HDL cholesterol, regular tobacco use, regular alcohol intake, diabetes mellitus or an 
HbA1c>6.1%, and pulse rate. 
- - 92 - 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Brachial systolic pressure (SBP)-independent relations between central aortic 
haemodynamics and end-organ measures (upper panel) or damage (lower panel). Pb, aortic 
backward (reflected) wave pressure; Pf, aortic forward wave pressure; RI, reflected wave index 
(Pb/Pf); LVMI, left ventricular mass index; PWV, aortic pulse wave velocity; IMT, carotid intima-
media thickness; E/A, transmitral early/atrial diastolic blood flow velocity; eGFR, estimated 
glomerular filtration rate; LVH, LV hypertrophy; Incr., increased; Decr., decreased. *Adjustments 
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are for SBP as well as sex, body mass index (except for LVMI which was adjusted for body 
weight), total cholesterol, HDL cholesterol, regular tobacco use, regular alcohol intake, diabetes 
mellitus or an HbA1c>6.1%, and pulse rate. 
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PWV (Tables 4.7 and 4.8), IMT (Tables 4.7 and 4.8), E/A (Table 4.7) and LVMI (Table 4.8) were 
retained. The non-age and age-adjusted relations noted in all participants were similarly also 
noted in participants not receiving antihypertensive therapy (Tables 4.9 and 4.10). Moreover, 
brachial BP-independent relations between either PPc or Pb and end-organ measures were 
largely reproduced in both women (Table 4.11) and men (Table 4.12).  
 
4.4.4 Reflected, but not forward wave pressures account for brachial BP-independent relations 
between aortic PP and end-organ measures or damage. 
 
Adjustments for Pb, but not for Pf eliminated or significantly attenuated brachial PP 
(Figure 4.5) or brachial SBP (Figure 4.6)-independent relations between aortic PP and end-
organ measures. 
 
4.4.5 Relative contribution of forward and backward wave pressures to pulse pressure 
amplification. 
 
Aortic Pb was more strongly correlated with aortic-to-brachial PP amplification than Pf 
(Figure 4.7) and these effects were noted in both women (Pb vs PP amplification, r=-0.57, 
p<0.0001; Pf vs PP amplification, r=-0.08, p<0.05) and in men (Pb vs PP amplification, r=-0.64, 
p<0.0001; Pf vs PP amplification, r=-0.27, p<0.001) (p<0.0001 for comparison of r values with z 
statistics in both women and in men). 
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Table 4.7 Brachial pulse pressure (PP) and age-independent relations between central aortic 
haemodynamics and end-organ measures. 
 
      n=        Partial r* (95% CI)     p value 
_______________________________________ 
Left ventricular mass index (LVMI) vs   
    PPc  786      0.04 (-0.03 to 0.11)    =0.21   
    Pf  786     -0.06 (-0.13 to 0.01)    =0.11   
    Pb  786      0.05 (-0.03 to 0.12)    =0.21  
    RI  786      0.07 (-0.01 to 0.14)    =0.06  
Aortic pulse wave velocity (PWV) vs    
    PPc  1019    0.08 (0.02 to 0.14)     <0.01  
    Pf  1019   -0.07 (-0.14 to -0.01)  <0.05  
    Pb  1019    0.10 (0.04 to 0.16)    <0.005  
    RI  1019    0.09 (0.03 to 0.16)    <0.005 
Carotid intima-media thickness (IMT) vs 
    PPc  578    0.10 (0.01 to 0.18)      <0.05 
    Pf  578    0.01 (-0.07 to 0.09)     =0.78   
    Pb  578    0.09 (0.01 to 0.17)      <0.05  
    RI  578    0.04 (-0.05 to 0.12)     =0.39 
Left ventricular E/A vs 
    PPc  779   -0.11 (-0.18 to -0.04)     <0.005 
    Pf  779    0.06 (-0.01 to 0.13)      =0.11   
    Pb  779   -0.12 (-0.19 to -0.05)    <0.005 
    RI  779   -0.11 (-0.18 to -0.04)    <0.005 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  1174  0.04 (-0.02 to -0.10)    =0.18 
    Pf  1174  0.003 (-0.05 to 0.06)   =0.91   
    Pb  1174  0.02 (-0.03 to -0.08)    =0.41 
    RI  1174  0.001 (-0.06 to 0.06)   =0.98 
________________________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
blood flow velocity.*Adjusted for brachial pulse pressure, age, sex, body mass index (except for 
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LVMI which was adjusted for body weight), total cholesterol, HDL cholesterol, regular tobacco 
use, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Table 4.8. Brachial systolic blood pressure (SBP) and age-independent relations between 
central aortic haemodynamics and end-organ measures. 
 
  n=        Partial r* (95% CI)       p value    
_________________________________________ 
Left ventricular mass index (LVMI) vs 
    PPc  786      0.10 (0.03 to 0.17)     <0.01  
    Pf  786      0.05 (-0.02 to 0.12)    =0.14  
    Pb  786      0.09 (0.02 to 0.16)     <0.02 
    RI  786      0.04 (-0.03 to 0.11)    =0.28 
Aortic pulse wave velocity (PWV) vs 
    PPc  1019    0.09 (0.03 to 0.15)     <0.005  
    Pf  1019    0.04 (-0.02 to 0.10)    =0.18  
    Pb  1019    0.10 (0.04 to 0.16)     <0.002 
    RI  1019    0.09 (-0.02 to 0.10)    =0.18 
Carotid intima-media thickness (IMT) vs 
    PPc  578      0.08 (0.00 to 0.16)     <0.05  
    Pf  578      0.05 (-0.03 to 0.13)    =0.21  
    Pb  578      0.09 (0.01 to 0.17)     <0.05 
    RI  578      0.01 (-0.07 to 0.09)    =0.79 
Left ventricular E/A vs 
    PPc  779      0.03 (-0.04 to 0.10)    =0.37  
    Pf  779      0.09 (0.02 to 0.16)     <0.05  
    Pb  779      0.002 (-0.07 to 0.07)  =0.97 
    RI  779     -0.09 (-0.16 to 0.02)   <0.02 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  1174     0.05 (-0.01 to 0.10)    =0.12 
    Pf  1174     0.01 (-0.04 to 0.07)    =0.62 
    Pb  1174     0.05 (-0.01 to 0.10)    =0.12 
    RI  1174     0.01 (-0.04 to 0.07)    =0.65 
_________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
blood flow velocity.*Adjusted for brachial SBP, age, sex, body mass index (except for LVMI 
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which was adjusted for body weight), total cholesterol, HDL cholesterol, regular tobacco use, 
regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Table 4.9. Brachial blood pressure (BP) independent relations between central aortic 
haemodynamics and end-organ measures in participants not receiving antihypertensive 
therapy. 
         Adjustments→    *+Brachial pulse pressure  *+Brachial systolic BP  
    n=        Partial r (95% CI)    p value         Partial r (95% CI)        p value 
____________________________________________________________________ 
Left ventricular mass index (LVMI) vs 
    PPc  584      0.16 (0.08 to 0.24)       <0.0001       0.15 (0.07 to 0.23)      <0.0005  
    Pf  584     -0.004 (-0.09 to 0.08)    =0.92           0.09 (0.01 to 0.17)      <0.05  
    Pb  584      0.14 (0.06 to 0.22)       <0.001         0.14 (0.06 to 0.22)      <0.001 
    RI  584      0.11 (0.03 to 0.19)       <0.01           0.07 (-0.01 to 0.15)    =0.08 
Aortic pulse wave velocity (PWV) vs 
    PPc  780     0.37 (0.31 to 0.43)         <0.0001        0.25 (0.19 to 0.32)    <0.0001  
    Pf  780    -0.15 (-0.22 to -0.08)      <0.0001        0.04 (-0.03 to 0.11)    =0.31  
    Pb  780     0.37 (0.31 to 0.43)         <0.0001        0.30 (0.24 to 0.36)    <0.0001 
    RI  780     0.32 (0.26 to 0.39)         <0.0001 0.25 (0.19 to 0.32)    <0.0001 
Carotid intima-media thickness (IMT) vs 
    PPc  431     0.30 (0.21 to 0.38)         <0.0001        0.25 (0.16 to 0.33)   <0.0001  
    Pf  431    -0.05 (-0.14 to 0.05)        =0.33 0.09 (-0.01 to 0.19)   =0.06  
    Pb  431     0.26 (0.16 to 0.34)         <0.0001 0.25 (0.16 to 0.34)    <0.0001 
    RI  431     0.22 (0.13 to 0.31)         <0.0001 0.18 (0.09 to 0.27)    <0.0002 
Left ventricular E/A vs 
    PPc  582   -0.37 (-0.40 to -0.26)     <0.0001         -0.16 (-0.24 to -0.08)   =0.0001 
    Pf  582    0.15 (0.07 to 0.23)        =0.0004          0.06 (-0.02 to 0.14)    =0.15  
    Pb  582   -0.32 (-0.39 to -0.24)     <0.0001         -0.20 (-0.28 to -0.12)   <0.0001 
    RI  582   -0.30 (-0.38 to -0.23)     <0.0001         -0.26 (-0.34 to -0.18)   <0.0001 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  892   -0.19 (-0.25 to -0.12)     <0.0001         -0.10 (-0.16 to -0.03)   <0.01 
    Pf  892    0.03 (-0.03 to 0.10)       =0.32            -0.004 (-0.07 to 0.06)   =0.91  
    Pb  892   -0.17 (-0.23 to -0.11)     <0.0001         -0.11 (-0.18 to -0.05)   <0.001 
    RI  892   -0.16 (-0.22 to -0.09)     <0.0001         -0.13 (-0.19 to -0.06)   <0.0005 
________________________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
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blood flow velocity.*Adjusted for brachial blood pressure as indicated, sex, body mass index 
(except for LVMI which was adjusted for body weight), total cholesterol, HDL cholesterol, 
regular tobacco use, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Table 4.10. Brachial blood pressure (BP) and age-independent relations between central aortic 
haemodynamics and end-organ measures in participants not receiving antihypertensive 
therapy. 
         Adjustments→    *+Brachial pulse pressure  *+Brachial systolic BP  
    n=        Partial r (95% CI)    p value         Partial r (95% CI)        p value 
____________________________________________________________________ 
Left ventricular mass index (LVMI) vs 
    PPc  584      0.11 (0.03 to 0.19)       <0.01           0.11 (0.03 to 0.19)       <0.01  
    Pf  584      0.02 (-0.06 to 0.10)      =0.59           0.09 (0.01 to 0.17)       <0.05  
    Pb  584      0.09 (0.01 to 0.17)       <0.05           0.10 (0.02 to 0.18)       <0.05 
    RI  584      0.06 (-0.02 to 0.14)      =0.13           0.03 (-0.06 to 0.11)      =0.53  
Aortic pulse wave velocity (PWV) vs 
    PPc  780     0.14 (0.07 to 0.21)         <0.0001       0.07 (0.01 to 0.14)       <0.05  
    Pf  780    -0.05 (-0.13 to 0.02)        =0.13           0.02 (-0.05 to 0.09)     =0.63  
    Pb  780     0.17 (0.10 to 0.24)         <0.0001        0.11 (0.03 to 0.17)     <0.005 
    RI  780     0.12 (0.05 to 0.19)         <0.002          0.06 (0.01 to 0.13)      =0.12 
Carotid intima-media thickness (IMT) vs 
    PPc  431     0.03 (-0.07 to 0.12)        =0.57           0.04 (-0.06 to 0.13)      =0.42  
    Pf  431     0.07 (-0.03 to 0.16)        =0.17           0.07 (-0.03 to 0.16)      =0.15  
    Pb  431     0.01 (-0.09 to 0.10)        =0.86           0.02 (-0.08 to 0.12)      =0.68 
    RI  431    -0.01 (0.11 to 0.08)         =0.80          -0.03 (-0.13 to 0.06)      =0.49 
Left ventricular E/A vs 
    PPc  582   -0.09 (-0.17 to -0.01)        <0.05           0.03 (-0.05 to 0.11)      =0.44  
    Pf  582    0.05 (-0.03 to 0.13)         =0.20           0.08 (-0.003 to 0.16)    =0.06  
    Pb  582   -0.11 (-0.19 to -0.02)        <0.02         -0.003 (-0.08 to 0.08)     =0.95 
    RI  582   -0.10 (-0.18 to -0.02)        <0.02         -0.08 (-0.17 to -0.003)    <0.05 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  892    0.02 (-0.05 to 0.08)        =0.59            0.05 (-0.01 to 0.12)      =0.12  
    Pf  892   -0.04 (-0.11 to 0.02)        =0.20            0.003 (-0.06 to 0.07)    =0.93  
    Pb  892    0.01 (-0.05 to 0.08)        =0.72            0.05 (-0.01 to 0.12)      =0.12 
    RI  892    0.02 (-0.05 to 0.08)        =0.59            0.03 (-0.04 to 0.10)      =0.36 
______________________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
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blood flow velocity.*Adjusted for brachial blood pressure as indicated, sex, body mass index 
(except for LVMI which was adjusted for body weight), total cholesterol, HDL cholesterol, 
regular tobacco use, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Table 4.11. Brachial blood pressure (BP) independent relations between central aortic 
haemodynamics and end-organ measures in women. 
         Adjustments→    *+Brachial pulse pressure  *+Brachial systolic BP  
    n=        Partial r (95% CI)      p value          Partial r (95% CI)        p value 
Left ventricular mass index (LVMI) vs 
    PPc  511      0.08 (-0.01 to 0.16)       =0.09           0.10 (0.02 to 0.19)      <0.01  
    Pf  511     -0.10 (-0.18 to -0.01)     <0.05            0.03 (-0.06 to 0.12)     =0.52  
    Pb  511      0.09 (0.00 to 0.17)       =0.05            0.11 (0.02 to 0.19)       <0.02 
    RI  511      0.11 (0.02 to 0.19)       <0.02            0.07 (-0.02 to 0.15)      =0.14  
Aortic pulse wave velocity (PWV) vs 
    PPc  645     0.25 (0.18 to 0.32)         <0.0001       0.11 (0.04 to 0.19)       <0.005  
    Pf  645    -0.10 (-0.17 to -0.02)       <0.02          0.003 (-0.07 to 0.08)     =0.93  
    Pb  645     0.22 (0.15 to 0.29)         <0.0001       0.12 (0.04 to 0.20)       <0.005 
    RI  645     0.23 (0.15 to 0.30)         <0.0001       0.14 (0.06 to 0.22)        <0.0005 
Carotid intima-media thickness (IMT) vs 
    PPc  377     0.25 (0.15 to 0.30)          <0.0001      0.04 (-0.06 to 0.13)      =0.42  
    Pf  377    -0.13 (-0.22 to -0.02)       <0.02          0.009 (-0.09 to 0.11)     =0.86  
    Pb  377     0.23 (0.13 to 0.32)          <0.0001      0.19 (0.09 to 0.29)        <0.0005 
    RI  377     0.22 (0.12 to 0.32)          <0.0001      0.17 (0.07 to 0.27)        <0.002 
Left ventricular E/A vs 
    PPc  506   -0.31 (-0.38 to -0.23)        <0.0001      -0.10 (-0.18 to 0.01)      <0.05  
    Pf  506    0.13 (0.04 to 0.22)           <0.005         0.08 (-0.01 to 0.17)      =0.07  
    Pb  506   -0.28 (-0.36 to -0.20)        <0.0001      -0.14 (-0.22 to -0.05)     <0.005 
    RI  506   -0.26 (-0.34 to -0.18)        <0.0001      -0.22 (-0.30 to -0.13)     <0.0001 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  764   -0.11 (-0.18 to -0.04)        <0.005        -0.03 (-0.10 to 0.04)       =0.38  
    Pf  764    0.06 (-0.01 to 0.13)          =0.12           0.02 (-0.05 to 0.09)       =0.60  
    Pb  764   -0.11 (-0.18 to -0.04)        <0.002         -0.05 (-0.12 to 0.02)      =0.17 
    RI  764   -0.12 (-0.19 to -0.05)        <0.001         -0.08 (-0.15 to -0.01)     <0.05 
________________________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
blood flow velocity.*Adjusted for brachial blood pressure as indicated, body mass index (except 
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for LVMI which was adjusted for body weight), total cholesterol, HDL cholesterol, regular 
tobacco use, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Table 4.12. Brachial blood pressure (BP) independent relations between central aortic 
haemodynamics and end-organ measures in men. 
         Adjustments→    *+Brachial pulse pressure  *+Brachial systolic BP  
    n=        Partial r (95% CI)    p value         Partial r (95% CI)     p value 
____________________________________________________________________ 
Left ventricular mass index (LVMI) vs 
    PPc  275      0.14 (0.02 to 0.26)       <0.05           0.20 (0.08 to 0.31)       <0.001  
    Pf  275     -0.02 (-0.14 to 0.10)      =0.80           0.13 (0.01 to 0.24)       <0.05  
    Pb  275      0.11 (-0.006 to 0.23)    =0.06           0.19 (0.07 to 0.30)       <0.005 
    RI  275      0.13 (0.01 to 0.24)        <0.05          0.14 (0.02 to 0.25)        <0.05  
Aortic pulse wave velocity (PWV) vs 
    PPc  374     0.28 (0.18 to 0.37)         <0.0001       0.37 (0.27 to 0.45)       <0.0001 
    Pf  374    -0.22 (-0.31 to -0.12)       <0.0001      0.14 (0.04 to 0.24)       <0.01  
    Pb  374     0.32 (0.22 to 0.41)         <0.0001       0.40 (0.31 to 0.48)      <0.0001 
    RI  374     0.31 (0.22 to 0.40)         <0.0001       0.30 (0.20 to 0.39)      <0.0001 
Carotid intima-media thickness (IMT) vs 
    PPc  201     0.34 (0.21 to 0.46)         <0.0001       0.36 (0.22 to 0.47)       <0.0001 
    Pf  201     0.03 (-0.11 to 0.17)        =0.64           0.22 (0.08 to 0.35)      <0.005  
    Pb  201     0.29 (0.15 to 0.41)         <0.0001       0.35 (0.22 to 0.47)       <0.0001 
    RI  201    0.20 (0.05 to 0.33)          <0.01           0.20 (0.06 to 0.33)       <0.01 
Left ventricular E/A vs 
    PPc  273   -0.36 (-0.46 to -0.25)        <0.0001     -0.19 (-0.30 to -0.07)     <0.005  
    Pf  273    0.16 (0.04 to 0.28)           <0.01          0.06 (-0.06 to 0.18)      =0.34  
    Pb  273   -0.35 (-0.45 to -0.24)        <0.0001     -0.23 (-0.34 to -0.11)     <0.0005 
    RI  273   -0.36 (-0.46 to -0.25)        <0.0001     -0.34 (-0.44 to -0.23)     <0.0001 
Estimated glomerular filtration rate (eGFR) vs 
    PPc  410   -0.17 (-0.27 to -0.08)        <0.001       -0.16 (-0.25 to -0.06)     <0.005  
    Pf  410    0.08 (-0.01 to 0.18)          =0.09         -0.04 (-0.13 to 0.06)      =0.48  
    Pb  410   -0.16 (-0.25 to -0.06)        <0.002       -0.16 (-0.26 to -0.07)      <0.001 
    RI  410   -0.19 (-0.28 to -0.09)        <0.0005     -0.19 (-0.28 to -0.09)      <0.0005 
________________________________________________________________________ 
PPc, central aortic pulse pressure; Pb, aortic backward (reflected) wave pressure; Pf, aortic 
forward wave pressure; RI, reflected wave index (Pb/Pf); E/A, transmitral early/atrial diastolic 
- - 106 - 
 
  
blood flow velocity.*Adjusted for brachial blood pressure as indicated, body mass index (except 
for LVMI which was adjusted for body weight), total cholesterol, HDL cholesterol, regular 
tobacco use, regular alcohol intake, diabetes mellitus or an HbA1c>6.1%, and pulse rate. 
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Figure 4.5. Impact of adjustments for forward (Pf) or backward (reflected) (Pb) wave pressures  
on the brachial pulse pressure (PP)-independent relations between central aortic pulse pressure 
(PPc) and end-organ measures. LVMI, left ventricular mass index; PWV, aortic pulse wave 
velocity; IMT, carotid intima-media thickness; E/A, transmitral early/atrial diastolic blood flow 
velocity; eGFR, estimated glomerular filtration rate. †Adjustments are for brachial PP as well as 
sex, body mass index (except for LVMI which was adjusted for body weight), total cholesterol, 
HDL cholesterol, regular tobacco use, regular alcohol intake, diabetes mellitus or an 
HbA1c>6.1%, and pulse rate. *p<0.005, **p<0.0001 versus without adjustments for Pb. 
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Figure 4.6. Impact of adjustments for forward (Pf) or backward (reflected) (Pb) wave pressures 
on the brachial systolic blood pressure (SBP)-independent relations between central aortic 
pulse pressure (PPc) and end-organ measures. LVMI, left ventricular mass index; PWV, aortic 
pulse wave velocity; IMT, carotid intima-media thickness; E/A, transmitral early/atrial diastolic 
blood flow velocity; eGFR, estimated glomerular filtration rate. †Adjustments are for SBP as well 
as sex, body mass index (except for LVMI which was adjusted for body weight), total 
cholesterol, HDL cholesterol, regular tobacco use, regular alcohol intake, diabetes mellitus or an 
HbA1c>6.1%, and pulse rate. *p<0.005, ** p<0.0001 versus without adjustments for Pb. 
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Figure 4.7. Bivariate relationships between either aortic forward (Pf) or backward (reflected) 
wave (Pb) pressures and aortic-to-brachial pulse pressure (PP) amplification. Comparison of r 
values using z-statistics, p<0.0001. 
r=-0.59  
p<0.0001 
n=1174 
r=-0.14  
p<0.0001 
n=1174 
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4.5 Discussion 
  
The main findings of the present study are as follows: In a large community-based 
sample of African ancestry after multivariate adjustments including adjustments for distending 
pressures (mean arterial pressure), independent relationships were noted between PPc, Pf, Pb 
or RI and several end-organ changes. However, with adjustments for brachial PP, aortic PPc, 
Pb and RI, but not Pf remained independently and directly associated with LVMI, PWV, and IMT 
or increases thereof and inversely associated with E/A and eGFR or decreases thereof. 
Furthermore, Pb, but not Pf accounted for the brachial BP-independent relations between aortic 
PP and end-organ measures. 
 Several studies have suggested that indices of aortic wave reflection provide unique 
prognostic information beyond brachial BP (Wang et al 2010, Chirinos et al 2012, Zamani et al 
2014, Hughes et al 2014). However, whether forward wave pressures, which have previously 
been demonstrated to account for most of the age-related (Mitchell et al 2010b) or 
hypertension-related (Mancia et al 2013) increases in aortic pulse pressure, also account for 
cardiovascular damage independent of brachial BP, is uncertain. Moreover, whether forward, or 
backward (reflected) wave pressures or both account for the brachial BP-independent 
relationship between aortic PP and cardiovascular damage (Safar et al 2002, Roman et al 2007, 
Jankowski et al 2008, Pini et al 2008, Wang et al 2009, Williams et al 2006, Benetos et al 2010, 
Regnault et al 2012, Benetos et al 2012, Vlachopoulos et al 2010, Roman et al 2014), is 
similarly unknown. In the present study I show that Pb and RI, but not Pf is associated with end-
organ measures and damage independent of brachial BP. Further, I show that the brachial BP-
independent relationships between aortic PP and end-organ measures are largely accounted for 
by Pb, but not by Pf. Hence, the present study suggests that brachial BP-independent relations 
between aortic pressure and cardiovascular end-organ changes are largely attributed to 
backward (reflected) rather than forward wave pressure effects. 
- - 111 - 
 
  
 An important caveat of the present study is that brachial BP-independent relationships 
between reflected, but not forward wave pressures does not imply that forward wave pressures 
do not contribute to end-organ measures. Indeed, with adjustments for mean arterial pressure 
(distending pressures), both forward and backward wave pressures contributed to variations in 
end-organ measures and damage. The results of the present study could be explained in two 
possible ways. First, as demonstrated in the present study, reflected wave pressures may be 
more closely associated with amplification of PP from the aorta to the brachial artery. Hence, 
relations between brachial BP and end-organs are likely to closely reflect associations between 
forward rather than backward wave pressures and end-organ measures. In contrast, backward 
wave pressure effects are more likely to be detected using aortic BP measurements. Second, 
as compared to relations between Pf and end-organ measures, the relations between Pb and 
end-organ measures had a greater slope (magnitude) and for several end-organs the 
relationship was also stronger. Hence, Pb may contribute more than Pf to variations in end-
organ measures. In this regard, prior studies have reported on closer relations between 
reflected as compared to forward wave indices and end-organ measures (Wang et al 2010, 
Weber et al 2012) or cardiovascular outcomes (Zamani et al 2014). However, in neither of the 
studies reporting on relations between Pf or Pb and end-organ measures (Wang et al 2010, 
Weber et al 2012) were these relations assessed with adjustments for brachial BP. 
Nevertheless, even without adjustments for brachial BP, Pb but not Pf has been demonstrated 
to predict cardiovascular outcomes (Zamani et al 2014). 
  The clinical implications of the brachial BP-independent relations between Pb, but not Pf 
and end-organ measures require consideration. The present results suggest that brachial BP-
independent relations between aortic pressure and cardiovascular damage (Safar et al 2002, 
Roman et al 2007, Jankowski et al 2008, Pini et al 2008, Wang et al 2009, Williams et al 2006, 
Benetos et al 2010, Regnault et al 2012, Benetos et al 2012, Vlachopoulos et al 2010, Roman 
et al 2014) are attributed largely to reflected wave pressure effects, with little contribution from 
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forward wave pressure effects. Hence, whilst the adverse effects of forward wave pressures are 
likely to be revealed using brachial BP measurements, backward wave pressure effects are 
unlikely to be readily detected using brachial BP measurements. These results may in-part 
explain why in community samples where the backward wave contributes little to age-related 
increases in aortic BP (Mitchell et al 2010b), aortic pressure does not predict cardiovascular 
outcomes beyond brachial BP (Mitchell et al 2010a), whilst in community samples where a 
strong age-related increase in the backward wave pressures occurs (Wang et al 2010), aortic 
BP predicts outcomes beyond brachial BP (Wang et al 2009). 
 Although I provide clear evidence that aortic PWV is more strongly associated with 
reflected as compared to forward wave pressures, it is possible that the association between 
PWV and Pb may be interpreted as an increased aortic stiffness enhancing the magnitude of 
wave reflection. However, more recent studies suggest that increases in aortic stiffness reduce 
the degree of wave reflection and hence cause microvascular damage by augmenting flow 
pulsatility (Mitchell et al 2011, Hashimoto et al 2011). Thus, it is possible that the association 
between Pb and PWV reflects an effect of Pb on aortic stiffness, rather than aortic stiffness on 
Pb. 
 The limitations of the present study are as follows: First, the present study was a cross-
sectional design and end-organ measures rather than hard outcomes were assessed. 
Therefore, I cannot determine whether relations between aortic haemodynamics and 
cardiovascular damage are indeed cause and effect. Further longitudinal studies with 
cardiovascular outcomes are required to determine these effects. Second, in the present study 
calibration of the radial waveform from brachial BP measurements ignores amplification of BP 
from brachial to radial arteries. Hence, aortic pressures may have been underestimated using 
the current approach. Third, as previously described (Westerhof et al 2006), a triangular aortic 
flow waveform was assumed for wave separation analysis, rather than separating forward and 
backward waves with measured aortic flows. In this regard, the assumptions intrinsic to the use 
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of the ‘triangulation method’ of wave separation may not be ideal (Kips et al 2009). Hence, it is 
possible that I may have over- or underestimated the contribution of forward or reflected waves 
to variations in end-organ measures. Fourth, the present study was conducted in a group of 
African ancestry and hence the results require confirmation in other ethnic groups. 
 In conclusion, in a group of African ancestry, I show that although both forward and 
reflected wave effects contribute to end-organ measures and damage, independent of brachial 
BP, the impact of aortic BP is accounted for largely by backward (reflected) wave effects. This 
finding is attributed in-part to reflected, rather than forward wave pressures contributing to 
aortic-to-brachial BP amplification and in-part to stronger relations between reflected rather than 
forward wave pressures and end-organ changes. These findings may explain why in community 
samples which show strong age-related increases in reflected wave pressures (Wang et al 
2010), aortic BP predicts outcomes beyond brachial BP (Wang et al 2009), whilst in community 
samples where backward waves contribute little to age-related increases in aortic BP (Mitchell 
et al 2010b), aortic pressure does not predict cardiovascular outcomes beyond brachial BP (Fok 
et al 2014b). 
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          CHAPTER 5 
 
 
 
Aortic Backward Waves Rather Than Stiffness Account for Independent 
Associations Between Pulse Pressure Amplification and Left Ventricular Mass in a 
Young-to-Middle Aged Sample. 
 
 
This chapter has been accepted for publication as the following paper: 
 
 
Moekanyi J Sibiya, Gavin R Norton, Hendrik L Booysen, Grace Tade, Carlos D Libhaber, 
Imraan Ballim, Pinhas Sareli, Angela J Woodiwiss. Aortic Backward Waves Rather Than 
Stiffness Account for Independent Associations Between Pulse Pressure Amplification and Left 
Ventricular Mass in a Young-to-Middle Aged Sample. J Am Soc Hypertens (in-press) 
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5.1 Abstract 
 
A decreased aortic-to-brachial pulse pressure amplification (PP amplification), which is 
independently associated with cardiovascular outcomes, may index several aortic functional 
changes. However, that aortic functional change most likely to account for this effect is 
uncertain. In 706 randomly selected community participants of African ancestry with a mean age 
of 44.4±18.2 years I assessed aortic function using radial applanation tonometry and 
SphygmoCor software (including forward [Pf] and backward [Pb] wave separation analysis 
assuming a triangular flow waveform) and left ventricular mass index (LVMI)(echocardiography). 
In multivariate models with the inclusion of brachial PP, 1/PP amplification (partial r=0.12, 
p<0.005), reflected wave pressures (partial r=0,09, p<0.05), and aortic pulse wave velocity 
(PWV) (partial r=0.09, p<0.05) were independently associated with LVMI. Similarly, in 
multivariate models with the inclusion of brachial PP, 1/PP amplification (p<0.005), the reflected 
wave pressure (p<0.01), and aortic PWV (p<0.01) were independently associated with LV 
hypertrophy (LVH). With adjustments for reflected wave pressures, the brachial PP-independent 
relationships between 1/PP amplification and LVMI or LVH were abolished (p>0.08 for both). 
However, adjustments for PWV failed to modify brachial PP-independent relations between 
1/PP amplification and LVMI or LVH. Similar results were noted when brachial SBP rather than 
PP was included in regression models and in sensitivity analysis conducted in participants not 
receiving antihypertensive therapy. In conclusion, the independent relations between the 
reciprocal of aortic-to-brachial PP amplification and LVMI or LVH in a largely young-to-middle-
aged sample are accounted for by variations in backward wave pressures rather than aortic 
stiffness. 
 
Key words: Central blood pressure, aortic pulse pressure, reflected waves, pulse pressure 
amplification, left ventricular mass. 
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5.2 Introduction 
 
Pulse pressure (PP) is a strong determinant of cardiovascular damage beyond steady-
state pressures and as such is incorporated in guidelines for risk prediction (Mancia et 2013). 
Brachial PP may not however accurately reflect aortic PP measurements. Indeed, PP is 
amplified from the aorta to the brachial artery (PP amplification) and this effect is due to 
differences in stiffness between the aorta and peripheral arteries (Avolio et al 2009, Nichols et al 
2011). With age, PP amplification is reduced due to increases in aortic stiffness and a 
consequent attenuation in the difference between the stiffness of the aorta and peripheral 
arteries, as well as because of an earlier timing and an increased amplitude of aortic backward 
waves (Avolio et al 2009, Nichols et al 2011). In this regard, reductions in PP amplification 
predict risk beyond brachial blood pressure (BP) (Benetos et al 2010, Regnault et al 2012, 
Benetos et al 2012, Bursztyn et al 2016). However, the mechanisms that explain the ability of 
PP amplification to risk predict beyond brachial PP are uncertain. 
Increases in aortic pulse wave velocity (PWV), an index of aortic stiffness, and a 
determinant of variations in PP amplification, is now an accepted measure of risk prediction 
beyond brachial BP (Vlachopoulos et al 2010a, Ben-Shlomo et al 2014). Moreover, several 
studies suggest that increases in aortic backward waves, which are also a determinant of 
variations in PP amplification, predict the risk of cardiovascular events (Vlachopoulos et al 
2010b, Wang et al 2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 2014), or associate 
with end-organ changes (Booysen et al 2015, Sibiya et al 2015) beyond brachial PP. However, 
no study has assessed whether increases in aortic stiffness or backward waves account for the 
brachial BP-independent association between PP amplification and cardiovascular end-organ 
changes. As one of the key end-organ changes that occur in response to aortic hemodynamic 
loads is left ventricular hypertrophy (LVH), in the present study I evaluated first whether PP 
amplification adds to brachial BP in associations with LV mass index (LVMI) and LVH in a large 
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randomly selected community-based sample of largely young-to-middle aged participants. I 
subsequently assessed whether this relationship can be accounted for either by aortic PWV, 
and/or by aortic backward wave function. 
 
5.3 Methods 
 
5.3.1 Study group. 
 
The present study was conducted according to the principles outlined in the Helsinki 
declaration. The Committee for Research on Human Subjects of the University of the 
Witwatersrand approved the protocol (approval number: M02-04-72 and renewed as M07-04-69 
and M12-04-108). Participants gave informed, written consent. The present study design has 
previously been described (Booysen et al 2015, Sibiya et al 2015, Norton et al 2008, Woodiwiss 
et al 2009, Redelinghuys et al 2010, Norton et al 2012). Briefly, 1197 participants from randomly 
recruited (from the population census figures of 2001) families of black African descent (Nguni 
and Sotho chiefdoms) from the South West Township (SOWETO) of Johannesburg, South 
Africa, with siblings older than 16 years with all central aortic haemodynamic measurements 
were evaluated. In a sub-study, 706 had left ventricular mass index (LVMI) determined by 
echocardiography and PWV assessments. 
 
5.3.2 Clinical, demographic and anthropometric measurements. 
 
See section 2.3.2 for details. 
  
5.3.3 Pulse wave analysis. 
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See section 2.3.4 for details. In addition, PP amplification was determined as the ratio of 
brachial-to-aortic PP. As PP amplification is inversely associated with cardiovascular damage, 
for comparisons of PP amplification-LVMI or LVH relations with relations between alternative 
indexes of aortic function and LVMI or LVH (which are directly proportional to LVMI and LVH), 
PP amplification was expressed as a reciprocal (1/PPamp).  
 
5.3.4 Echocardiography. 
 
See sections 2.3.5 for details (Chirinos et al 2010). In the present study sample, in 
bivariate analysis height is correlated with LVM (r=0.19, p<0.0001), height becomes inversely 
correlated with LVM when indexed to height2.7 (r=-0.24 p<0.0001), but no significant relationship 
between height and LVM is noted when LVM is indexed to height1.7 (r=-0.07, p=0.08). In 
addition, left ventricular hypertrophy (LVH) was identified as an LVMI-ht1.7>80 g/m1.7 for men 
and >60 g/m1.7 for women (Chirinos et al 2010). Left ventricular end diastolic and systolic 
volumes were determined from M-mode images using the Teichholz method. Left ventricular 
ejection fraction (EF) was calculated as [(LV end diastolic volume-LV end systolic volume)/ LV 
end diastolic volume] x 100. 
 
5.3.5 Data analysis. 
 
For database management and statistical analysis, SAS software, version 9.3 (SAS 
Institute Inc., Cary, NC) was employed. Multiple linear regression analysis was performed to 
determine the independent relations between aortic hemodynamic parameters and LVMI 
(continuous data). Multivariate adjusted logistic regression analysis was performed to determine 
the independent relations between aortic haemodynamic parameters and LVH (discrete data). 
Adjustments included in multivariate models were those correlated with central haemodynamic 
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variables and LVMI in bivariate analysis. To determine probability values, further adjustments 
for non-independence of family members was performed using non-linear regression analysis 
(mixed procedure as defined in the SAS package). Regression coefficients were compared with 
z statistics. In order to ensure that the results were not influenced by the presence of 
antihypertensive therapy, sensitivity analysis was also conducted in participants not receiving 
antihypertensive therapy. Moreover, to ensure that wave separation analysis using the 
triangular flow wave did not influence our results, we evaluated whether the essential findings of 
the study could be replicated in the 336 participants in whom wave separation analysis was 
conducted using aortic flow measurements and who had aortic pulse wave velocity 
measurements. 
 
5.4 Results 
 
5.4.1 Characteristics of the participants. 
 
The clinical and demographic characteristics of the participants are shown in Table 1. 
Body mass index and aortic PWV were modestly greater in those in whom echocardiography 
was not available (Table 5.1). Otherwise, no marked differences in the clinical and demographic 
characteristics of the participants included in the echocardiographic sub-study were noted as 
compared to those not included in the sub-study (Table 5.1). The study sample was largely 
young-to-middle aged. 2% of participants had a history of cardiovascular disease. Importantly, a 
high proportion of participants had hypertension, and a significant proportion were not receiving 
therapy (Table 5.1). Moreover, 35% of all participants and 58% of participants receiving 
antihypertensive therapy had uncontrolled hypertension. Of the participants, 45% had LVH. 
 
5.4.2 Relations between aortic hemodynamic measures and PP amplification. 
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PP amplification was correlated with several aortic hemodynamic measures including 
PPc, Pb, PWV and AIx, but not with Pf (Table 5.2). Importantly, the correlation between Pb and 
PP amplification was markedly stronger than that between PWV and PP amplification (Table 
5.2). The relations between aortic Pb, as determined using the aortic flow wave, and PPc 
(r2=0.95), PP amplification (r2=0.36), Pf (r2=0.59), PWV (r2=0.21), and AIx (r2=0.31), were similar  
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Table 5.1. Characteristics of the study sample. 
     Echocardiographic  No  
          Sub-study  echocardiography 
_____________________________________________________________ 
Sample size (% Female)             706 (64.7) 491 (66.3)   
Age (years)                 44.4±18.2 44.1±18.5     
Body mass index (kg/m2)     29.0±7.4 30.3±8.8*                              
% Obese                   42.1     45.6       
Regular tobacco (% subjects)                       16.5     13.8       
Regular alcohol (% subjects)              19.7     21.7       
% with DM or HbA1c>6.1%                                24.5     26.9       
% Hypertensive         45.8     45.9       
% Treated for hypertension         25.8     21.9       
Pulse rate (beats/min)                                        69±10            69±11     
Brachial SBP/DBP (mm Hg)                         128±23/84±12 129±23/84±13                       
Brachial pulse pressure (PP)(mm Hg)               45±17            45±16   
Central aortic SBP (mm Hg)                            120±23            120±23                  
Central aortic PP (PPc) (mm Hg)                      35±15             35±15 
PP amplification (PPamp) (mm Hg)                1.29±0.18        1.30±0.18 
Augmentation index (AIx) (%)                           141±25           142±25 
Aortic forward wave pressure (Pf) (mm Hg)      24±10              24±8 
Aortic reflected wave pressure (Pb)(mm Hg)    17±8                17±8 
Aortic pulse wave velocity (PWV) (m/sec)        6.14±2.71        6.71±2.48** 
Left ventricular mass index (g/m1.7)                   66.2±21.7           - 
_____________________________________________________________ 
Data expressed as mean ± SD or proportions. DM, diabetes mellitus; HbA1c, glycosylated 
haemoglobin; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; PP amplification, aortic-
to-brachial PP amplification. *p<0.05, **p<0.005 vs echocardiographic sub-study group. 
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Table 5.2. Correlations (r2 values) between aortic hemodynamic variables in a community 
sample (n=706). 
 
PPamp PPc            Pb  Pf              AIx  PWV  
____________________________________________________________________  
PPamp                - 
PPc   0.27*  - 
Pb   0.37*  0.95*          - 
Pf   0.02  0.73*         0.57*    - 
AIx   0.63*  0.19*         0.30*   0.002*         - 
PWV   0.10*†  0.32*          0.28*    0.22*         0.09*             - 
_____________________________________________________________________ 
See table 1 for abbreviations. *p<0.0001 for significant correlations. †p<0.0001 versus 
correlation between PP amplification and Pb. 
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to those relations obtained between aortic Pb, as determined using the triangular wave form and 
these aortic hemodynamic variables (Table 5.2). 
 
5.4.3 Associations between aortic function and LVMI or LVH. 
 
Aortic PP, 1/PP amplification, Pb and PWV, but not AIx or Pf were associated with LVMI (Table 
5.3) and LVH (Table 5.4) independent of brachial PP or SBP and additional confounders. The 
relations between Pb or Pf and LVMI obtained with a triangular flow wave were similar to these 
relations determined using Pb and Pf obtained using an actual aortic flow wave (Table 5.3). 
Importantly, 1/PP amplification added to the ability of brachial BP to associate with LVMI or LVH 
(Tables 5.3 and 5.4). Indeed, with the inclusion of 1/PP amplification together with brachial BP 
in multivariate models, brachial BP retained similar independent relations with LVMI or LVH and 
1/PP amplification further added to these effects (Tables 5.3 and 5.4). Of importance, the 
brachial PP-independent relationship between Pb and LVMI was similar after (partial r=0.09, 
p=0.02) as compared to before (partial r=0.09, p=0.02) adjustments for LV ejection fraction. 
 
5.4.4 Aortic function variables that accounts for relations between 1/PP amplification and LVMI 
or LVH. 
 
Adjustments for Pb attenuated the relations between 1/PP amplification and LVMI, or 
LVH (Tables 5.5 and 5.6). However, adjustments for PWV, Pf or AIx failed to modify the 
relations between 1/PP amplification and LVMI, or LVH (Tables 5.5 and 5.6). Importantly, the 
impact of adjustments for Pb and Pf on relations between 1/PP amplification and LVMI were 
similar irrespective of whether Pb or Pf were derived from wave separation analysis performed 
using a triangular wave form or an actual aortic flow wave (Table 5.5). 
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Table 5.3. Relations between brachial or aortic hemodynamic parameters and left ventricular 
mass index in all participants and participants having never received antihypertensive therapy 
(untreated). 
 Models with→          Pulse pressure (PP)            Systolic BP (SBP) 
     Adjustors        Partial r                 p-value          Partial r              p-value   
                 (95% CI)              (95% CI)     
__________________________________________________________________________  
Models: LVMI-ht1.7 vs         
      All participants (n=706) 
1. Brachial PP/SBP     *   0.185 (0.112 to 0.256)  <0.0001     0.204 (0.131 to 0.274)  <0.0001       
2. Brachial PP/SBP     *   -0.009 (-0.083 to 0.065) =0.81   0.025 (-0.049 to 0.099)  =0.50     
    PPc/SBPc        0.080 (0.005 to 0.153)  <0.05         0.021 (-0.053 to 0.095)  =0.58         
3. Brachial PP/SBP     *    0.183 (110 to 0.254)     <0.0001     0.187 (0.114 to 0.257)  <0.0001        
    1/PP amplification         0.120 (0.046 to 0.193)  <0.005       0.091 (0.017 to 0.165)  <0.02      
4. Brachial PP/SBP     *    0.047 (-0.028 to 0.121) =0.22         0.082 (0.007 to 0.156)  <0.05      
    Pb         0. 092 (0.018 to 0.166)  <0.02         0.082 (0.007 to 0.156)  <0.05      
5. Brachial PP/SBP     *    0.157 (0.083 to 0.229)  <0.0001      0.173 (0.099 to 0.244)  <0.0001        
    Pf        -0.055 (-0.129 to 0.0.020) =0.15     -0.023 (-0.098 to 0.051) =0.54      
6. Brachial PP/SBP     *    0.154 (0.080 to 0.226)  <0.0001    0.170 (0.097 to 0.241)  <0.0001        
    PWV        0.093 (0.019 to 0.166)  <0.05    0.080 (0.006 to 0.154)  <0.05 
7. Brachial PP/SBP     *    0.186 (0.113 to 0.257)  <0.0001      0.199 (0.126 to 0.269)  <0.0001          
    AIx                    0.051 (-0.023 to 0.125) =0.18          0.018 (-0.056 to 0.092)  =0.63 
8. Brachial PP/SBP     * 
   Pb† (n=336)   *   0. 130 (0.022 to 0.236)  <0.02          0.130 (0.019 to 0.236)  <0.05 
9. Brachial PP/SBP     * 
    Pf† (n=336)  *    -0. 107 (-0.213 to 0.007)  =0.54       -0.066 (-0.174 to 0.043) =0.      
             Untreated participants (n=524) 
1. Brachial PP/SBP     *   0.224 (0.140 to 0.304)  <0.0001     0.227 (0.143 to 0.307)  <0.0001       
2. Brachial PP/SBP     *   -0.039 (-0.125 to 0.047) =0.37   0.008 (-0.079 to 0.094)  =0.86     
    PPc/SBPc        0.126 (0.039 to 0.210)  <0.005      0.048 (-0.038 to 0.134)  =0.27         
3. Brachial PP/SBP     *    0.226 (142 to 0.306)     <0.0001    0.204 (0.119 to 0.285)  <0.0001        
    1/PP amplification         0.194 (0.109 to 0.275)  <0.0001    0.164 (0.078 to 0.247)  <0.0005      
4. Brachial PP/SBP     *    0.048 (-0.039 to 0.135) =0.28         0.062 (-0.026 to 0.148) =0.17      
    Pb         0. 148 (0.062 to 0.232)  <0.001      0.155 (0.068 to 0.239)  =0.0005      
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5. Brachial PP/SBP     *    0.153 (0.067 to 0.237)  =0.0005      0.161 (0.074 to 0.244)  <0.0005        
    Pf        -0.007 (-0.094 to 0.0.080) =0.88       0.029 (-0.058 to 0.116) =0.51      
6. Brachial PP/SBP     *    0.185 (0.100 to 0.267)  <0.0001     0.181 (0.096 to 0.263) <0.0001        
    PWV        0.095 (0.008 to 0.180)  <0.05     0.094 (0.008 to 0.179)  <0.05 
7. Brachial PP/SBP     *    0.225 (0.141 to 0.305)  <0.0001      0.220 (0.136 to 0.300)  <0.0001          
    AIx                    0.068 (-0.018 to 0.154) =0.12          0.033 (-0.054 to 0.119)  =0.46      
_________________________________________________________________________ 
LVMI-ht1.7, left ventricular mass indexed to height1.7. See table 1 for additional abbreviations. 
Untreated refers to never having received antihypertensive therapy *Adjustments are for age, 
sex, body weight, pulse rate, regular smoking, regular alcohol intake, diabetes mellitus or an 
HbA1c>6.1% and treatment for hypertension (in all). †Refers to data obtained in 392 participants 
in whom wave separation analysis was performed using aortic flow assessments. Variance 
inflation factors (VIF) for all aortic function variables except PPc/SBPc ranged from only 1.43 to 
4.39. VIFs for aortic PPc or SBPc were however 12.31-30.56. VIFs for 1/PP amplification were 
only 1.55 to 1.60.   
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Table 5.4. Relations between brachial and aortic hemodynamic parameters and left ventricular 
hypertrophy (LVH) (317 of all 706 participants and 202 of 524 participants never having 
received antihypertensive therapy [untreated]). 
Models with→          Pulse pressure (PP)           Systolic BP (SBP) 
   Adjustors         OR (95% CI)          p-value      OR (95% CI)           p-value 
_________________________________________________________________________ 
Models: LVH versus      
                     All participants 
1. Brachial PP/SBP    *    1.020 (1.008 to 1.032)  <0.001    1.016 (1.007 to 1.025)  <0.001 
2. Brachial PP/SBP    *     0.988 (0.956 to 1.022)   =0.49       0.995 (0.956 to 1.035)  =0.81 
    PPc/SBPc       1.040 (1.000 to 1.081)   <0.05  1.022 (0.981 to 1.065)   =0.30 
3. Brachial PP/SBP    *    1.020 (1.008 to 1.032)   <0.005     1.013 (1.004 to 1.023)   <0.005 
    1/PP amplification       36.2 (4.2 to 309.6)        <0.005      21.99 (2.51 to 192.71)   =0.005 
4. Brachial PP/SBP     *    0.997 (0.976 to 1.019)  =0.78        1.003 (0.990 to 1.016)   =0.67     
    Pb         1.066 (1.016 to 1.118)  <0.01        1.053 (1.011 to 1.097)   <0.02 
5. Brachial PP/SBP     *    1.025 (1.004 to 1.047)  <0.02        1.015 (1.004 to 1.027)   <0.01 
    Pf          0.997 (0.953 to 1.023)  =0.47        1.000 (0.974 to 1.026)   =0.97 
6. Brachial PP/SBP    *    1.015 (1.003 to 1.028)   <0.05        1.012 (1.002 to 1.021)   <0.02 
    PWV        1.132 (1.037 to 1.236)   <0.01         1.125 (1.030 to 1.229)   <0.01 
7. Brachial PP/SBP     *    1.020 (1.008 to 1.032)  <0.001        1.016 (1.006 to 1.025)   <0.001    
    AIx         1.003 (0.995 to 1.011)  =0.42          1.001 (0.993 to 1.009)   =0.81 
                     Untreated participants 
1. Brachial PP/SBP    *    1.021 (1.006 to 1.036)    <0.01    1.016 (1.005 to 1.027)  <0.005 
2. Brachial PP/SBP    *     0.971 (0.930 to 1.013)   =0.18       0.984 (0.938 to 1.032)  =0.50 
    PPc/SBPc       1.063 (1.012 to 1.117)   <0.02  1.035 (0.985 to 1.087)   =0.17 
3. Brachial PP/SBP    *    1.021 (1.005 to 1.036)   <0.01        1.013 (1.002 to 1.025)   <0.02 
    1/PP amplification       93.6 (7.7 to 999.1)        <0.0005    59.62 (4.82 to 737.82)   <0.005 
4. Brachial PP/SBP     *    0.995 (0.968 to 1.022)  =0.70        1.002 (0.985 to 1.018)   =0.85     
    Pb         1.079 (1.016 to 1.146)  <0.02        1.066 (1.012 to 1.122)   <0.02 
5. Brachial PP/SBP     *    1.015 (0.994 to 1.037)  =0.17        1.013 (0.999 to 1.027)   =0.07 
    Pf         1.009 (0.970 to 1.049)  =0.66        1.011 (0.979 to 1.045)   =0.50 
6. Brachial PP/SBP    *    1.015 (1.000 to 1.031)   <0.05       1.013 (1.000 to 1.026)   <0.05 
    PWV        1.133 (1.006 to 1.275)   <0.05        1.139 (1.004 to 1.293)   <0.05 
7. Brachial PP/SBP     *    1.021 (1.006 to 1.036)  <0.01         1.016 (1.005 to 1.027)   =0.005    
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    AIx         1.004 (0.995 to 1.013)  =0.43         1.002 (0.993 to 1.011)    =0.74 
____________________________________________________________________ 
 OR, odds ratios. See table 1 for additional abbreviations. * Adjustments are for age, sex, body 
weight, pulse rate, regular smoking, regular alcohol intake, diabetes mellitus or an HbA1c>6.1% 
and treatment for hypertension (in all). 
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Table 5.5. Impact of adjustments for aortic function measurements on relations between the 
reciprocal of pulse pressure amplification (1/PP amplification) and left ventricular mass index 
(LVMI) or LV hypertrophy (LVH) (317 of 706 participants) in all participants. 
 
        Adjustors        β-coeff±SEM†         Partial r (95% CI)         p-value    
__________________________________________________________________________ 
LVMI-ht1.7 vs         
     With adjustments for brachial pulse pressure 
1/PP amplification        *         29.0±9.1              0.120 (0.046 to 0.193)    <0.005 
1/PP amplification        * + PWV        29.5±9.1              0.123 (0.049 to 0.195)     =0.001 
1/PP amplification        * + AIx        40.6±12.8            0.119 (0.045 to 0.192)     <0.005     
1/PP amplification        * + Pf        25.6±9.6              0.102 (0.027 to 0.176)     <0.01       
1/PP amplification        * + Pb              20.0±11.7            0.065 (-0.010 to 0.139)    =0.09 
1/PP amplification†        *                       
1/PP amplification†        * + PWV         
1/PP amplification†        * + AIx  
1/PP amplification†        * + Pf               
1/PP amplification†        * + Pb        
     With adjustments for brachial systolic blood pressure 
1/PP amplification        *         22.3±9.2              0.091 (0.017 to 0.164)    <0.02 
1/PP amplification        * + PWV        23.8±9,2              0.098 (0.023 to 0.171)    <0.01 
1/PP amplification        * + AIx        37.4±12.9            0.110 (0.036 to 0.183)     <0.005     
1/PP amplification        * + Pf        20.6±9.9              0.079 (0.004 to 0.153)     <0.05       
1/PP amplification        * + Pb              13.1±10.3            0.049 (-0.026 to 0.123)    =0.20 
1/PP amplification†        *                      31.1±13.0            0.131 (0.023 to 0.237)      <0.02 
1/PP amplification†        * + PWV         
1/PP amplification†        * + AIx  
1/PP amplification†        * + Pf              32.0±13.8            0.129 (0.020 to 0.234)      =0.02 
1/PP amplification†        * + Pb             21.4±14.7            0.081 (-0.029 to 0.189)     =0.15 
        Adjustors       Odds ratio (95% CI)     Wald Х2 p-value 
____________________________________________________________________ 
LVH versus      
     With adjustments for brachial pulse pressure 
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1/PP amplification        *       36.2 (4.2 to 309.6)  10.73  <0.005 
1/PP amplification        * + PWV        37.9 (4.3 to 330.7)  10.80  =0.001   
1/PP amplification        * + AIx      324.4 (15.8 to 999.0)         14.1               <0.0005 
1/PP amplification        * + Pf             32.4 (3.4 to 309.9)              9.12               <0.005  
1/PP amplification        * + Pb            10.0 (0.6 to 157.9)              2.66                =0.10 
     With adjustments for brachial systolic blood pressure 
1/PP amplification        *       22.0 (2.5 to 192.7)  7.79  =0.005 
1/PP amplification        * + PWV        27.9 (3.0 to 242.3)  8.66  <0.005   
1/PP amplification        * + AIx      264.4 (12.5 to 989.9)        12.85               <0.0005 
1/PP amplification        * + Pf             25.4 (2.4 to 264.9)              7.30               <0.01  
1/PP amplification        * + Pb            7.3 (0.6 to 82.4)                  2.58                =0.11 
____________________________________________________________________ 
 See table 1 for abbreviations. * Adjustments are for brachial pulse pressure or systolic blood 
pressure as indicated, age, sex, body weight, pulse rate, regular smoking, regular alcohol 
intake, diabetes mellitus or an HbA1c>6.1% and treatment for hypertension. †Refers to data 
obtained in 336 participants where Pb and Pf were derived from wave separation analysis using 
actual aortic flow waves Variance inflation factors for 1/PP amplification for all models ranged 
from only 1.55 to 3.12. 
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Table 5.6. Impact of adjustments for aortic function measurements on relations between the 
reciprocal of pulse pressure amplification (1/PP amplification) and left ventricular mass index 
(LVMI) in participants not receiving antihypertensive therapy (n=524). 
 
        Adjustors        β-coeff±SEM†         Partial r (95% CI)         p-value    
__________________________________________________________________________ 
LVMI-ht1.7 vs         
     With adjustments for brachial pulse pressure 
1/PP amplification        *         44.8±9.2              0.211 (0.126 to 0.292)    <0.0001 
1/PP amplification        * + PWV        44.7±9.2              0.206 (0.121 to 0.287)    <0.0001 
1/PP amplification        * + AIx        64.0±12.9            0.215 (0.131 to 0.296)     <0.0001     
1/PP amplification        * + Pf        45.8±9.7              0.207 (0.121 to 0.289)     <0.0001       
1/PP amplification        * + Pb              30.0±11.6            0.114 (0.027 to 0.200)†     <0.05 
 
     With adjustments for brachial systolic blood pressure 
1/PP amplification        *         39.5±9.4              0.184 (0.098 to 0.266)    <0.0001 
1/PP amplification        * + PWV        39.2±9.4              0.183 (0.097 to 0.265)    <0.0001 
1/PP amplification        * + AIx        61.7±13.0            0.207 (0.122 to 0.288)    <0.0001     
1/PP amplification        * + Pf        44.4±10.1            0.194 (0.108 to 0.276)    <0.0001       
1/PP amplification        * + Pb              24.0±10.5            0.101 (0.014 to 0.187)    <0.05 
____________________________________________________________________ 
 See table 1 for abbreviations. *Adjustments are for brachial pulse pressure or systolic blood 
pressure as indicated, age, sex, body weight, pulse rate, regular smoking, regular alcohol 
intake, and diabetes mellitus or an HbA1c>6.1%. †p=0.05 versus adjustors alone. Variance 
inflation factors for 1/PP amplification for all models ranged from only 1.55 to 3.08. 
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5.5 Discussion 
  
The main findings of the present study are as follows: In a community-based sample of 
largely young-to-middle-aged participants of African ancestry I show that the reciprocal of PP 
amplification was independently associated with and added to the ability of brachial BP to 
associate with LVMI and LVH. This was noted even when aortic PP, although showing 
independent relations with LVMI and LVH replaced rather than added to brachial BP in 
associations with LVMI and LVH. The brachial BP-independent relations between the reciprocal 
of PP amplification and LVMI or LVH were abolished with adjustments for the reflected 
(backward) wave pressure (Pb), but not aortic PWV, suggesting that variations in wave 
reflection largely account for the ability of PP amplification to associate with LVMI and LVH 
beyond brachial BP in this community sample. 
Several studies have demonstrated a brachial BP-independent relationship between 
aortic-to-brachial PP amplification and outcomes (Benetos et al 2010, Regnault et al 2012, 
Benetos et al 2012, Bursztyn et al 2016). However, the mechanisms of this effect are uncertain. 
To the best of our knowledge, the present study represents the first study to show an ability of 
the reciprocal of PP amplification to add to the ability of brachial BP to associate with LVMI or 
LVH, suggesting that adverse effects on cardiovascular outcomes may be mediated in-part 
through an independent effect on LVM. 
 Prior studies reporting on the adverse effects of PP amplification on outcomes (Benetos 
et al 2010, Regnault et al 2012, Benetos et al 2012, Bursztyn et al 2016) have assumed that all 
of those physiological factors that determine variations in PP amplification contribute to the 
ability of this aortic function variable to risk predict. In this regard, amplification of PP from the 
aorta to the brachial artery is largely determined by increments in stiffness from the aorta to the 
brachial artery (Avolio et al 2009, Nichols et al 2011). With an increasing aortic stiffness whilst 
brachial stiffness remains relatively stable, PP amplification decreases and hence associations 
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between a reduced PP amplification and LVMI are thought to be through an enhanced aortic 
stiffness. However, the inclusion of aortic PWV in multivariate models, an accepted referent 
method of assessing aortic stiffness, failed to modify relations between PP amplification and 
LVMI or LVH. Thus, the ability of PP amplification to independently associate with LVMI and 
LVH in the young-to-middle-aged is unlikely to be accounted for by variations in aortic stiffness. 
 Decreases in PP amplification are also determined by increases in aortic backward 
waves, produced either by increments in the magnitude of the pressure or the speed of 
backward wave travel (Avolio et al 2009, Nichols et al 2011). An increased magnitude of the 
backward wave or an earlier time of backward wave arrival will enhance aortic PP with a lesser 
effect on brachial PP, the consequence being a reduced PP amplification. In the present study, 
as with PP amplification, reflected wave pressure was also independently related to LVMI and 
LVH. Moreover, adjusting for reflected wave pressure markedly attenuated or abolished the 
independent relations between the reciprocal of PP amplification and LVMI and LVH and the 
ability of the reciprocal of PP amplification to add to brachial PP-LVMI or LVH associations. 
These data suggest that reflected wave pressure may in-part account for the independent 
relations between the reciprocal of PP amplification and LVMI and LVH in the young-to-middle-
aged. 
 Pulse pressure amplification is often attributed to increases in aortic PWV causing a 
greater speed of wave reflection, an enhanced overlap between the forward and reflected 
waves and an increase in aortic augmentation index and hence aortic PP. However, PP 
amplification was more strongly correlated with reflected wave pressure (r2=0.37) than with 
PWV (r2=0.10). Moreover, whilst reflected wave pressure was independently associated with 
LVMI and LVH and made a significant contribution to relations between PP amplification and 
LVMI or LVH, augmentation index was not independently associated with LVMI and LVH and 
made no significant contribution to relations between PP amplification and LVMI or LVH. Hence, 
the contribution of reflected wave pressure to variations in PP amplification or to the relationship 
- - 133 - 
 
  
between PP amplification and LVMI or LVH cannot be attributed to an enhanced overlap 
between the forward and reflected waves with a consequent increase in augmentation index. 
 The present study design (cross-sectional) does not allow me to draw conclusions as to 
cause and effect. It may therefore be argued that LVH enhances systolic function and hence 
aortic backward wave pressures (reverse causality) rather than increases in aortic backward 
wave pressures increase LVMI. However, the relationship between aortic backward wave 
pressure and LVMI or LVH was unchanged with adjustments for LV ejection fraction. Hence, I 
assume that this relationship is explained by increases in backward wave pressures resulting in 
increases in LVMI and LVH rather than LVH promoting an enhanced systolic function and hence 
an increased backward wave pressure.    
 A caveat of the present study is that the present results do not discount the possible role 
of aortic PWV in mediating brachial PP-independent relations between PP amplification and 
LVMI or LVH at an older age. In this regard, aortic PWV only begins to increase to a marked 
extent between 50 to 60 years of age (Mitchell et al 2010b), which is at least a decade older 
than the average age of the present study group. Hence, in the present sample PWV may not 
contribute to any marked extent to PP amplification, but may in samples represented by an 
older age group. Indeed, the correlation (r2) between PWV and PP amplification in the present 
study sample was only 0.10 (p<0.0001). The present study nevertheless highlights the 
importance of aortic backward wave function in mediating cardiovascular end-organ changes 
and explains at least a significant portion of the independent relation between the reciprocal of 
PP amplification and LVMI and therefore possibly some of the independent relations between 
PP amplification and outcomes (Benetos et al 2010, Regnault et al 2012, Benetos et al 2012, 
Bursztyn et al 2016). 
A further caveat of the present study is that I studied only one ethnic group (black 
African) in which aortic backward waves are markedly higher than in alternative groups 
(Chirinos et al 2011). In this regard some populations, such as the Framingham sample, where 
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a high proportion of participants were receiving antihypertensive therapy which decreases 
backward wave pressures, show only small age-related increases in aortic backward waves and 
hence only modest age-related increments in PP amplification (Mitchell et al 2010b). In the 
Framingham sample therefore, PP amplification was not an independent predictor of outcomes ( 
Mitchell et al 2010a).    
 There are several limitations to the present study that warrant consideration. First, the 
present study was a cross-sectional design and cardiovascular end-organ measures were 
employed as surrogates of outcomes. Hence, the present study provides no conclusive 
evidence that aortic backward waves mediate the relationship between PP amplification and 
LVMI and whether similar relations with hard end-points is unknown. Further longitudinal and 
intervention (targeting backward waves) studies are therefore required with hard end-points 
included as outcomes. Second, the assumptions intrinsic to the use of the ‘triangulation method’ 
of aortic wave separation may not be ideal (Kips et al 2009). However, in 392 participants of the 
present sample with aortic velocity measurements, we were able to show a correlation (r2) 
between Pb derived from the ‘triangulation method’ versus ‘actual aortic flow’ methods of wave 
separation of 0.82 and a correlation (r2) between Pf derived from the ‘triangulation method’ 
versus ‘actual aortic flow’ methods of wave separation of 0.88. Moreover, in sensitivity analysis 
conducted in those participants in whom wave separation analysis was performed using aortic 
flow waveforms and in whom aortic PWV measurements were available, relations between Pb 
and other aortic hemodynamic variables were similar to those between Pb determined using a 
triangular flow wave, and these aortic variables. Furthermore, irrespective of whether wave 
separation analysis was performed using a triangular wave form or an actual aortic flow wave, 
relations between Pb or Pf and LVMI were similar and the impact of adjustments for Pb and Pf 
on relations between PP amplification and LVMI were the same. Hence, at least in the present 
study, the use of the ‘triangulation method’ is unlikely to have significantly affected our results. 
Third, in the present study, calibration of the radial waveform from brachial BP measurements 
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ignores amplification of BP from brachial to radial arteries (Picone et al 2015). Hence, aortic 
pressures are likely to have been underestimated using the current approach. However, Pb and 
Pf are equally susceptible to errors in calibration and Pb and not Pf accounted for the ability of 
PP amplification to associate with LVMI and LVH beyond brachial BP. 
 In conclusion, in the present study I show in a largely young-to-middle aged community 
sample, that the reciprocal of PP amplification adds to the ability of brachial PP and 
conventional risk factors to associate with LVMI and LVH and that this is in-part accounted for 
by an increased backward wave pressures, but not by aortic pulse wave velocity. These findings 
may add to our understanding of the ability of aortic functional variables to detect end-organ 
changes beyond brachial BP. 
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6.1 Introduction 
 
In the present thesis I have performed a series of studies in a group of African ancestry 
living in SOWETO, South Africa (previously disadvantaged community) that have advanced our 
knowledge on the role of various indices of aortic function as possible factors that are 
associated with cardiovascular end-organ measures beyond brachial blood pressure (BP). In 
the present chapter I will summarize these findings and place them in context with the field of 
aortic function in general and with the possibility of how aortic function may be employed to 
enhance risk prediction beyond conventional risk factors in a resource limited country such as 
South Africa. In this regard, it is important to first emphasize several points highlighted in 
chapter 1 regarding cardiovascular disease in South Africa. 
There is no question that the world’s burden of cardiovascular disease is now in 
developing rather than in developed nations, and South Africa, as an economically developing 
nation, is no exception to this finding (Roth et al 2015). Whilst in developed countries age-
adjusted mortality rates attributed to cardiovascular disease in 2013 were estimated to be 160 
per 100 000 persons, in South Africa they were estimated to be 250-to-325 per 100 000 people 
(Roth et al 2015). In this regard, there are several factors which may account for these higher 
mortality rates attributed to cardiovascular disease in South Africa as compared to developed 
nations. As with other developing nations around the world, South African populations are 
undergoing an epidemiological transition, where diseases of lifestyle are beginning to replace 
diseases of poverty (infectious diseases and malnutrition). Lifestyle changes in developing 
nations that are likely to account for a higher prevalence of cardiovascular diseases include 
more tobacco use, a more sedentary work and social environment, less time to walk to work or 
other destinations and an easier access to motor vehicles (and hence lower levels of activity), 
higher stress occupations, and easier access to fast foods with an emphasis on dietary habits 
that provide instant gratification (high sodium, saturated fat, and high glycaemic index-sugar 
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diets). All of these changes promote the development of cardiovascular risk factors (an 
increased BP, cholesterol concentrations and a greater risk of type II diabetes mellitus) and 
through limited overall education levels in developing nations (few gain tertiary level education), 
a lack of awareness of the importance of early identification of risk factors and the variety of 
safe means to treat these risk factors. 
The aforementioned factors that contribute toward increasing prevalence rates of 
cardiovascular risk factors and a lack of awareness and treatment of these risk factors, are all 
confounded by limited resources at a primary healthcare level. For example primary healthcare 
clinics in South Africa often do not carry appropriate medication (lipid lowering therapy is not 
available); do not have the means to assess blood and other markers useful for risk prediction 
(e.g the assessment of lipid profiles, markers of renal function, glycated haemoglobin levels for 
patients with diabetes mellitus and electrocardiography); and do not have access to reliable BP 
monitors (they are often not serviced or for cost purposes are purchased having never been 
validated). A limited number of primary healthcare clinics and understaffing results in long 
patient waiting times (often entire days of work are lost) and a lack of faith in healthcare 
services. Limited budgets necessitates the dispensation of chronic medication on a monthly 
rather than 6 monthly basis and hence the need for frequent visits to clinics with further loss of 
work and greater costs to patients. In addition, because of low doctor-patient ratios, primary 
health care is often only provided by nurses with a limited ability to detect pathology or refer on 
to secondary or tertiary hospitals. Moreover, limited resources in developing countries prevents 
appropriate tertiary healthcare so that patients who have an event do not receive the same level 
of care as in developed countries (e.g. patients with stroke seldom receive thrombolysis; 
patients with myocardial infarction requiring catheterization and stenting often do not receive 
this care; and patients requiring valve replacements or bypass grafts do not receive these 
procedures). It is only with economic development, better education, and more resources for 
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healthcare that many of the aforementioned factors responsible for the burden of cardiovascular 
deaths in developing nations can be addressed. 
Despite all of the problems listed above, there is overwhelming consensus that 
prevention of an event is more cost-effective than managing the event once it has occurred. 
Hence, the focus in developing nations should always be on early cardiovascular risk 
identification and management of risk factors. As indicated in chapter 1 of the present thesis, of 
all the risk factors for cardiovascular disease most population attributable risk for cardiovascular 
events is determined by hypertension (Steyn et al 2005, Rayner et al 2010, Huang et al 2013, 
Park et al 2015) and presently Africa has the highest prevalence of hypertension (NCD-RisC 
2017). For the past century BP has been determined at the brachial artery and there is no 
question that brachial BP is a strong cardiovascular risk predictor. However, in South Africa and 
elsewhere in the world there are several reasons to believe that the ability to predict 
cardiovascular risk may, in the future, be better determined using a combined approach which 
employs both brachial and aspects of aortic BP measurements. Given the ease (non-invasive 
and requires little expertise to perform the measurement with accuracy) and reproducibility with 
which these aortic BP measurements can be made, together with the declining costs of 
measurement devices (often no more expensive than a reliable and validated oscillometric BP 
device), due consideration has to be given to the ability to add to risk prediction in South Africa 
using these approaches. What is the evidence to indicate that the measurement of certain 
aspects of aortic BP may enhance risk prediction beyond brachial BP; are there compelling 
reasons why these measurements should be made in Africa; and how has the present thesis 
added to our understanding of what aspects of aortic BP measurement may add to risk 
prediction in South Africa? 
 
6.2 Aortic BP measurements and risk prediction beyond brachial BP. A need for clarity  
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 As highlighted in chapter 1 of the present thesis there is considerable controversy as to 
whether aortic systolic BP (SBP) or pulse pressure (PP) add to brachial SBP or PP in risk 
prediction. There are several studies that suggest that aortic SBP or PP are more strongly 
associated with end-organ measures than brachial BP or associated with end-organ measures 
independent of brachial BP (Safar et al 2002, Williams et al 2006, Roman et al 2007, Jankowski 
et al 2008, Pini et al 2008, Wang et al 2009, Benetos et al 2010, Regnault et al 2012, Dart et al 
2006, Norton et al 2012, Booysen et al 2013). The results of many of these studies has recently 
been included in a meta-analysis and this meta-analysis clearly shows a stronger association of 
aortic SBP or PP with end-organ measures than does brachial SBP or PP (Kollias et al 2016). In 
South Africa, there is also evidence, produced by our group, to show that aortic PP is 
associated with end-organ measures independent of brachial SBP or PP (Norton et al 2012). In 
that study (Norton et al 2012) the authors provided the evidence to show that the second 
systolic shoulder of the peripheral pulse, which closely approximates aortic SBP or PP derived 
from conversion of the radial into an aortic pulse wave using a generalized transfer function 
(GTF), is as closely associated with end-organ measures beyond brachial SBP or PP as is 
aortic SBP or PP derived from a GTF. These data suggested that the GTF, which because it 
has not been disclosed by the manufacturer has thus been a subject of much criticism, is 
unnecessary to identify end-organ changes beyond brachial BP (first systolic shoulder). This 
finding (Norton et al 2012) therefore raised the question of whether simpler approaches 
(peripheral pulse wave analysis without the need to convert the data to aortic pressures) was 
sufficient to risk predict beyond brachial pressures. These findings (Norton et al 2012) therefore 
also raised the question of whether the cost of risk predicting beyond brachial BP using pulse 
wave analysis may not be considerably cheaper (some of the cost is in the GTF which has a 
patent on it) than even present costs (which are no more expensive than some validated 
oscillometric brachial BP devices). However, in contrast to the relatively consistent findings of a 
brachial SBP and PP- independent relationship between aortic PP and SBP (derived either from 
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the GTF or estimated only from the second systolic shoulder of the peripheral pulse wave) and 
end-organ measures, the role of aortic SBP or PP in actual risk prediction beyond brachial BP 
has been far more controversial. What are the important features of this controversy? 
 As reviewed in section 1.2.4 of chapter 1 of the present thesis, although several initial 
studies demonstrated that aortic SBP or PP predicted risk beyond brachial BP, there were 
additional studies that failed to do so and a meta-analysis of these studies (Vlachopoulos et al 
2010), showed only a trend for a stronger relationship with cardiovascular outcomes than 
brachial SBP or PP. Subsequent larger studies have similarly failed to show consistency, with 
some (Williams et al, 2006, Wang et al 2010), but not others (Mitchell et al 2010a, Benetos et al 
2010, Regnault et al 2012, Benetos et al 2012, Chirinos et al 2012, Bursztyn et al 2016) 
demonstrating a stronger relationship between aortic PP or SBP and outcomes than brachial 
SBP or PP. These inconsistent findings are likely to be attributed to the strong correlations 
between aortic and brachial SBP or PP (r2=0.96 0r 0.91, p<0.0001 in our large [n=1185] 
community-based sample) despite often considerable differences in aortic and brachial BP, and 
question the value of using aortic SBP or PP to replace brachial SBP or PP. These inconsistent 
findings have led many investigators to seek alternative indices of aortic function when adding 
to risk prediction beyond aortic BP. What are some of these indices; is there sufficient evidence 
to support the use of these approaches in Africa and around the world; and how has the current 
thesis added to our overall understanding of these issues? 
 
6.3 Aortic reflected waves as determined using augmentation indices: Should these be used 
to risk predict in Africa and elsewhere? 
 
There are two essential explanations for variations in the difference between aortic and 
peripheral arterial BP and these have been described in chapter 1 of the present thesis (see 
sections 1.2.2, 1.2.3 and 1.2.4). To recapitulate, these are differences in stiffness between the 
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aorta and peripheral arteries, where an increased aortic stiffness reduces the difference 
between aortic and brachial pulse pressure (PP), and the effect of increases in aortic backward 
(reflected) wave pressures which similarly reduce the difference between aortic and brachial 
PP. At present aortic stiffness, as determined using aortic pulse wave velocity (PWV) is 
recommended for risk prediction (Vlachopoulus et al 2010, Ben-Shlomo et al 2014). However, 
the role of aortic reflected wave function is more controversial. As highlighted throughout this 
thesis, there are two fundamental approaches to assessing aortic backward (reflected) wave 
effects. The more commonly employed and easier to use approach is to determine indices of 
aortic systolic pressure augmentation and these include augmented pressure (Pa) and 
augmentation index (AIx). In this regard, as described by a collaborative study involving various 
populations around the world, including the SOWETO community sample reported on in the 
present thesis, marked ethnic differences in AIx occur with the highest values reported in people 
living in SOWETO (black African ancestry) (Chirinos et al 2011). These data suggest that if 
aortic backward wave function is important as a determinant of cardiovascular damage, that 
brachial BP in groups of African ancestry may be insufficient to detect the adverse effects of 
increased pressures on the cardiovascular system and that AIx may be an important additional 
measurement. In work performed by our group at a similar time on the community sample 
reported on in the present thesis, we demonstrated that salt intake as indexed by urinary 
Na+/K+, was independently associated with AIx (Redelinghuys et al 2010). These data 
(Redelinghuys et al 2010) suggested a possible mechanism for the increased AIx in the study 
sample reported on (Chirinos et al 2011) as it is well recognized that groups of African descent 
have a higher prevalence of salt sensitive hypertension than other ethnic groups. The question 
therefore is whether AIx should be employed to add to brachial BP to enhance risk prediction in 
groups of African ancestry in South Africa? 
As described in chapter 1 (section 1.3.3) of the present thesis, earlier studies 
demonstrated that aortic backward (reflected) waves, as determined from indices of pressure 
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augmentation (Pa or AIx) are associated with cardiovascular damage (Hashimoto et al 2007, 
Hashimoto et al 2006, Weber et al 2006, Westerbacka et al 2005, Sibiya et al 2014), and predict 
cardiovascular outcomes (Chirinos et al 2005, London et al 2001, Ueda et al 2004, Weber et al 
2005) independent of brachial BP. A meta-analysis of these and other outcome driven studies 
provides clear evidence that indices of aortic pressure augmentation predict outcomes beyond 
brachial BP (Vlachopoulos et al 2010). However, several additional studies (Dart et al 2006, Pini 
et al 2008, Roman et al 2007, Safar et al 2002,), including the Framingham Heart Study 
(Mitchell et al 2010a) failed to show that indices of aortic pressure augmentation predict 
outcomes independent of brachial BP. Nevertheless, it has become apparent that Pa and AIx 
are determined by several factors other than aortic reflected wave magnitude, including 
changes in aortic reservoir function, the timing or magnitude of the aortic forward wave, the 
timing rather than the magnitude of the aortic reflected wave, and left ventricular systolic 
function (Aviolo et al 2009, Agabiti-Rosei et al 2007, London 2001 et al 2001, Ueda et al 2004, 
Weber et al 2005). It is therefore conceivable that indices of aortic pressure augmentation may 
be useful for risk prediction in some, but not others, depending on the extent to which the 
magnitude of wave reflection or other factors play a role in determining Pa or AIx and whether 
these factors contribute significantly to end-organ changes. What are the possible factors that 
may modify whether Pa or AIx add to risk prediction? 
The impact of gender on aortic augmentation index (AIx) (augmentation pressure/aortic 
pulse pressure), is well-recognized. In this regard, women may have a higher AIx than men 
(Weber et al 2005, Mtchell et al 2010b) , but these differences may be attributed to factors 
unrelated to aortic wave reflection, including a greater forward wave magnitude (Weber et al 
2005). Hence, depending on the contribution of these alternative factors to cardiovascular 
disease, the impact of AIx on cardiovascular damage in women may not be as strong as that in 
men. Indeed, while AIx predicts outcomes in men, similar relationships may be diminished in 
women (Wang et al 2010. Nevertheless, in that study (Wang et al 2010) unadjusted  
- - 144 - 
 
  
relationships between AIx and end-organ changes were no different in women as compared to 
men. However, multivariate adjusted relationships between AIx and end-organ changes were 
not reported on (Wang et al 2010). To clarify whether gender influences relationships between 
AIx and cardiovascular end-organ changes, as part of the present thesis (chapter 2, Sibiya et al 
2014) I therefore compared the association between AIx and left ventricular mass index (LVMI) 
in men and women in a large, community-based sample in SOWETO. In this regard, LVMI and 
the regression thereof with antihypertensive therapy are well-recognised independent predictors 
of cardiovascular outcomes (Hughes et al 2014, Norton et al 2008, Woodiwiss et al 2009, 
Redelinghuys et al 2010, Norton et al 2012, Westerhof et al 2006, Sahn et al 1978, Devereux et 
al 1986).  What were the findings and clinical implications of that study?   
In that study described in chapter 2, and published in the journal Hypertension Research 
(Sibiya et al 2014) I demonstrated that AIx was independently associated with LVMI in men, but 
not in women. As indicated in the discussion to this chapter (chapter 2), there are several 
possible explanations for the gender-specific impact on relations between AIx and LVMI noted 
in that study, or between AIx and cardiovascular outcomes in a previous study (Wang et al 
2010). Whether the lack of independent association between AIx and LVMI in women in that 
study was attributed to the confounding effect of several factors other than reflected wave 
magnitude contributing to AIx but not LVMI was uncertain at the time of the original publication. 
Indeed, in women AIx may not depend on reflected wave magnitude as much as on forward 
wave magnitude, and the timing of aortic forward and backward waves (Weber et al 2005). 
Some of these factors may have little impact on cardiovascular risk and hence create a low 
signal-to-noise ratio. Alternatively, reflective wave function may contribute little toward the 
impact of aortic PPc on cardiovascular damage in women, whereas the effect is prominent in 
men. Indeed, in a large, community-based study, both AIx and the reflection index derived from 
wave separation analysis predicted cardiovascular outcomes in men, but not in women (Wang 
et al 2010). As I did not have access to software to separate the forward and the backward 
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waves at the time of publishing the data in chapter 2 (Sibiya et al 2014), I could not determine 
whether the sex-specific relationship reported on was attributed to AIx being a poor index of 
reflected wave magnitude, or because reflected waves contribute little toward LVMI in women of 
African ancestry. Hence, further studies were required employing wave separation analysis to 
address these questions. With the acquisition of the software to separate forward and backward 
waves, I subsequently performed these analyses and these findings are reported in chapter 3. 
What are the implications of the findings in chapter 3? 
 
6.4 Aortic reflected waves as determined using wave separation analysis: Should these be 
used to risk predict in Africa and elsewhere? 
 
As indicated in chapter 1 (sections 1.3.3, 1.3.4 and 1.3.5), there are several studies that 
have described an association of reflected waves (Pb or the reflected wave index) derived from 
wave separation analysis with end-organ changes (Wang et al 2010, Weber et al 2012) or an 
ability of Pb or the reflection index (RI)(or reflected wave magnitude) to risk predict beyond 
brachial BP (Wang et al 2010, Weber et al 2012, Chirinos et al 2012, Zamani et al 2014). 
Although there is now considerable evidence to support a role of aortic backward waves in risk 
prediction, neither Pb nor the reflected wave index were independently associated with 
cardiovascular outcomes in the Framingham Heart study (Cooper et al 2014). Nevertheless as I 
have repeatedly pointed out, a high proportion of the participants of the Framingham Study were 
receiving antihypertensive therapy, and as discussed in section1.3.6, antihypertensive agents 
reduce aortic backward wave pressures. Consequently, aortic backward waves in the 
Framingham Heart Study failed to contribute as much as aortic forward waves to age-related 
increases in aortic PP as did aortic forward wave pressures (Mitchell et al 2010b). Hence, it is 
likely that the use of antihypertensive therapy confounded the cardiovascular outcomes data in 
the Framingham Heart study (Cooper et al 2014). As pointed out by the data reported on in 
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chapter 2 (Sibiya et al 2013), an additional possibility is that aortic reflected waves do not 
contribute to risk prediction in women. To draw this conclusion nevertheless, it was necessary 
for me to evaluate relations between aortic backward waves, determined from, wave separation 
analysis, and aortic PP and LVMI in the SOWETO cohort. This approach is clearly not 
confounded by the many determinants of Pa and AIx, including forward wave pressures and the 
timing of forward and backwards waves. In this regard, the manufacturer of the device 
employed to assess aortic function had recently introduced software to perform wave separation 
analysis using an assumed ‘triangular’ flow wave, and hence this afforded me the ability to 
address this question. What are the results and the implications of this study (chapter 3, 
Booysen et al 2015)? 
As reported in chapter 3, and published in the journal Hypertension (Booysen et al 2015) 
where I am a co-author and responsible for the sex-specific analyses, I have shown that the 
contribution of aortic backward waves, determined from wave separation analysis, to variations 
in aortic PP and hence LVMI is similar in men as it is in women (Booysen et al 2015). In 
contrast, as described in chapter 2 and again shown in chapter 3, Pa and AIx were correlated 
with LVMI in men, but not in women. These results (Booysen et al 2015) therefore provided the 
evidence to suggest that the use of Pa or AIx was a particularly poor index of the adverse 
effects of backward wave function on aortic PP or end organ measures in women (Booysen et 
al 2015). Moreover, in that study (Booysen et al 2015), although AIx and Pa were independently 
associated with aortic PP and LVMI in men, even in men the relatively greater contribution of 
aortic backward as compared to forward wave function was markedly underestimated when AIx 
or Pa were employed as measures of aortic backward wave pressures. Hence, at least in the 
African context these data suggest that AIx and Pa should not be employed as approximates of 
aortic backward wave effects in either women or men (Booysen et al 2015). Rather, these data 
(Booysen et al 2015) suggest that adverse effects of aortic backward waves can only be 
accurately assessed using wave separation analysis. Hence, these findings support the view 
- - 147 - 
 
  
that further outcome-based studies assessing the ability of aortic backward wave function, as 
determined using wave separation analysis, to risk predict in groups of African descent, are 
required. 
 
6.5 Aortic reflected waves as determined using wave separation analysis: Are they better 
associated with end organ measures than forward wave pressures? 
 
As indicated throughout the present thesis, aortic PP is determined by both forward and 
backward waves. As also demonstrated in chapter 3, aortic backward wave pressures 
contribute more toward variations in aortic PP and LVMI than aortic forward wave pressures and 
this is not sex-specific (Booysen et al 2015) as previous data had suggested (Sibiya et al 2014). 
In this regard, several studies have similarly evaluated the relative contribution of forward and 
backward wave pressures to variations in end-organ measures or cardiovascular outcomes 
(Wang et al 2010, Chirinos et al 2012, Weber et al 2012, Zamani et al 2014, Hughes et al 2014). 
Importantly, in some of these studies (Wang et al 2010, Chirinos et al 2012, Zamani et al 2014, 
Hughes et al 2014) indices of reflected waves predicted cardiovascular outcomes independent 
of brachial BP. However, whether forward wave pressures also associate with cardiovascular 
damage independent of brachial BP, and the relative contribution of forward and backward 
wave pressures to the brachial BP-independent relationship between aortic PP and 
cardiovascular damage was uncertain. In these prior studies, closer relations between reflected 
as compared to forward wave indices and end-organ measures (Wang et al 2010, Weber et al 
2012) or cardiovascular outcomes (Zamani et al 2014) were reported on. However, neither of 
the studies reporting on relations between forward or backward wave pressures and end-organ 
measures (Wang et al 2010, Weber et al 2012) were these relations assessed with adjustments 
for brachial BP. Nevertheless, even without adjustments for brachial BP, backward but not 
forward wave pressures had been demonstrated to predict cardiovascular outcomes (Zamani et 
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al 2014). The question of whether aortic forward wave pressures also contribute to 
cardiovascular damage beyond brachial BP is essential to an understanding of whether aortic 
PP (which reflects the composite of forward and backward wave pressures) or aortic backward 
wave pressures (or the reflected wave magnitude) per se should be determined when risk 
predicting. In this regard, because forward wave pressures are amplified from the aorta to the 
brachial artery, and because aortic backward wave pressures appear as a lower second systolic 
shoulder on the peripheral pulse, either forward or backward wave pressure effects on end-
organ measures could be underestimated with brachial BP measurements. What has the 
present thesis added to our understanding of the relative role of aortic forward and backward 
wave pressures, independent of brachial BP, to end-organ measures? 
 In chapter 4 and published in J Hypertension (Sibiya et al 2015) I have provided strong 
evidence to show that backward wave pressures and the reflected wave magnitude or index, 
but not forward wave pressures are associated with end-organ measures and damage 
independent of brachial BP. Further, I show that the brachial BP-independent relationships 
between aortic PP and end-organ measures are largely accounted for by backward wave 
pressures, but not by forward wave pressures. Nevertheless, without adjustments for brachial 
BP, but with adjustments for steady-state pressures (mean arterial pressure) both forward wave 
and backward wave pressures were associated with end-organ measures. Importantly, unlike in 
chapters 2 and 3 where my focus was on LVMI as the main end-organ change, in chapter 4 my 
findings were largely reproduced across several end-organ measures involving LV structure and 
diastolic function, carotid intima-media thickness, an index of atherosclerosis, aortic PWV, an 
index of arteriosclerosis, and estimated glomerular filtration rate, an index of renal function. 
Hence, the present study suggests that although both forward and backward wave pressures 
contribute to end-organ changes, brachial BP-independent relations between aortic pressure 
and cardiovascular end-organ changes are largely attributed to backward (reflected) rather than 
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forward wave pressure effects. As pointed out in chapter 4, these findings have several 
important clinical implications. What are these implications? 
The findings reported in chapter 4 suggest that whilst the adverse effects of forward 
wave pressures are likely to be revealed using brachial BP measurements, backward wave 
pressure effects are unlikely to be readily detected using brachial BP measurements. The fact 
that forward wave pressures are associated with end organ measures, but not independent of 
brachial BP, suggests that brachial and aortic PP share similar features (both signal forward 
wave pressure effects) and hence that the better aortic function index to add to risk prediction 
beyond brachial BP is backward wave pressure effects. The results described in chapter 4 may 
also in-part explain why in community samples where the backward wave contributes little to 
age-related increases in aortic BP (Mitchell et al 2010b) aortic pressure does not predict 
cardiovascular outcomes beyond brachial BP (Mitchell et al 2010a), whilst in community 
samples where a strong age-related increase in the backward wave pressures occurs (Wang et 
al 2010), aortic BP predicts outcomes beyond brachial BP (Wang et al 2009). 
 
6.6 Are there alternative approaches to assessing aortic reflected wave effects? 
 
To recapitulate, the work that I have conducted as part of the present thesis and 
described in chapters 2-4, has demonstrated that although both aortic forward and backward 
waves associate with end-organ measures independent of steady-state pressures (mean 
arterial pressure), aortic backward, but not forward waves account for the brachial PP or SBP-
independent relations between aortic PP and end organ measures (chapter 4 and published as 
Sibiya et al 2015). The independent relations between aortic backward wave pressures and 
end-organ measures are nevertheless poorly indexed by aortic augmented pressure or 
augmentation index (chapters 2 and 3 and published as Sibiya et al 2013 and Booysen et al 
2015) as surrogates of backward wave function. Moreover, the use of aortic augmented 
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pressure or augmentation index as indexes of the adverse effects of aortic backward wave 
function on end-organ measures is particularly inappropriate in women (chapter 2 and published 
as Sibiya et al, 2014). These findings together therefore suggest that in groups of African 
ancestry in South Africa, aortic backward wave function may enhance risk prediction beyond 
brachial BP, but that simple approaches to detecting backward wave effects, such as the use of 
augmented pressure or augmentation index, are inappropriate for routine use. Assuming that 
these findings translate into cardiovascular outcomes, how does this information better inform 
as to how best to risk predict in Africa? 
Until devices or approaches that assess aortic backward wave effects become no more 
expensive than validated oscillometric devices employed to assess brachial BP, and where 
brachial BP and aortic backward wave pressures can be measured together (only one device is 
required), it is unlikely that developing countries will ever adopt aortic backward wave 
measurements as part of routine risk prediction. However, more recently, several studies, 
including data from our own group (Bursztyn et al 2016) have demonstrated that aortic PP can 
be relatively accurately imputed from simple clinical measures that can be obtained at no 
additional cost (Benetos et al 2010, Bursztyn et al 2016). Although as highlighted in previous 
discussion aortic PP may add little to risk prediction beyond brachial BP, findings supported by 
these studies (Benetos et al 2010, Bursztyn et al 2016), both of these studies provided the 
evidence to show that aortic-to-brachial PP amplification, calculated from imputed aortic PP, 
considerably added to (rather than replacing) the ability of brachial PP to risk predict (Benetos et 
al 2010, Bursztyn et al 2016). As highlighted in chapter 1 (section 1.3.5), there are essentially 
two factors that determine variations in PP amplification and these are aortic stiffness and aortic 
backward wave pressures. This then raised the question as to what extent relationships 
between PP amplification and either end organ measures or cardiovascular outcomes are 
attributed to backward wave effects? If relations between PP amplification and cardiovascular 
damage are largely accounted for by backward wave effects, rather than increases in aortic 
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stiffness, then a simple and costless approach to assessing backward wave effects (imputing 
aortic PP and calculating PP amplification) would be available. 
 
6.7 To what extent are relations between PP amplification and end-organ measures 
accounted for by aortic reflected wave effects? 
 
 As part of the present thesis I addressed the question as to what extent relationships 
between PP amplification and end organ measures are attributed to backward wave effects. 
These data are described in chapter 5 and have been accepted for publication in the J Am Soc 
Hypertens (Sibiya et al 2017 in-press). In this study I showed in a community-based sample of 
largely young-to-middle-aged participants of African ancestry that the reciprocal of PP 
amplification was independently associated with and added to the ability of brachial BP to 
associate with LVMI and LV hypertrophy (LVH). This was noted even when aortic PP, although 
showing independent relations with LVMI and LVH replaced rather than added to brachial BP in 
associations with LVMI and LVH. The brachial BP-independent relations between the reciprocal 
of PP amplification and LVMI or LVH were abolished with adjustments for the reflected 
(backward) wave pressure, but not aortic PWV, suggesting that variations in wave reflection 
largely account for the ability of PP amplification to associate with LVMI and LVH beyond 
brachial BP in this community sample. 
  There are several aspects of the design of this study that warrant further comment. In 
this regard, the only end-organ assessment that I studied in this chapter was LVMI, whilst 
several other end-organ measures were at this time, available. However, in the present 
community sample aortic PWV was noted to independently associate with LVMI (in women) and 
estimated glomerular filtration rate (eGFR) (in men and women), but not carotid intima-media 
thickness or LV diastolic function (Peterson et al 2016). Hence, there was no value in assessing 
whether relations between PP amplification and carotid intima-media thickness or LV diastolic 
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function are attributed to PWV. Moreover, as demonstrated in chapter 4, relations between 
aortic backward wave pressures and eGFR were not independent of age, and hence there was 
no value in assessing the contribution of aortic backward waves to independent relations 
between PP amplification and eGFR. Nevertheless, it is important to note that in-keeping with 
results with LVMI, without adjustments for age (which is the main determinant of PP 
amplification and backward wave pressures), PP amplification was associated with carotid 
intima-media thickness, LV diastolic function, and eGFR, and that adjustments for backward, 
but not forward wave pressures or PWV markedly attenuated these relations (data not shown).  
 The obvious clinical implication of the findings of chapter 5 are that PP amplification may 
be a surrogate of aortic backward wave effects on cardiovascular end-organ measures. If these 
results are confirmed in outcome-based studies, these data provide a cost-effective approach 
(calculating PP amplification from brachial PP and imputed aortic PP derived from simple 
clinical measures) to estimating the adverse effects of aortic backward waves and hence risk 
predicting using this approach. 
 
6.8 Limitations 
 
The limitations of the present thesis have largely been addressed in the discussion to 
each data chapter or stated in preceding discussion in the present chapter and hence will not be 
reiterated. 
 
6.9 Conclusions 
 
 In conclusion, the present thesis has demonstrated that although both aortic forward and 
backward waves associate with end-organ measures independent of steady-state pressures 
(mean arterial pressure), aortic backward, but not forward waves account for the brachial PP or 
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SBP-independent relations between aortic PP and end organ measures (chapter 4 and 
published as Sibiya et al 2015). Moreover, the present thesis indicates that the independent 
relations between aortic backward wave pressures and end-organ measures are poorly indexed 
by aortic augmented pressure or augmentation index (chapters 2 and 3 and published as Sibiya 
et al 2014 and Booysen et al 2015). Furthermore, the present thesis suggests that the use of 
aortic augmented pressure or augmentation index as indexes of the adverse effects of aortic 
backward wave function on end-organ measures is particularly inappropriate in women (chapter 
2 and published as Sibiya et al, 2014). In addition, the present thesis shows that the reciprocal 
of PP amplification is independently associated with and added to the ability of brachial BP to 
associate with end-organ measures and that this was noted even when aortic PP, although 
showing independent relations with end-organ measures replaced rather than added to brachial 
BP in associations with end organ measures (chapter 5 and in-press as Sibiya et al 2017). 
Importantly, the brachial BP-independent relation between the reciprocal of PP amplification and 
end-organs was abolished with adjustments for the reflected (backward) wave pressure, but not 
aortic PWV, suggesting that variations in wave reflection largely account for the ability of PP 
amplification to associate with end-organs beyond brachial BP (chapter 5 and in-press as Sibiya 
et al 2017). These findings taken together and if reproduced in longitudinal or intervention 
studies with hard outcomes as the end point, suggest that in groups of African ancestry in South 
Africa, aortic backward wave function may enhance risk prediction beyond brachial BP; that 
simple approaches to detecting backward wave effects, such as the use of augmented pressure 
or augmentation index, are inappropriate for routine use; but that the use of the reciprocal of PP 
amplification, which can be imputed from simple and costless clinical measurements, may be 
employed as a surrogate of aortic backward wave effects to add to brachial BP when risk 
predicting. 
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